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ABSTRACT 
Introduction. Osteoporosis is a chronic disease characterized by the loss of bone mass and the 
deterioration of bone micro-architecture leading to a subsequent increase in fracture risk. High-
resolution peripheral quantitative computed tomography (HR-pQCT) provides non-invasive 
measures of bone micro-architecture and strength in live humans but its ability to monitor small 
skeletal changes is yet poorly understood. The objectives of this thesis were to 1) determine HR-
pQCT precision for volumetric density, geometry, cortical and trabecular micro-architecture, as 
well as estimates of bone strength; 2) determine the monitoring time interval (MTI) and least 
significant change (LSC) metrics; and 3) to characterize annual changes in bone area, density, 
and micro-architecture at the distal radius and tibia using HR-pQCT in postmenopausal women. 
Methods. To determine precision error as well as monitoring and change metrics of the distal 
radius and tibia, 34 postmenopausal women (mean age 74, SD±7 years) from the Saskatoon 
cohort of the Canadian Multicentre Osteoporosis Study (CaMos) were measured using HR-
pQCT. To characterize the annual change in bone outcomes of this same cohort, 51 women 
(mean age±SD: 77±7 years) were measuring at baseline and again 1 year later. Precision errors 
were calculated as coefficient of variation (CV% and CV%RMS). The LSC was determined from 
precision errors and then divided by the median annual percent changes to define MTIs for bone 
area, density, and micro-architecture. Repeated measures analysis of variance (ANOVA) with 
Bonferroni adjustment for multiple comparisons were used to characterize the mean annual 
change in total density, cortical perimeter, trabecular and cortical bone area, density, content, and 
micro-architecture. Significant changes were accepted at P<0.05. 
 iii 
Results and Discussion. HR-pQCT precision errors were <10% for bone densitometric, 
geometric, and mechanical properties; while precision errors were <16% for cortical and 
trabecular micro-architectural outcomes. Further, the use of either automatic or modified contour 
methods for the dual-threshold technique for cortical micro-architectural analysis provided 
similar precision. Densitometric and geometric outcomes had longer monitoring times (>3 
years), while micro-architecture had monitoring times of ~2 years. The observed annual changes 
were statistically significant for several outcomes; however, only cortical and trabecular area, as 
well as cortical density at the distal tibia changed beyond the LSC. Overall, thesis findings will 
assist design and interpretation of prospective HR-pQCT studies in postmenopausal women. 
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Where: 
MAT - Mid-axis transformation between trabecular bone ridges (sphere)  
DT - Distance transform between trabecular bone ridges (sphere diameter) 
p - Distances between the ridges, expressed as an average over all inter-ridge 
voxels 
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TbN - Trabecular number 
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1 INTRODUCTION 
1.1 Overview 
Osteoporosis is a chronic disease characterized by the loss of bone mass and the deterioration of 
bone micro-architecture which results in an increase in fracture risk
[15]
. Osteoporosis is 
colloquially referred to as the "silent disease" or the "silent thief" because bone loss occurs 
gradually over many years and presents no obvious signs or symptoms until fracture occurs
[16,17]
. 
Osteoporosis and related fractures occur at multiple skeletal sites; the most common fracture site, 
however, is at the distal forearm and wrist
[18]
. 
 Bone strength is the ability to resist fracture when the bone is subjected to an applied 
load. Bone mineral content (BMC, or bone mass) and areal bone mineral density (aBMD) are 
important factors for bone stiffness
[19,20]
, and are clinically monitored to estimate bone strength 
as well as diagnose osteoporosis
[21]
. However, the exclusive use of these measures does not 
predict osteoporotic fracture risk
[19,20,22]
, as evidenced by more than half of the women who 
suffer an osteoporotic fracture being diagnosed with osteopenia, not osteoporosis
[21,23,24]
. This 
indicates that other factors influence bone strength independent of bone mass and density, such 
as: bone size/geometry and micro-architecture
[25,26]
, bone material properties
[20,26,27]
, as well as 
other risk factors such as: age, sex, medication, and falls
[28]
. To date, much of our understanding 
of bone micro-architecture and strength in the elderly has come from cadaveric specimens and 
cross-sectional evidence
[29-35]
, making it impossible to determine how bone micro-architecture 
and strength change over time. Further, dual-energy x-ray absorptiometry (DXA)—the currently 
used clinical tool for monitoring bone strength and diagnosing osteoporosis—is neither capable 
of measuring bone micro-architecture
[36]
 nor can it predict fractures on an individual basis
[37]
. 
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 There is a need for a clinical tool to non-invasively assess and monitor age-related 
changes in bone micro-architecture and strength in living people (i.e., in vivo). Various studies 
have indicated that the micro-architecture of the outer cortical and inner trabecular bone tissues 
are important for bone strength (determined by finite element (FE) modeling), and that these 
tissues are compromised in fracture cases compared to non-fracture controls
[29,38-44]
. However, 
there is a lack of prospective information pertaining to how the micro-architecture of these 
tissues change with age and how this affects bone strength. In order to separately measure 
cortical and trabecular bone micro-architecture, 3-dimensional (3D) imaging tools with high 
resolution are required. High resolution peripheral quantitative computed tomography (HR-
pQCT) is an x-ray based 3-dimensional (3D) imaging modality that provides high resolution (82 
µm, isotropic) for in vivo measures of bone density, geometry, and micro-architecture at the 
periphery of the human skeleton (distal radius and distal tibia)
[13,45]
. 
 Beyond density, geometry and micro-architectural outcomes, HR-pQCT can provide 
estimates of bone strength through the use of FE modeling. FE modeling is an engineering-based 
computational technique that simulates mechanical testing to failure and evaluates how the 
structure behaves when subjected to the loads
[11]
. Direct mechanical testing of bone to failure is 
the gold standard to determine bone strength; however, the destructive nature of this technique 
renders it unacceptable for use in vivo. Therefore, FE modeling is the best known tool to non-
invasively estimate bone strength in vivo. The use of the integrated FE modeling with HR-pQCT 
images could help explain the role of bone micro-architecture in determining bone strength and 
define how these outcomes change with age.  
 There is presently a lack of information for monitoring micro-architecture and strength in 
elderly individuals. High precision (low precision error) is essential to reliably monitor small 
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bone changes over time, changes due to drug therapy or intervention, and to compare minute 
differences between groups of people
[9,12]
. Precision information can be used to plan prospective 
and longitudinal studies and facilitate the interpretation of the longitudinal results
[9,12]
. Once 
precision is estimated it can be used in conjunction with a selected level of statistical confidence 
to determine the least significant change (LSC) and the monitoring time interval (MTI)
[9]
. The 
MTI is important in order to determine the length of time required between measures to have 
skeletal change. Further, the LSC will help establish whether skeletal change was captured 
beyond the precision error of the scanner
[12]
. To date, there is no evidence-based MTIs available 
for HR-pQCT and the reported LSC relies on long term measures of precision estimates
[46]
, 
which incorporates both precision error and skeletal change and should be interpreted with 
caution
[12]
. 
 The overall goal of this thesis was to investigate HR-pQCT precision for all outcomes, 
establish the least significant change (LSC) and monitoring time interval (MTI) as tools to 
determine if true change in bone outcomes has occurred, and use prospective data to characterize 
changes in bone density, geometry, and micro-architecture in postmenopausal women using HR-
pQCT. 
 
1.2 Anatomy and Physiology of Long Bones 
Generally, the adult human has 206 bones of various shapes and sizes in the axial and 
appendicular skeleton
[47]
. There are 5 categories for bone shapes: long bones (e.g., radius, tibia), 
short bones (e.g., carpals), flat bones (e.g., mandible), irregular bones (e.g., vertebrae), and 
sesamoid bones (e.g., pisiform)
[47]
. Of particular interest to this dissertation are the long bones of 
the appendicular skeleton—particularly the radius and tibia. 
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1.2.1 Long Bone Anatomy 
1.2.1.1 Gross Anatomy 
Long bones are divided into 3 regions: epiphysis, metaphysis, and diaphysis
[47]
. The epiphyses 
are situated at the distal and proximal regions of all long bones and form the subchondral bony 
regions of joints
[47]
 (Figure 1.1). Each epiphysis transitions into a flute-shaped metaphyseal 
region (or metaphysis; Figure 1.1)
[47]—the location of osteoporosis-related fractures of the distal 
forearm and wrist
[18,48]
. The epiphysis and metaphysis originate from two independent 
ossification centers and are consequently separated by a developmental zone called the growth 
plate—which fuses during late adolescence and early adulthood[47]. The middle division of long 
bones is a pipe-like region called the diaphysis
[47]
 (Figure 1.1). The metaphyseal and epiphyseal 
regions are primarily comprised of trabecular (or cancellous, spongy) bone, surrounded by a thin 
layer of cortical (or dense, compact) bone—called the thin cortical shell. The diaphysis, 
however, is typically made of thick cortical bone.  
 Macroscopically, cortical bone appears to be a solid tissue (hence it is synonymously 
termed dense or compact bone), comprising approximately 80% of the skeleton
[47,49,50]
 (Figures 
1.1-1.3). Younger individuals and males have been shown to have thicker cortices at all sites and 
cortical thickness has been reported to decline with age and disease status (e.g., osteoporosis)
[29]
. 
For instance, the cortex at the distal radius metaphysis of young adult women (mean age: 34 
years) has been reported to be approximately 1.0 mm thick, while in postmenopausal women 
(mean age: 69 years) cortical thickness was reported to be as thin as 0.5 mm
[29]
 (Figure 1.2). This 
age-related decrease in cortical thickness has been attributed to increased voids within the cortex 
(cortical pores), particularly along the cortical-trabecular junction—called the endocortex[51,52] 
(Figures 1.1 and Figure 1.2). The diaphyseal regions of long bones do not escape this age-related 
decline in cortical thickness. At the 30% site of the radial shaft, cortical thickness has been 
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shown to be 3.5 mm in young adults (mean age: 28 years)
[53]
, and 1.9 mm in aged radii (mean 
age: 78 years)
[54]
 (Figure 1.7). Just as cortical thickness varies along the longitudinal axis of the 
bone, research has also illustrated that the thickness of the cortex is not uniform around the bone 
cross-section. For instance, the cortices of the distal radius and tibia tend to be thicker on the 
anterior and posterior surfaces, although thinner on the medial and lateral surfaces at distal bone 
sites
[55]
. 
 Trabecular bone is noticeably different from cortical bone—macroscopically spongy in 
appearance. In trabecular bone, there are large spaces between the bony lattice-like network of 
horizontally and vertically oriented plates and rods that comprise approximately 20% of the 
skeleton
[47,50]
 (Figure 1.1 and Figure 1.2). Trabecular bone is found primarily at long bone 
epiphyses and metaphyses, as well as within vertebral bodies
[47,50]
 (Figure 1.1 and Figure 1.2). 
Spaces within the trabeculae (trabecular pores) are filled with bone marrow, which is continuous 
with the medullary cavity of long bone diaphyses
[56]
. The thickness of the trabeculae (i.e., plates 
and rods) have been reported to be, on average, 50-150 µm thick in young adults (age range: 20-
35 years)
[57,58]
 (Figure 1.2). In postmenopausal women with osteoporosis, however, trabeculae 
can be as thin as 20 µm
[32]
 (Figure 1.2). With increased age, cross-sectional cadaveric research 
suggests that trabecular erosion occurs, which explains the thinning trabeculae
[59]
 (Figure 1.2 and 
Figure 1.6). Further, trabecular erosion can progress into the perforation of plates and rods 
resulting in a loss in trabecular number
[59]
 (Figure 1.2 and Figure 1.6). 
 
  
Figure 1.1. Anatomy of long bones. Left: Distal and proximal bone locations illustrating the 3 regional divisions: epiphysis (E), 
metaphysis (M), and diaphysis (D). Middle: Enlarged distal radius highlighting the 2 bone tissues and 3 bone surfaces: outer 
periosteum, inner endosteum, and cortical-trabecular divisional endocortex. Far Right, Top: Enlarged cortical region illustrating the 
outer periosteum (with anchoring Sharpey's fibers), cortical bone osteons (with neurovascular supply), longitudinal Haversian canals 
and transverse Volkmann canals. Far Right, Bottom: Exploded section of the distal radius metaphysis showing the outer, cortical 
(pink) and inner, trabecular (green) bone tissues. [Modified from: Martini et al (2012)
[47]
, Mueller et al (2009). Bone
[33]
]. 
6
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Figure 1.2. Cortical and trabecular micro-architecture. Top: Section through a young distal 
radius. Illustrating dense cortical (green) and trabecular (red) bone mass. Trabeculae are 
numerous and thick (right insert), while cortical pores are small and evenly distributed through 
the cortex (left inserts). Bottom: Section through an osteoporotic distal radius, illustrating low 
cortical (green) and trabecular (red) bone mass. Trabecular micro-architecture have thin plates 
and rods with large separations (right insert), while cortical pores are large and irregularly 
shaped (left inserts). [Modified from: Zebaze et al (2010). Lancet
[51]
 and Guesens et al (2014). 
Nature Reviews: Rheumatology
[60]
]. 
 
1.2.1.2 Bone Histology 
At the tissue level, bone exists in two distinct forms: woven bone and lamellar bone
[56]
. Woven 
bone is disorganized bone found in fetus' and in the callus produced during the reparation of 
injury or fracture
[56,61]
. Lamellar bone replaces woven bone and is organized in concentric rings 
of tissue called lamellae
[56,62]
. Lamellar bone can be further divided into primary and secondary 
bone. Secondary lamellar bone is developed through a process called remodeling—formed by 
the replacement of existing primary bone
[63]
. Of interest to this thesis is the mature secondary 
lamellar bone which can be subdivided into cortical and trabecular (cancellous) tissues. 
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 Cortical bone consists of numerous densely arranged osteons (~280 µm) (Figures 1.1-
1.3). Cancellous bone, however, does not contain true osteons—instead they consists of 
trabeculae, which are concentric lamellae arranged into plates and rods (Figures 1.3) and hemi-
osteons
[64]
. At the center of every osteon is a longitudinally oriented central or Haversian canal—
characteristic of the Haversian system or secondary osteon—that distributes neurovascular 
structures throughout the cortex
[50,56,65]
 (Figure 1.1 and Figure 1.3). The neurovascular supply is 
also distributed throughout the cortex via transversely oriented Volkmann canals
[65]
 (Figure 1.1 
and Figure 1.3). Radiating outward from the central Haversian canal of every osteon are 
numerous concentric lamellar rings
[50,56]
. The lamellar rings are perforated with small holes 
called lacunae
[47,49,50]
 (Figure 1.3). Within the lacunae there may be active osteocytes (mature 
bone cells; see next section on Bone Physiology). Interconnecting each lacuna are tiny channels 
called canaliculi which allow for cellular communication between osteocytes within the bone and 
to bone lining cells which line the periosteum and endosteum
[49]
 (Figure 1.3). 
 Cortical and trabecular tissues are not naked—their surfaces are enveloped in protective 
and cytogenic membranes. All bones have 3 bone surfaces: outer periosteum, inner endosteum, 
and a distal cortical-trabecular divisional endocortex (Figure 1.1)―in the shaft of long bones, the 
endocortex and endosteum can be used synonymously. The outer surface of bone is encased in a 
double layered membrane called the periosteum
[47,49]
 (Figure 1.1 and Figure 1.3). The outer layer 
of the periosteum is a fibrous layer composed of dense connective tissue, which contains blood 
vessels (to nourish the bone) and nerve endings (sp. nocioceptors)
[47]
. The outer fibrous layer of 
the periosteum is anchored to the bone by collagenous fibers (called Sharpey's fibers) that 
penetrate into the cortex and provide support for musculotendinous insertions
[47,49]
 (Figure 1.1 
and 1.3). The inner layer of the periosteum, however, is an osteogenic cellular layer that contains 
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chondroblastic and osteoblastic progenitor cells
[47,50]
. Immediately beneath the periosteum and 
inside the endocortex are the outer and inner circumferential lamellae, respectively—parallel 
lamellar rings that follow the perimeter of long bones—developed from these osteogenic cellular 
membranes of the inner periosteum and the endosteum
[47]
 (Figure 1.3). 
 Distally dividing the cortical and trabecular bone tissues is the endocortical surface 
(endocortex) (Figure 1.1). The endocortex is a transitional zone having intermediate geometrical 
and topological attributes between the cortex and trabecular tissues
[66]
. Identifying the 
endocortex from trabecular bone is challenging, especially when the cortex has large, irregularly 
shaped pores and is highly trabecularized. 
 The inner surface of long bone is lined by a thin, membranous sheath called the 
endosteum
[47,50]
 (Figure 1.1). The endosteum is in direct contact with the medullary cavity and 
bone marrow
[47]
, and the membrane is lined with bone lining cells
[50,56]
. The endosteum and the 
bone marrow are primarily supplied with blood from the vessels traversing the nutrient 
foramina
[50]
 (Figure 1.1). While we have a distinct description of the endosteum, it is difficult to 
differentiate trabeculae from the bone marrow at distal bone regions. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3. Cortical and trabecular bone histology. Central: Illustration of the outer periosteum, middle cortical and inner trabecular 
bone tissues. Bone tissues have numerous osteons with concentric lamellar rings (Haversian system). Within the Haversian system are 
lacunae filled with an osteocyte and outwardly directed canaliculi (illustrated in right (cortical) and left (trabecular) insets). Left: 
Illustration of concentric lamellae comprising trabecular plates and rods. [Modified from: http://higheredbcs.wiley.com, retrieved 01-
MAY-2015] 
1
0
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1.2.2 Material Properties of Bone Strength 
In order for human long bones to function properly they must be strong, stiff and yet flexible 
(tough)—able to resist deformation and fracture (to make locomotion possible) and yet able to 
bend (in order to absorb energy associated with loading and movement)
[67]
. Accomplishing these 
contradictory roles is a function of bone's size, structure, and material properties. Bone material 
properties include: mineral composition (mainly inorganic hydroxyapatite (HA), 
Ca10(PO4)6(OH)2), type I collagen and water (organic), as well as the number, size, and location 
of any (micro)damage
[26,56,68-70]
. 
 Bone strength and bone stiffness are often used synonymously as being the amount of 
force or stress
1
 that can be applied to the bone, resulting in fracture
[67,68]
. Bone stiffness is 
determined by the mineralization of the matrix
[67]
; specifically, the concentration of inorganic 
hydroxyapatite (HA) crystals saturated within the collagen matrix
[26]
. Stiffness is defined as the 
mechanical behavior of the bone structure
[11,62]
. At the tissue level, stiffness is referred to as the 
modulus of elasticity (elastic modulus or Young's modulus)
[11,62]
. Mathematically, stiffness is the 
ratio of the stress (σ)1 to strain (ɛ)2 within the linear-elastic region of the loading phase (the slope 
of the linear region of the stress-strain curve)
[11,62]
 (Figure 1.4). The mineralization of the bone 
matrix will increase bone stiffness and, theoretically, strength; however, it will also make the 
tissue brittle, reducing the energy to fracture
[26,70]
 (Figure 1.4). Aged bone is more mineralized 
compared to young bone, resulting in an age-related decline in bone flexibility and a 
simultaneous increase in bone brittleness
[70-72]
; making bone easier to fracture
[62]
. 
 Bone flexibility (ductility or toughness) is a function of the collagen component of bone 
and defines the required energy to cause a fracture
[26,73]
. Mathematically, bone toughness is 
                                                 
1
 Stress (σ) is the force per unit area of the structure that the force is applied (i.e., Force [N]/Area [m2])[10]. 
2
 Strain (ɛ) is the ratio of the change in length to the original length of the object ([original length - deformed 
length]/original length)
[10]
. 
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determined by the area under the stress-strain curve
[68]
 (Figure 1.4). A tough bone is one where 
strain increases faster than stress does
[74]
. Increasing levels of collagen (or decreasing levels of 
bone mineralization) will allow the bone to undergo more deformation; that is, the bone will 
absorb more strain energy prior to fracture (i.e., bone is less stiff or more flexible)
[26,73]
 (Figure 
1.4). While not contributing a significant proportion to bone stiffness in the linear-elastic region, 
the collagen matrix has been proposed to have a greater role in the post-yield properties of bone 
tissue (non-linear plastic region) by minimizing the accumulation of microdamage and inhibiting 
the growth of already initiated microcracks
[26,70]
. Type I collagen fibers comprise 85-90% of the 
protein in bone
[56]
; however, bone's collagen content decreases with age, consequently increasing 
the mineralization of the bone, which in turn facilitates microcrack initiation and accumulation, 
resulting in fracture with less plastic deformation
[70,75,76]
. 
 Within the linear-elastic region of the stress-strain curve, load applied to bone will 
deform the bone allowing the bone to return to its original shape and size once the load is 
removed, according to Hooke's Law
[11,62,67,68]
. The collagen within the bone will facilitate this 
reversible deformation, allowing for the absorption of the loading energy (i.e., toughness)
[67,68]
. 
However, if the applied load exceeds the bone's ability to elastically deform (i.e., yield failure), 
the bone will undergo plastic deformation—permanently changing the shape of the bone (non-
linear plastic region)
[11,62,67,68]
 (Figure 1.4). The permanent change in the shape of bone is 
associated with the development of microdamage; the function of which is to allow for the 
release of energy and prevent fracture or ultimate failure
[26,67]
. However, if the applied load is 
enough to exceed both the linear-elastic and non-linear plastic regions, the bone will completely 
fracture (ultimate failure or failure load; Figure 1.4)
[11,62,67,68]
. 
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Figure 1.4. Graphical illustration of the stress-strain (tissue level) or load-deformation (structure 
level) curve. a) Slope of the line in the linear-elastic region indicates bone stiffness where 
loading does not permanently deform the bone. The non-linear plastic region follows yield 
failure (green circle), where the bone undergoes permanent deformation under load. Continued 
application of load exceeding plastic deformation results in fracture (failure load; purple circle). 
b) Graphical illustration of differences among brittle, normal, and tough bone. Bone toughness is 
defined as the area-under-the-curve. Notice: the non-linear plastic region (or post-yield strain) 
decreases as bone becomes more brittle, indicating that brittle bone absorbs less energy prior to 
fracture. 
 
1.2.3 Forces and Osteoporotic Fracture 
Forces acting on long bones come from all directions and the skeletal system must adapt to these 
loads in order to resist fracture. The composite nature of bone allows it to withstand compressive 
and tensile loads, as well as bending and torsion moments
[62]—if the bone or region is adapted to 
these mechanical environments
[74,77]
. For instance, osteoporotic fragility fractures most 
commonly occur at the distal radius
[18,48]
. Fractures at long bone metaphyseal regions occur more 
readily than at the diaphyseal regions because the bone metaphyses are mainly adapted to 
compression about the longitudinal axis of the bone
[74,77]
. Long bone metaphyses adapt to 
compression because the adjacent joint (wrist) protects the metaphysis from large shearing, 
bending, and torsional loads
[74,77]
. This is unlike long bone (radius) diaphyses, which are 
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repeatedly loaded in, and thereby adapted to, compression, bending, and torsional loads from the 
muscles
[74,77]
. However, when a fall occurs, the combined bending, shearing, and torsional loads 
from impact are more likely to create a fracture in the metaphysis of the impacting limb because 
it is the region that is least adapted to these loading environments
[74,77]
. 
1.2.4 Bone Physiology 
The word "skeleton" comes from the Greek word "skeletos" which means "dried up" suggesting 
that bone is an inanimate object
[78]
; however, the skeleton is anatomically complex as well as 
physiologically dynamic. Being a dynamic tissue, bone continually adapts to its internal and 
external environment in order to produce a structure that is capable of supporting the functional 
needs of the body―processes known as modeling and remodeling[47,79-81]. There are 3 cells 
within the basic multi-cellular unit (BMU) that are imperative in orchestrating the remodeling 
process: osteoblasts (mononucleate bone forming cells), osteoclasts (multinucleate bone 
resorbing cells), and osteocytes (mature bone cells responsible for intercellular communication 
and mechanosensation)
[81,82]
 (Figure 1.5).  
1.2.4.1 Bone Modeling 
Bone's ability to maintain its shape and adapt its geometry and material properties to meet 
mechanical demands is a function of modeling and is indicative of the strong influence that 
applied external forces have on bone
[79-81]
. Bone modeling is a process where bone formation is 
not preceded by bone resorption and bone shifts its position in space
[47,49,83,84]
. Bone modeling 
occurs during development of the skeleton as well as in adult life; however, in adulthood 
modeling occurs less frequently
[49]
. During this process, the BMU will respond to mechanical 
loading by adding material to the periosteal surface (periosteum) and resorbing material from the 
endosteal surface (endosteum); thereby increasing the medullary cavity, maintaining cortical 
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thickness, and increasing bone's resistance to bending
[59,79-81,85]
. Overall, once the ground matrix 
is laid down, bone forming cells begin the mineralization process. The matrix becomes 
mineralized through the deposition of HA crystals. 
1.2.4.2 Bone Remodeling 
Bone remodeling is a phenomenon that involves the removal of bone followed by the deposition 
of new bone (i.e., bone reconstruction)
[84]
. This phenomenon occurs in 5 phases: activation, 
resorption, reversal, formation, and resting
[49,82]
. The first phase of remodeling involves the 
activation of the BMU. This signal can take several forms varying from direct mechanical strain 
to hormonal signals (e.g., parathyroid hormone, PTH)
[49]
. During the resorption phase, the 
osteoclasts remove bone using an acid secretion to dissolve the inorganic mineral and lysosomal 
enzymes to digest the organic matrix, thereby creating an erosion cavity in the bone
[49]
 (Figure 
1.5). This step takes approximately 2-4 weeks to complete
[49,82]
. The second step, reversal, is 
where the osteoclasts are finished resorbing the bone and undergo apoptosis (programmed 
cellular death). Following osteoclast apoptosis, osteoblasts begin synthesizing bone matrix to fill 
in the erosion cavity with new bone—the formation phase[49,82] (Figure 1.5). During the bone 
formation process, some osteoblasts are trapped in the ground matrix and become osteocytes, 
others differentiate into flattened bone lining cells that cover the bone surfaces
[49]
. The formation 
phase takes approximately 2-4 months to complete
[49,82]
. The final phase is a resting period that 
will continue until a new remodeling cycle begins (Figure 1.5). One remodeling cycle takes 
approximately 6 months to complete
[49,65,82]
. 
 The 5 phases of remodeling are equivalent regardless of location, however, the 
phenotypic characteristics are tissue-dependent
[82]
. In trabecular bone, bone remodeling occurs 
directly on the bone surface creating saucer-shaped erosion cavities called Howship's lacunae or 
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hemi-osteons that are subsequently filled in
[49,64,82]
 (Figure 1.5). In cortical bone, however, 
resorption proceeds headed by a cutting cone filled with osteoclasts that actively dissolve cortical 
bone matrix
[65,86]
 (Figure 1.5). Immediately following the cutting cone is the closing cone which 
is filled with osteoblasts that are depositing bone matrix—thereby closing the resorption cavity 
and creating a new secondary osteon
[65,86]
 (Figure 1.5).  
Figure 1.5. Illustration of the remodeling process. Note that the same process occurs differently 
in the cortical bone (left) and trabecular bone (right). Left: Cortical bone basic multi-cellular unit 
(BMU) showing the cutting cone through the bone's Haversian canal (red arrow indicates 
direction of cone movement). Right: Trabecular bone BMU showing the osteoclasts (OC; purple) 
and osteoblasts (OB; blue) resorbing and adding bone, respectively, to the trabecular surface. 
[Modified from: www.Medscape.org, retrieved on 14-APR-2015]. 
 
1.2.4.3 Bone Remodeling in Aging and Osteoporosis 
Remodeling turns over internal bone and is required to replace dead or damaged bone tissue and 
gives bone the ability to adapt to different loading conditions and to respond to metabolic 
changes
[56,86,87]
. As described above, modeling facilitates changes of bone in space (i.e., 
periosteal and endosteal expansion increasing bone bending strength). At the completion of 
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growth, however, periosteal apposition slows and bone damage will be removed without a 
change in bone's volume (i.e., maintenance)—that is, the coupling of the cells in the BMU are in 
balance
[68,81]
. However, when the activities of these cells are out of balance, skeletal pathologies 
result. For instance, around midlife women enter menopause
3
 where estrogen levels drastically 
drop, increasing osteoclast activity
[88,89]
. Ex vivo research suggests that the increased osteoclast 
activity (beyond osteoblast activity) leads to reduced bone mass, deteriorated micro-architecture, 
and compromised structural integrity; over time resulting in osteoporosis and, when a fall 
happens, fractures occur
[68,81]
. 
 The rate of BMU remodeling within the cortical and trabecular tissues depends, in part, 
on the exposed surface area. Traditionally it was believed that trabecular bone has a higher 
surface area facilitating higher BMU activity
[51]
. According to cross-sectional and cadaveric 
research, the increased osteoclast activity associated with old age will compromise trabecular 
micro-architecture through the thinning and loss of trabeculae leading to fractures in bone 
containing large amounts of trabeculae (i.e., distal ends of long bones and vertebrae)
[51]
 (Figure 
1.2 and Figure 1.6). Mechanically, bone is 2-5 times weaker when the trabecular number is 
reduced compared to when the trabeculae are thinned; this is because the trabecular plates and 
rods are present, yet thinned, and able to continue supporting the cortex during loading
[59,67,68,90]
 
(Figure 1.6). Cortical bone, however, has many Haversian and Volkmann canals, the lining of 
which provides a surface for BMU activity
[51]
. Considering cortical bone comprises the majority 
of the skeleton (i.e., ~80%), it has a larger absolute surface area for bone remodeling compared 
to trabecular bone (Figure 1.2 and Figure 1.7). With age, BMUs acting on the cortical surface 
have been suggested to increased cortical porosity—a process commonly referred to as cortical 
                                                 
3
 Menopause is a natural event for women around age 50 years and is defined as a 12 month period where women no 
longer have a menstrual period and marks the end of ovulation and reproductive capability
[85]
. 
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trabecularization
[51,52,91]
. According to cadaveric research, higher cortical porosity is associated 
with decreased bone strength and toughness
[59,67]
 (Figure 1.7). These age-related changes to the 
bone remodeling process manifest in the deterioration of cortical and trabecular micro-
architecture leading to reduced bone strength with age (Figure 1.2, Figure 1.6 and Figure 1.7). 
These manifestations in the micro-architecture were captured using cross-sectional and cadaveric 
data. Prospectively monitoring natural postmenopausal changes in bone micro-architecture are 
needed in order to understand how bone strength changes with age and optimize fracture 
prevention techniques. 
 The factors underpinning bone strength are not completely understood and therefore 
fracture prediction and prevention is not fully achieved. As a result, current therapeutic 
techniques rely on the use of medication to slow the deterioration of bone micro-architecture 
elicited by the BMU. For instance, bisphosphonates have been reported as the most widely used 
treatment for osteoporosis and prevention of osteoporotic fracture by reducing osteoclast activity 
and minimizing bone remodeling
[92]
. Because estrogen deficiency plays an important role in the 
development of osteoporosis, another common therapy used in osteoporosis treatment and 
fracture prevention is hormone replacement therapy
[89,92]
. Both therapies have been reported to 
maintain or increase bone mineral density and reduce fracture risk with short term use
[92,93]
. 
However, there is limited information pertaining to how these therapies effect bone micro-
architecture. Research indicates that bisphosphonates are beneficial for preserving trabecular 
micro-architecture in vivo
[93,94]
; however, there is a lack of in vivo evidence characterizing the 
effects of hormone replacement therapy (i.e., estrogen) on micro-architectural changes in cortical 
and trabecular bone tissues. 
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Figure 1.6. Images from 
scanning electron 
microscopy illustrating 
trabecular bone a) thinning 
and b) perforation (leading 
to loss in trabecular 
number). The graph at the 
right c) illustrates the 
reduction in bone strength 
as a function of loss in 
trabecular thickness (25% 
reduction in strength) and 
trabecular number (60% 
reduction in strength). 
[Modified from Seeman 
(2013). J Gerontol A Biol 
Med Sci.
[59]
; Seeman 
(2008). JBMR
[67]
]. 
 
 
Figure 1.7. Top: Histomorphometric images of cortical bone sections from cadaveric bone shafts 
illustrating increased cortical porosity with age (age increases to the right). Bottom Left: Graph 
illustrating cortical porosity increases with age. Bottom Middle: Graph illustrating that ultimate 
stress (and therefore bone strength) decreases as a function of increased cortical porosity. Bottom 
Right: Graph illustrating that bone toughness decreases with increase cortical porosity. [Modified 
from Zebaze et al. (2010). The Lancet
[51]
; Seeman et al (2008).JBMR
[67]
]. 
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1.3 Osteoporosis and Related Fractures 
1.3.1 Epidemiology and Impact 
Osteoporosis and related fractures are global public health concerns that currently affect 200 
million people worldwide
[95]
 and are a major cause of mortality, morbidity, chronic pain, and 
loss of independence
[96]
. What is concerning is that the prevalence of osteoporosis and related 
fractures are projected to increase by approximately 50% by 2025, as a result of the aging 
population
[97]
. 
 Osteoporosis and related fracture incidence are detrimental to the individual and the 
health care system
[97]
. For instance, Budhia and colleagues (2012)
[98]
 reported that the medical 
costs, to the individual who sustained an osteoporotic fracture, ranged from 1.6 - 6.2 times higher 
than that of their non-fracture counterparts. Further, in 1995 the national health care costs related 
to osteoporotic fractures amounted to approximately $8.6 billion US
[98]
. In 2005, however, the 
medical cost of osteoporosis and related fractures had increased to between $13.7 - 20.3 billion 
US
[97]
. As a result of the aging population, it has been predicted that the prevalence of 
osteoporosis will increase from 10 million to more than 14 million people by 2020 in the United 
States alone, and will amount to more than $25.3 billion US in medical costs as a result of 
fragility fractures
[97]
. Therefore, further research into the factors underpinning bone strength is 
warranted in order to circumvent these projected figures from becoming a reality. 
1.3.2 Disease Characteristics 
Osteoporosis is a chronic and multifactorial bone disease typically diagnosed after the 
occurrence of a low-trauma fracture
[21]
. Morphologically, osteoporosis is characterized by the 
reduction of bone mass and the deterioration of cortical and trabecular bone micro-
architecture
[15]
 (Figure 1.2, Figure 1.6, Figure 1.7). Biomechanically, osteoporosis is identified 
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by altered bone mechanical properties―such as: brittle behaviour of bone, decreased bone 
toughness, low compressive fracture force
[99,100]
 (Figure 1.4, Figure 1.6 and Figure 1.7). 
Clinically, osteoporosis is diagnosed from bone mineral mass (bone mineral content, BMC) per 
unit area—a measure called areal bone mineral density (aBMD)[101]. BMC and aBMD are 
important factors in bone strength as identified by small increases corresponding to large 
increase in bone tissue stiffness
[19,20]
. For instance, a 10% increase in adult aBMD at the femoral 
neck can reduce the risk of a hip fracture by 50%
[22]
. However, the use of BMC and aBMD do 
not predict osteoporotic related fractures on an individual basis
[102,103]
. Incorporating estimates of 
bone geometry and micro-architecture may better predict fractures on an individual 
basis
[5,29,30,32,40,41,104-107]
. 
1.3.3 Assessment Techniques 
1.3.3.1 Dual-energy X-ray Absorptiometry (DXA) 
Presently, dual-energy x-ray absorptiometry (DXA) is the clinically recommended tool for 
diagnosing osteoporosis
[21]
. DXA acquires a 2D projection of BMC (g) in a defined area 
(cm
2
)
[101]
. Using DXA, osteoporosis has been operationally defined based on aBMD, where the 
average BMC of each pixel is divided by the projection area (g/cm
2
)
[21,101,108]
. According to the 
World Health Organization (WHO), osteoporosis is clinically defined as an aBMD that lies 2.5 
standard deviations or more below the average value for healthy 30 year old women (i.e., T-score 
of ≤-2.5 SD)[21]. DXA can perform measures on the whole body, however, aBMD measures at 
the femoral neck are used in the diagnosis of osteoporosis because they have been reported to be 
more strongly related to common osteoporotic fracture types
[96,103]
. 
 While DXA is considered the clinical tool for diagnosing osteoporosis, it significantly 
under predicts osteoporotic fractures at an individual level
[102,103]
. For instance, 20-60% of 
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individuals that have sustained an osteoporotic related fragility fracture have been pronounced 
osteopenic by DXA (i.e., T-score between -1.0 and -2.4 SD), and not osteoporotic
[21,23,24]
. It is 
evident that these fractures are not completely related to aBMD, and that the loss of bone 
strength is more likely the result of deteriorated bone micro-architecture
[25]
. Kazakia and 
colleagues (2011)
[25]
 reported that participants with identical DXA-derived aBMD at the distal 
radius had significant variations in their cortical and trabecular micro-architecture at the same 
site (Figure 1.8). Therefore, DXA's ability to measure areal bone properties and the inability to 
separately measure cortical and trabecular bone properties
[37,101,108]
 prevents DXA from acquiring 
any information of bone geometry and micro-architecture—biomechanically important 
properties of bone strength that are independent of aBMD
[5,29,30,32,40,41,104-107]
.  
Figure 1.8. HR-pQCT 
(XtremeCT) scans of the 
distal radius illustrating 
identical DXA derived 
aBMD and T-score values 
however variations in 
selected micro-architectural 
and biomechanical indices. 
[Modified from Kazakia et 
al (2011)
[25]
]. 
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1.3.3.2 Peripheral Quantitative Computed Tomography (pQCT) 
Advances in bone research have shifted the focus of bone strength beyond 2D measures of bone 
mass (as measured by DXA) to measure 3D bone density (volumetric BMD, vBMD), geometry 
and micro-architecture
[107,109]
. Recent developments in imaging technology have yielded high-
resolution peripheral quantitative computed tomography (HR-pQCT). HR-pQCT is a novel 3D 
imaging modality with an in vivo resolution of 82 µm, rendering this scanner capable of 
separately measuring cortical and trabecular bone vBMD, geometry, and bone micro-architecture 
in vivo in humans. Before the advent of HR-pQCT, measuring bone micro-architecture was 
accomplished by means of histomorphometry, either ex vivo or invasively in vivo using small 
bone biopsies of the iliac crest
[39,110]
.  
 Beyond density, geometry and micro-architectural outcomes, HR-pQCT can provide 
estimates of bone strength through the application of an engineering-based computational 
technique known as finite element (FE) modeling or FE analysis. Using structural and material 
components of bone (i.e., geometry, micro-architecture, tissue stiffness, etc.), FE modeling will 
simulate mechanical testing to failure, provide metrics of tissue stiffness and bone strength 
(ultimate failure load), as well as estimates of internal stress and strain distribution. While direct 
mechanical testing of bone to failure is the gold standard to determine bone strength, the 
destructive nature of this technique renders it is unacceptable for use in vivo. Therefore, FE 
modeling is the best known tool to non-invasively estimate bone strength in vivo.  
 There are numerous studies available validating different linear and non-linear FE models 
with HR-pQCT on long bones
[7,111-115]
. Linear FE models define the stress-strain relationship 
within the elastic region of bone—that is, the region prior to yield failure[11]. Non-linear FE 
models, however, define the stress-strain relationship within the plastic region of bone
[11]
. Aged 
bone is brittle relative to the more compliant young bone resulting in limited or no plastic region 
 24 
prior to ultimate failure
[100]
 (Figure 1.4). Therefore, a linear model may be sufficient for 
estimating failure load in an elderly population (linear FE models association to compressive 
failure testing: R
2
=0.66-0.95
[7,111,112,116]
). 
 Although HR-pQCT is an advanced in vivo technique for capturing 3D bone properties 
and strength estimates, it is limited to measuring the distal sites of the peripheral skeleton and is 
unable to measure the hip and vertebral column. However, the distal radius is an important site 
for scientific investigation because fragility fractures at the distal radius are a sentinel for future 
osteoporotic fracture at other sites
[117,118]
. Further, regarding density measures (the metric used to 
diagnose osteoporosis), research has reported that HR-pQCT derived density at the tibia are 
correlated with DXA-derived hip aBMD (r=0.51-0.70)
[106]—another weight bearing skeletal 
site―suggesting that HR-pQCT may be a competent imaging modality for density-based 
osteoporosis assessments. Importantly, HR-pQCT derived outcomes have been reported to 
outperform DXA-derived outcomes in discerning postmenopausal women with and without a 
fracture
[39,40,44]
 (Figure 1.9). These data suggest that HR-pQCT (combined with FE modeling) at 
the distal radius and tibia provide important insights into densitometric, geometric, and micro-
architectural factors underpinning bone strength and may be a new method for monitoring 
skeletal changes in postmenopausal women—a population most in need of monitoring. 
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Figure 1.9. HR-pQCT scans 
of the distal radius 
comparing participants with 
low-trauma forearm fracture 
to age-matched non-fracture 
controls regarding DXA-
derived aBMD at the ultra 
distal radius (UDR) and 
selected HR-pQCT measures 
of bone geometry, micro-
architecture, and 
biomechanical indices. 
[Modified from Nishiyama et 
al (2012)
[40]
]. 
 
 
 
 
 
 
1.3.4 Risk Factors for Osteoporosis and Related Fractures 
It is well established that age and sex play a significant role in the development of osteoporosis. 
Specifically, the risk of developing osteoporosis increases with age
[119,120]
 and women are more 
inclined to develop the disease relative to men
[119,121]
. Beyond age and sex, the development of 
osteoporosis is linked to genetics
[119,122]
, inadequate peak bone mass accrued during puberty and 
young adulthood
[119,121]
, poor lifestyle choices (physical inactivity, poor nutrition)
[27,120]
, 
hormonal status (e.g., amenorrhea, use of certain birth contraceptives)
[119,120]
, onset of 
menopause and resultant decline in estrogen
[119,120]
, as well as long term use of certain 
medications (e.g., cortisone)
[120,123]
. Osteoporosis itself is a manageable disease, however, if not 
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diagnosed and/or treated properly the compounded influence of other age-related conditions 
(e.g., sarcopenia, peripheral neuropathy, etc.) can increase the risk of osteoporotic fragility 
fractures
[120]
. Fragility fractures are a detrimental outcome of osteoporosis that typically result 
from a fall
[124]
. 
 It is well documented that falls are a problem for older adults and that the cause is 
multifactorial in nature
[125]
. Approximately 1-in-3 community dwelling individuals over the age 
of 65 years will succumb to at least one fall that results in physical injury (fracture, soft tissue 
damage, loss of physical function) and/or psychological damage (fear of falling, loss of 
independence)
[126-130]
. Forearm or wrist fractures are a common consequence of falls, especially 
in those individuals with low bone strength
[131]
. The most common scenario, and consequently 
the worst-case scenario, associated with osteoporotic fractures at the forearm or wrist is falling 
onto the hand of the outstretched forearm from low fall heights (e.g., standing height 
falls)
[132,133]
. Further, research has shown that previous fractures increase the risk for subsequent 
fractures at multiple skeletal sites
[134-136]
. Therefore, fall prevention is important to reduce 
fracture risk
[28,137-141]
. 
 
1.4 Evidence of Skeletal Change with Age 
It is important to understand how bone mass, geometry and micro-architecture change with 
increasing age as this could elucidate new and important causative mechanisms, as well as 
preventative and/or treatment options for osteoporosis. The majority of information regarding 
bone mass and density changes with age come from DXA-based studies. It is generally accepted 
that aBMD declines at a rate of 1-2% per year (depending on site) around menopause
[142,143]
. 
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Further, this accelerated rate of bone loss has been reported to continue for 5-10 years following 
menopause and gradually decline thereafter
[144]
.  
 Despite the plethora of DXA research available, certain aspects of bone loss in 
postmenopausal women remain unclear. For instance, DXA does not capture aspects of geometry 
or micro-architecture and thereby offers limited information regarding bone strength estimates. 
Peripheral QCT evidence has indicated an annual 0.5-2% decline in cortical and trabecular bone 
vBMD at both radius and tibia
[145-147]
. However, there is still limited evidence regarding changes 
in bone geometry, micro-architecture, and strength with age. HR-pQCT has been used to 
describe these age-related changes using cross-sectional data. Yet, characterizing change from 
cross-sectional studies introduces error resulting from genetic and environmental differences 
(e.g., nutrition status, health related habits, socioeconomic status, etc.). Longitudinal studies are 
required to determine how bone geometry, micro-architecture and strength change with age and 
to minimize the effect of these confounding errors. Specifically, longitudinal research using HR-
pQCT is necessary in order to establish how bone micro-architecture changes with age. 
1.4.1 Cross-sectional HR-pQCT Research 
1.4.1.1 Radius 
Various cross-sectional studies regarding age-related differences in bone properties at the distal 
radius report similar cross-study findings among women aged 20 to 99 years of age
[29,32,57]
. 
Specifically, these cross-sectional studies suggest lower total (23-36%)
[29,32]
, cortical (11-
24%)
[29,32,57]
, and trabecular (23%)
[29]
 bone mineral densities from 20 to 99 years. Further, this 
research described lower trabecular bone volume fraction (23-27%)
[29,32,57]
, which relates to 
lower trabecular number (13-21%)
[29,32,57]
 and trabecular thickness (2-18%)
[29,32,57]
, as well as the 
greater trabecular separation (27-34%)
[29,32,57]
 (Figure 1.10). There is also an age-related 
difference in cortical thickness (29-52%)
[29,32,57]
 in favor of young adults (Figure 1.10). Based on 
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these cross-sectional observations, it has been suggested that the thinning of the cortex is a result 
of elevated age-related cortical porosity (176%)
[32]
. This research also reports a 57% lower 
ultimate stress and a 46% lower age-related failure load from 20 to 99 years
[32]
. 
1.4.1.2 Tibia 
At the tibia, cross-sectional studies suggested lower total (25-37%)
[29,32]
, cortical (13-32%)
[29,32]
, 
and trabecular (19%)
[29]
 bone mineral densities from 20 to 99 years. Regarding trabecular micro-
architecture, research indicated lower trabecular bone volume fraction (18-19%)
[29,32]
, trabecular 
number (10-12%)
[29,32]
, and trabecular thickness (6-8%)
[29,32]
 in favor of young adults (Figure 
1.10). Further, trabecular separation (16-21%) was lower among women aged 20 to 99 years
[29,32]
 
(Figure 1.10). There was also an age-related difference in cortical micro-architecture, 
specifically, lower cortical thickness (24-28%)
[29,32]
 with an higher cortical porosity (259%)
[32]
. 
This research also indicates that there is a 49% lower ultimate stress and a 35% lower age-related 
failure load from 20 to 99 years
[32]
. 
Figure 1.10. 3D 
reconstructed images 
from HR-pQCT 
illustrating age-
related changes in 
bone density and 
micro-architecture at 
the distal radius (left) 
and tibia (right) 
based on cross-
sectional research 
across age (21-82 
years). [Modified 
from Boutroy et al 
(2005)
[29]
]. 
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 While this research provided unique information pertaining to the effect of the age-
related changes on bone micro-architecture, it begs the question of whether these same 
differences would be seen if the same cohorts were followed longitudinally. 
1.4.2 Longitudinal HR-pQCT Research 
Prospectively following a group of people over time is the only way to capture true changes in 
bone. However, these studies are costly and have a yearly participant attrition rate which makes 
it difficult to acquire unbiased longitudinal data
[148]
. To date, there is only one prospective study 
using HR-pQCT to investigate micro-architectural changes in peri-menopausal women not 
related to intervention effects
[14]
. However, the authors described this research as being 
'preliminary' as they measured 17 postmenopausal women (53±3 years) using a prototype HR-
pQCT scanner with an isotropic resolution of 165 µm
[14]
. Laib and colleagues (1998)
[14]
 
measured these women at baseline, 6 months and again 1 year later. They report an average 
annual decrease in trabecular density (-3.4%), trabecular number (-1.2%), and cortical thickness 
(-2.0%); they also report an average annual increase in trabecular separation (+1.2%)
[14]
. 
Authors concluded that the number of participants included in the study was too small to 
accurately judge the sensitivity of the HR-pQCT to measure the structural indices of the 
trabecular bone tissue. Therefore, there is a need to determine whether the annual changes are 
similar using the standard HR-pQCT scanner (isotropic resolution: 82 µm) and with a larger 
sample of postmenopausal women―the population most in need of bone micro-architectural 
monitoring. 
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1.5 Monitoring Skeletal Change 
1.5.1 Measurement Precision 
In its most general definition, precision is the ability of a measurement to be consistently 
reproduced under the same conditions. Additionally, the amount that the repeated measurements 
change is the precision error. Generally, changes in skeletal tissue can be detected with non-
invasive imaging techniques after 6 months—the average length of the bone remodeling 
cycle
[82]
. Therefore, precision (reproducibility) of an imaging technique is dependent on the time 
interval between repeated measurements, with short-term precision errors being generally 
smaller than long-term precision errors because true skeletal change can be expected to occur 
over longer periods of time (i.e., >6 months)
[9,12]
. Consequently, high precision (low precision 
error) is essential to reliably monitor small bone changes over time, changes due to drug therapy 
or intervention, and to compare minute differences between groups of people
[9,12]
.  
1.5.2 Precision Information in Research and Clinically 
What is real, meaningful change? Is change a statistically significant difference between follow-
up measurements, or is the measured difference a factor of the technique's measurement error? 
How do researchers and clinicians know if actual skeletal change has occurred and that this 
difference is beyond the (precision) error of the technique? For researchers and clinicians, it is 
important to know what magnitude of measured change is required to be sure the participant or 
patient has responded to intervention or treatment versus being non-responsive to either. Once 
precision is estimated it can be used in conjunction with a selected level of statistical confidence 
to determine the least significant change (LSC) and the monitoring time interval (MTI)—tools 
that will facilitate the answering of these questions. 
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1.5.2.1 Least Significant Change 
The International Society for Clinical Densitometry (ISCD) recommends estimating the LSC to 
determine if true skeletal change has occurred beyond precision error
[149]
. The LSC is determined 
in relation to measurement precision errors and a statistical confidence value
[9]
. LSC provides a 
percentage outcome that can be used with baseline measures to determine the magnitude 
difference required to have change in follow-up measures. Currently, the only available LSC 
data for HR-pQCT estimate LSC values using long-term precision from postmenopausal 
women
[46]
. These results need to be interpreted with caution because long-term precision 
determined using follow-up data 1 year from baseline incorporate both precision error and non-
linear skeletal changes into the precision estimate thereby obfuscating actual user precision and 
confounding the difference required between measures to have change
[12,150]
. 
1.5.2.2 Monitoring Time Interval 
Using the ratio of LSC and the median annual percent change provides the MTI—an estimate of 
the time (in years) required between baseline and follow-up measures that is necessary to capture 
change
[9,10,151]
. The use of MTIs are important when planning or developing longitudinal or 
follow-up studies because their use will allow follow-up measures to be performed within the 
optimal window for capturing true skeletal change, as well as minimizing patient radiation 
exposure and costs associated with repeated scanning in prospective studies. To date, there are 
no MTIs available for HR-pQCT outcomes. 
 
1.6 Summary 
1. Osteoporosis and related fractures manifest in older age—especially after menopause in 
women. There is evidence that bone mass/density, geometry, and micro-architecture are 
important for bone strength. However, the exact skeletal measures underpinning bone 
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strength are currently unknown; therefore, it remains unclear what measures should be 
monitored with aging. 
2. Menopause is associated with a rapid drop in estrogen. Cross-sectional evidence has 
indicated that low estrogen levels are associated with higher osteoclast activity, speeding 
the remodeling process, and exacerbating micro-architectural deterioration. 
Bisphosphonates and hormone replacement therapy (e.g., estrogen) have been shown to 
reduce remodeling and positively affect bone mass (BMC) and aBMD. Research 
indicates that bisphosphonates preserve trabecular micro-architecture, however, it 
remains unknown how hormone replacement therapy affects micro-architecture. 
3. Research indicates that bone mass and density are important outcomes to prevent 
osteoporosis and related fracture; however, the majority of osteoporotic fractures occur in 
women diagnosed with osteopenia. This indicates that other factors beyond bone mass 
and density are responsible for bone strength and thereby fracture prevention. There is 
evidence that suggests bone geometry and micro-architecture are vital for bone strength, 
independent of bone mass and density. High-resolution imaging techniques are required 
in order to capture information regarding bone micro-architecture. 
4. Cross-sectional ex vivo research indicates that bone becomes more mineralized and loses 
collagen content with age―resulting in bone that can withstand less strain prior to 
fracture and has little or no post-yield deformation before failure. Research also indicates 
that a linear-elastic model is accurate in predicting failure of this type of bone. However, 
the in vivo repeatability of these models remains unknown. 
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5. The effect of aging on cortical and trabecular micro-architecture in postmenopausal 
women is unclear. Cross-sectional evidence indicates that cortical and trabecular bone 
micro-architecture deteriorates with increasing age. There is need for longitudinal studies 
using non-invasive, high-resolution imaging tools to monitor bone micro-architecture in 
postmenopausal women to gain a better understanding of how bone changes with age. 
6. Understanding how bone density, geometry, and micro-architecture change with age can 
improve osteoporosis prevention, diagnosis, and treatment options. However, it is unclear 
what time interval and what amount of difference between follow-up measures is 
required to actually capture skeletal change, beyond measurement error (precision)—
particularly for bone micro-architecture.  
7. Previous research suggests that the age-related increase in remodeling (especially after 
menopause) results in an overall loss of bone mass and deteriorated micro-architecture. It 
is unclear whether this deterioration would affect the precision for bone micro-
architectural outcomes. Understanding the affect of menopause on micro-architectural 
precision is important when planning studies and interpreting information from studies 
interested in monitoring changes in micro-architectural outcomes in postmenopausal 
women. 
 
1.7 Research Questions and Objectives 
The overall goal of this thesis was to investigate precision for all HR-pQCT outcomes, establish 
the least significant change (LSC) and monitoring time interval (MTI), as well as characterize 
bone changes in density, geometry, and micro-architecture using HR-pQCT. In order to 
accomplish these goals I needed to determine precision of bone micro-architecture and strength 
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outcomes, estimate the LSC and the annual change of these outcomes. Using HR-pQCT images, 
in combination with FE modeling, I aimed to answer the following research questions: 
1. What is the precision of HR-pQCT (standard) outcomes of density, geometry, and micro-
architecture in postmenopausal women and young adults? 
2. Can postmenopausal women and young adults be measured by HR-pQCT with 
comparable precision? 
3. Does manual modification of the endocortical contour in the analysis of cortical bone 
micro-architecture affect precision or outcome values in postmenopausal women or 
young adults? 
4. What is the precision of bone strength estimates derived from 3 commonly used HR-
pQCT integrated FE models? Which of the 3 models is more precise? 
5. What are the minimal differences in bone area, density, and micro-architecture between 
follow-up measures required in order to be 95% confident that change has occurred in 
postmenopausal women? 
6. What is the minimum amount of time required between follow-up measures in order to be 
95% confident that the minimal differences are attained in postmenopausal women? 
7. How does bone micro-architecture change over one year in postmenopausal women? 
To answer the questions posed in this study, our objectives were to: 
1. To define and compare in vivo precision errors and outcomes for HR-pQCT derived: 
a) density, geometry, and micro-architecture in postmenopausal women and young 
adults. 
b) cortical bone micro-architecture in 2 groups (postmenopausal women and young 
adults) using 2 different cortical bone evaluation methods (automatically generated 
endocortical contours and manually modified endocortical contours). 
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c) estimates of bone strength from 3 FE models: i) single tissue model (STM), ii) dual 
tissue model (DTM), and iii) scaled model based on bone mineral density (E-BMD). 
2. To define the LSC and MTIs for HR-pQCT-derived bone area, density, and micro-
architecture in postmenopausal women. 
3. To characterize annual changes in bone area, density, and micro-architecture at the distal 
radius and tibia using HR-pQCT in postmenopausal women. 
 
1.8 Chapter Scope 
Chapter 2 presents three in vivo precision studies for HR-pQCT-derived bone density, geometry, 
cortical and trabecular micro-architecture, as well as FE estimates of bone strength. Specifically, 
chapter 2 addresses whether HR-pQCT precision for bone micro-architecture can be measured 
comparably between postmenopausal women and young adults. Chapter 2 also answers whether 
manual modification of the endocortical contour affects cortical micro-architectural precision 
and/or outcomes in both age groups. The final section in chapter 2 defines the precision for three 
FE models and determines which is most precise. Chapter 3 describes the minimum differences 
between follow-up measures required in order to be confident change has occurred (LSC) as well 
as the minimum amount of time required between follow-up measures in order to be confident 
minimal differences are attained (MTI) in postmenopausal women for bone density, geometry 
and micro-architecture. Chapter 4 characterizes one year change in bone density, geometry, and 
micro-architecture in postmenopausal women. Chapter 5 reviews study findings and offers 
suggestions for future research. 
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2 STUDY 1: HR-PQCT PRECISION 
SYNOPSIS: Measurement reproducibility is essential to reliably monitor bone 
micro-architectural changes over time. Methodological limitations and 
selective outcome reporting have merited further investigation into HR-pQCT 
precision of bone density, geometry, micro-architecture, and FE-derived 
estimates of bone strength. Therefore, the overall aim of this study was to 
determine precision in these outcomes for the standard HR-pQCT evaluation 
technique, the advanced dual-threshold analysis for cortical bone micro-
architecture using 2 evaluation methods, and 3 different FE-models.  
2.1 Area, Geometry, and Micro-architecture
4
 
2.1.1 Introduction 
Osteoporosis is a multi-factorial disease characterized by low bone mass and the deterioration of 
bone micro-architecture resulting in bone fragility and a subsequent increase in propensity to 
fracture
[15]
. Dual-energy x-ray absorptiometry (DXA) is used for assessing areal bone mineral 
density (aBMD, mg/cm
2
) to diagnose osteoporosis
[101,152]
. However, the majority of fragility 
fractures occur in women whose DXA-derived aBMD and related T-scores are above the 
osteoporosis diagnostic threshold
[24,153,154]
. Some of these fractures are unrelated to aBMD and 
are likely due to the deterioration of bone micro-architecture and bone strength which planar 2-
dimensional (2D) DXA measures cannot detect. This premise is supported by evidence from 
women with equal DXA-derived aBMD at the ultradistal radius but substantially different bone 
micro-architectural properties and strength estimates acquired using high-resolution peripheral 
                                                 
4
 Published as: Kawalilak CE, Johnston JD, Olszynski WP, Leswick D, Kontulainen SA (2014). Comparison of 
short term in vivo precision of bone density and micro-architecture at the distal radius and tibia between 
postmenopausal women and young adults. Journal of Clinical Densitometry, 17(4): 541-517. 
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quantitative computed tomography (HR-pQCT)
[25]
. Micro-architectural properties at distal bone 
sites are able to differentiate postmenopausal women who have had a fragility fracture from their 
non-fracture counterparts
[38-41,44,106,155,156]
. Therefore, the use of in vivo 3-dimensional (3D) high-
resolution imaging techniques may improve osteoporosis diagnostics and fracture risk 
assessment, as well as offer a monitoring tool for micro-architectural deterioration in 
postmenopausal women. 
 Measurement reproducibility is essential to reliably monitor bone micro-architectural 
changes over time, changes due to drug therapy or intervention, and to compare difference 
between groups of people
[9,12]
. HR-pQCT in vivo precision errors, in terms of coefficient of 
variation (CV%RMS), have been reported to vary between 0.1-5% for selected standard outcomes 
in cortical and trabecular tissues at the distal radius and tibia
[5,29,157]
. However, the majority of in 
vivo precision studies using HR-pQCT have been completed with young and middle-aged 
adults
[29,157]
. It has been suggested that precision errors derived from young adults may 
underestimate errors in older adults, including clinically relevant postmenopausal women
[149,158]
. 
For example, older adults may have more difficulty remaining still during scanning (e.g., 
tremors), and optimum positioning may be difficult to achieve due to reduced range of motion. 
In addition, age-related deterioration in bone micro-architecture may challenge the repeatability 
in HR-pQCT analysis. Evidence from one HR-pQCT study suggested comparable precision 
errors between young adults and older females (minimum cut-off age: 40 years)
[5]
. However, 
measurements from older females were repeated on the same day
[5]
, which has been shown to 
enhance the pQCT repeatability
[159]
. Notwithstanding, there is a need for comparison data from 
older postmenopausal women to confirm if menopausal status influence precision errors of HR-
pQCT derived bone properties measured at least 24 hours apart. Finally, previous HR-pQCT 
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precision studies reported a selection of standard outcome variables. For example, precision of 
trabecular meta and inner densities are unknown. The objective of our study was to assess 
whether postmenopausal women could be scanned using HR-pQCT with comparable precision 
to young adults. We hypothesized that postmenopausal women would have higher precision 
errors (i.e., poorer repeatability) when compared to young adults.  
2.1.2 Methods 
2.1.2.1 Participants 
The first group of was a random sub-sample of 34 postmenopausal women from the Saskatoon 
cohort of the Canadian Multi-centre Osteoporosis Study (CaMos) (Table 2.1)
[160]
. 
Postmenopausal status was assessed using a questionnaire (Table 3.1). We obtained osteoporosis 
status based on femoral neck (FN) T-scores from the Saskatoon CaMos database (Table 2.1)
[96]
, 
and compared osteoporosis status in our sample to the literature to substantiate that the bone 
health in our sample was representative to postmenopausal women
[160-162]
. The second, 
comparison group was a convenient sample of 15 female and 15 male volunteers (Table 2.1). We 
combined the sexes to form an "ideal group" of young adults with optimal bone properties for 
comparison with the postmenopausal women. There was no effect of sex on precision in young 
adults (data not shown). Participant consent was attained prior to the study. This study was 
approved by the University of Saskatchewan Biomedical Research Ethics Board. 
2.1.2.2 HR-pQCT Imaging 
All participant had their non-dominant arm and ipsilateral leg immobilized in the manufacturer 
provided cast prior to imaging in order to acquire the correct limb position and to prevent gross 
participant movement
[163]
. After comfortably positioning the participant's limb in the scanner, a 
2D anterior-posterior scout view scan was used to set the reference line and define the region of 
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interest (Figure 2.1). High-resolution pQCT (XtremeCT; Scanco Medical AG, Brüttisellen, 
Switzerland) was used to acquire 110 parallel CT slices over a 9.02 mm region of the distal 
radius and distal tibia (Figure 2.1). The radius and tibia regions of interest were 9.5 mm and 22.5 
mm, respectively, proximal to the reference line placement (Figure 2.1). The field of view was 
reconstructed over a 1536 x 1536 matrix using an isotropic resolution of 82 μm. The effective 
dose was <4 μSv and the measurement time was approximately 2.8 minutes for each scan[163]. 
Figure 2.1. Standard HR-pQCT anterior-posterior scout view and location of the scan for a) 
distal radius and b) distal tibia. Solid line indicates the reference line location. Dashed lines 
represent the scanned volume of interest. 
 
2.1.2.3 HR-pQCT Analysis 
One trained operator (CK) scanned, graded, and analyzed all images. The postmenopausal 
women had follow-up measures a minimum of 1 week (9.9 ± 3.7 days) after the first 
measurement, while the young adults had follow-up measures a minimum time period of 1 day 
(24.0 ± 4.8 hours) from the first scan. All images were grading for quality according to a 5 point 
scale defined by the manufacturer and reported in a previous publication
[164]
. Upon detection of 
motion artifacts (e.g., streaking or broken cortices) a repeat scan was performed. Images graded 
as quality 4 and 5 were excluded from the study. At the radius, 5 scans from the older adult 
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group and 1 scan from the young adult group were removed because of excessive movement 
artifact. We also excluded an additional 2 older adult radius scans due to a skeletal defect noted 
by the study radiologist (DL). At the tibia, 2 scans were removed in postmenopausal women 
because of movement artifact. In total, 27 older adult radius scans and 29 young adult radius 
scans, as well as 32 older adult tibia scans and 30 young adult tibia scans were included in the 
study. 
Image analysis was completed according to the manufacturer‘s standard in vivo 
evaluation protocol to acquire cortical and trabecular bone density, area, and micro-architectural 
values. Specifically, the periosteum of the radius and tibia was contoured from the soft tissue 
using a semi-automatic edge-finding algorithm in a slice-by-slice manner. Where the contour 
strayed from the periosteal boundary, the contour line was manually corrected. The cortex was 
separated from the trabecular bone using a coarse Gaussian filter to smooth the image and filter 
out thin structures. Using support and sigma values of 3 and 2, respectively, the image was 
binarized and a 7x7x7 voxel-based filter block was applied to fully isolate and define the 
cortex
[42]
. Mean cortical thickness (CtTh; µm) was calculated as the mean cortical volume 
divided by the mean periosteal surface area
[14,25]
. Cortical area (mm
2
) and trabecular area (mm
2
) 
were defined as the area of pixels included in the segmented cortical and trabecular 
compartments, respectively. Total bone density (mg HA/ cm
3
) was determined as the average 
mineral density within the bone volume defined by the outer bone contour. Similarly, cortical 
and trabecular bone densities (mg HA/ cm
3
) were defined as the average mineral density within 
cortical and trabecular bone volumes, respectively. Trabecular density was farther subdivided 
into ‗Meta‘ (between) and ‗Inner‘ trabecular bone densities. These densities were defined as the 
average mineral density within the 40% (Meta) and 60% (Inn) of the trabecular bone region. 
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Trabecular bone volume fraction (BV/TV, %) was defined as the trabecular density divided by 
the assumed mineral density of fully mineralized bone (i.e., 1200 mg HA/cm
3
)
[14,25]
. A Laplace-
Hamming filter (epsilon 0.5; cut-off frequency 0.4) was applied to enhance the edges of the 
trabeculae in order to compensate for HR-pQCT resolution constraints and associated partial 
volume effects, which limited HR-pQCT to measure individual trabeculae (spatial resolution: 
105 µm)
[165,166]
. After binarization and the application of the Laplace-Hamming filter, a ridge 
detection method and distance transform were used to define the trabecular number (TbN, 
1/mm)
[14,167]
. Trabecular thickness (TbTh, µm), trabecular separation (TbSp, µm), and the 
standard deviation of the trabecular separation (Tb1/NSD or TbSpSD; trabecular heterogeneity, 
µm) were calculated using the bone volume fraction and trabecular number based on plate model 
assumptions (theoretical basis previously described in detail
[14]
).  
2.1.2.4 Statistical Analysis 
We assess the precision of HR-pQCT derived bone outcomes using both coefficients of variation 
(CV%) and root-mean-squared coefficients of variation (CV%RMS), as recommended by Glüer et 
al. (1995) and presented below 
𝐶𝑉% =   
Σ𝑗=1
𝑚  
𝑆𝐷
𝑥 𝑗
𝑚
 𝑥 100%                                                                                                        (2.1) 
𝐶𝑉%𝑅𝑀𝑆 =    
𝐶𝑉%𝑗
2
𝑚
𝑚
𝑗=1                                                                                                             (2.2) 
where SD was the standard deviation between the two measurements, xj was the mean of the two 
measurements, and m was the number of participants in the analysis. Using the above measures 
of repeatability, together with sufficient number of participants to acquire 27 degrees of freedom, 
allow us to achieve 90% confidence in our precision error estimates
[12]
. The two measures (i.e., 
CV% and CV%RMS) were included because CV% is calculated for each individual, while the 
(
2
) 
(
1
) 
 42 
CV%RMS is a geometric mean and therefore only one value is provided for each outcome. In 
order to make statistical comparisons between the two groups we needed more than one value; 
hence all statistical comparisons were completed using CV%. 
We also provided information on precision in absolute terms using the 95% limits of 
agreement (95% LOA). The 95% LOA was previously defined by Bland and Altman (1986) and 
presented below: 
95% 𝐿𝑂𝐴 =  𝑑 ±  1.96 𝑥𝑆𝐷𝑚𝑒𝑎𝑠                                                                                              (2.3) 
where d was the average measurement bias, and SDmeas was the standard deviation of the 
differences between the two measurements
[8]
. 
To determine the distribution of our dataset, we calculated the z-score for skewness and 
kurtosis for the precision error and 95% LOA for all standard outcome variables for both the 
young adult and older adult groups. The variables with skewness or kurtosis z-scores greater than 
1.96 had a non-parametric distribution. We performed 13 Mann Whitney U-tests (with 
Bonferroni adjustments for multiple comparisons) to compare the CV% between young adults 
and postmenopausal women for each standard outcome variable. Significance was set to 
P<0.004. 
2.1.3 Results 
Mean standard outcome variables at baseline and follow-up scans are presented in Table 2.2 for 
the group of postmenopausal women, and Table 2.3 for the young adult group. The CV%RMS and 
95% LOA are also presented in Tables 2.2 and 2.3 for the postmenopausal women and the group 
of young adults, respectively. The standard outcome variables did not differ between the groups 
(Table 2.4). 
 
(
3
) 
  
Table 2.1. Participant demographics (mean ± SD); including the number (N) and proportion (%) of: participants with osteopenia or 
osteoporosis. 
    Postmenopausal Young adults 
  
Females Males Females 
Age (years)   74 ± 7   25 ± 4   26 ± 8 
Height (cm) 160.1 ± 5.7 179.5 ± 4.1 166.5 ± 4.6 
Weight (kg)     72.4 ± 12.9  88.5 ± 4.1     71.4 ± 12.4 
Osteopenia N (%)         20 (63%) -- -- 
Osteoporosis N (%)          5 (16%) -- -- 
 
 
 
Table 2.2. Mean (±SD) of the baseline and follow-up scans, mean (±SD) of both measurements, precision error (CV%RMS), and the lower and upper 
bounds for the 95% limits of agreement (LOA) for the CaMos Saskatoon cohort of postmenopausal women at a) distal radius and b) distal tibia. 
 
Baseline  ± SD Follow-up ± SD Mean  ± SD CV%RMS 
95% LOA 
Lower  Upper 
a) Radius (n=27) 
         Area 
            Cortical (mm
2
) 37.9 ± 13.9 37.9 ± 14.2 37.9 ± 14.0 2.9 -1.6 1.6 
  Trabecular (mm
2
) 242.4 ± 46.2 242.3 ± 46.3 242.3 ± 46.2 0.4 -1.2 1.5 
           Density 
            Total  (mg HA/cm
3
) 245.1 ± 54.8 245.3 ± 55.6 245.2 ± 55.2 1.4 -5.3 4.9 
  Cortical  (mg HA/cm
3
) 774.3 ± 101.8 771.7 ± 103.7 773.0 ± 102.6 1.1 -9.5 14.7 
  Trabecular  (mg HA/cm
3
) 131.0 ± 34.4 131.3 ± 34.1 131.2 ± 34.3 1.2 -2.9 2.3 
       Meta (mg HA/cm
3
) 188.0 ± 31.2 189.0 ± 31.6 188.5 ± 31.3 1.6 -5.5 3.6 
       Inner (mg HA/cm
3
) 91.7 ± 39.1 92.5 ± 38.3 91.6 ± 38.7 2.1 -2.5 2.9 
           Micro-architecture 
           CtTh (μm) 522.1 ± 199.2 522.9 ± 204.2 522.5 ± 201.5 3.1 -21.5 20.1 
  BV/TV (%) 10.9 ± 2.9 10.9 ± 2.9 10.9 ± 2.9 1.2 -0.2 0.2 
  TbN (1/mm) 1.8 ± 0.4 1.8 ± 0.3 1.8 ± 0.4 6.0 -0.2 0.1 
  TbTh (μm) 60.9 ± 11.0 60.3 ± 10.7 60.6 ± 10.6 5.4 -4.8 5.9 
  TbSp (μm) 522.9 ± 139.3 514.8 ± 129.4 518.8 ± 132.2 6.1 -41.5 57.8 
  TbSpSD (μm) 277.0 ± 156.7 281.1 ± 158.0 279.1 ± 156.6 6.5 -31.3 23.1 
           
4
3
 
  
b) Tibia (n=32) 
         Area 
            Cortical (mm
2
) 85.3 ± 26.6 84.9 ± 26.3 85.1 ± 26.4 1.1 -1.0 1.9 
  Trabecular (mm
2
) 622.7 ± 102.6 623.3 ± 102.6 623.0 ± 102.6 0.1 -1.9 0.7 
           Density 
            Total  (mg HA/cm
3
) 244.9 ± 48.1 244.0 ± 47.5 244.5 ± 47.8 0.9 -2.5 4.2 
  Cortical (mg HA/cm
3
) 776.2 ± 77.0 776.3 ± 75.6 776.2 ± 76.3 0.3 -3.4 3.2 
  Trabecular (mg HA/cm
3
) 155.8 ± 41.5 155.4 ± 40.8 155.6 ± 41.4 1.3 -2.6 3.3 
       Meta (mg HA/cm
3
) 224.5 ± 38.1 224.2 ± 37.3 224.3 ± 37.6 1.1 -3.5 4.0 
       Inner (mg HA/cm
3
) 109.2 ± 46.7 108.7 ± 46.0 108.9 ± 46.3 1.9 -2.2 3.1 
           Micro-architecture 
           CtTh (μm) 812.5 ± 260.1 807.8 ± 255.5 810.2 ± 257.7 1.4 -13.1 22.4 
  BV/TV (%) 13.0 ± 3.5 12.9 ± 3.4 13.0 ± 3.4 1.3 -0.2 0.3 
  TbN (1/mm) 1.7 ± 0.4 1.7 ± 0.3 1.7 ± 0.3 6.7 -0.2 0.2 
  TbTh (μm) 78.0 ± 17.7 77.8 ± 17.0 77.9 ± 17.0 6.2 -6.1 6.5 
  TbSp (μm) 550.8 ± 177.6 549.4 ± 168.0 550.1 ± 170.9 6.8 -50.8 53.6 
  TbSpSD (μm) 299.3 ± 232.0 302.4 ± 235.1 300.9 ± 233.3 6.2 -24.3 18.2 
 
  
4
4
 
  
Table 2.3. Mean (±SD) of the baseline and follow-up scans, mean (±SD) of both measurements, precision error (CV%RMS), and the 
lower and upper bounds for the 95% limits of agreement (LOA) for the young adult group at a) distal radius and b) distal tibia. 
 
Baseline  ± SD 
Follow-
up ± SD Mean  ± SD CV%RMS 
95% LOA 
Lower  Upper 
a) Radius (n=29)           
Area 
            Cortical (mm
2
) 62.5 ± 18.6 61.4 ± 18.0 62.0 ± 18.3 3.1 -1.5 3.8 
  Trabecular (mm
2
) 274.5 ± 60.1 275.4 ± 60.3 274.9 ± 60.2 0.6 -3.7 1.8 
           Density 
            Total  (mg HA/cm
3
) 328.1 ± 50.5 324.7 ± 49.1 326.4 ± 49.7 1.6 -4.3 11.1 
  Cortical  (mg HA/cm
3
) 866.6 ± 53.1 861.1 ± 57.3 863.9 ± 54.8 1.2 -10.6 21.4 
  Trabecular  (mg HA/cm
3
) 192.7 ± 46.4 191.9 ± 45.7 192.3 ± 46.0 0.9 -2.0 3.6 
       Meta (mg HA/cm
3
) 248.9 ± 44.8 248.0 ± 44.7 248.4 ± 44.8 0.8 -2.2 4.0 
       Inner (mg HA/cm
3
) 154.0 ± 48.2 153.3 ± 47.1 153.6 ± 47.6 1.4 -2.7 4.0 
           Micro-architecture 
           CtTh (μm) 796.9 ± 180.0 782.8 ± 172.3 789.8 ± 175.6 3.3 -19.8 48.1 
  BV/TV (%) 16.0 ± 3.9 16.0 ± 3.8 16.0 ± 3.8 0.9 -0.2 0.3 
  TbN (1/mm) 2.2 ± 0.3 2.2 ± 0.3 2.2 ± 0.3 5.7 -0.2 0.2 
  TbTh (μm) 72.8 ± 12.7 73.0 ± 12.0 72.9 ± 11.9 5.9 -6.8 6.5 
  TbSp (μm) 391.1 ± 67.6 393.2 ± 62.3 392.2 ± 63.0 5.7 -36.7 32.6 
  TbSpSD (μm) 154.7 ± 31.9 156.5 ± 30.7 155.6 ± 30.1 8.0 -20.3 16.7 
           
b) Tibia (n=30) 
         Area 
            Cortical (mm
2
) 151.4 ± 40.0 150.6 ± 39.0 151.0 ± 39.5 0.9 -1.5 3.2 
  Trabecular (mm
2
) 626.7 ± 132.9 627.4 ± 133.3 627.0 ± 133.1 0.2 -2.5 1.1 
           Density 
            Total  (mg HA/cm
3
) 350.8 ± 56.8 349.6 ± 55.7 350.2 ± 56.2 0.7 -2.6 5.1 
  Cortical (mg HA/cm
3
) 918.9 ± 34.3 918.5 ± 33.5 918.7 ± 33.8 0.4 -5.3 6.0 
  Trabecular (mg HA/cm
3
) 212.8 ± 48.4 212.1 ± 47.6 212.4 ± 48.0 0.8 -1.8 3.3 
       Meta (mg HA/cm
3
) 275.7 ± 45.0 275.1 ± 44.7 275.4 ± 44.8 0.6 -1.8 3.0 
       Inner (mg HA/cm
3
) 170.1 ± 51.8 169.3 ± 50.7 169.7 ± 51.2 1.4 -2.3 4.1 
           
4
5
 
  
Micro-architecture 
           CtTh (μm) 1382.0 ± 285.8 1377.0 ± 278.5 1379.5 ± 282.0 0.9 -15.8 25.8 
  BV/TV (%) 17.7 ± 4.0 17.7 ± 4.0 17.7 ± 4.0 0.9 -0.2 0.3 
  TbN (1/mm) 2.1 ± 0.4 2.0 ± 0.4 2.0 ± 0.4 4.0 -0.3 0.3 
  TbTh (μm) 86.0 ± 14.9 86.7 ± 14.3 86.4 ± 14.5 3.8 -5.3 3.9 
  TbSp (μm) 413.3 ± 96.7 417.3 ± 91.6 415.2 ± 93.4 4.0 -28.8 20.4 
  TbSpSD (μm) 178.3 ± 52.1 181.0 ± 50.0 180.0 ± 50.7 5.0 -14.6 9.2 
 
 
 
 
 
 
4
6
 
 47 
Table 2.4. Median difference (young adults - postmenopausal women) for the percent coefficient 
of variation (CV%) between the group of postmenopausal women and the young adult group 
with their corresponding P-values for the a) distal radius, and b) distal tibia. 
 
CV% Median 
Difference 
P-value 
a) Radius (n=56) 
  
Area  
  
  Cortical (mm
2
) -0.5 0.264 
  Trabecular (mm
2
)  0.2 0.071 
  
  
Density  
  
  Total  (mg HA/cm
3
) -0.1 0.543 
  Cortical  (mg HA/cm
3
)  0.0 0.383 
  Trabecular  (mg HA/cm
3
)  0.0 0.481 
       Meta (mg HA/cm
3
) -0.2 0.021 
       Inner (mg HA/cm
3
) -0.4 0.090 
  
  
Micro-architecture 
  
  CtTh (μm)  0.0 0.810 
  BV/TV (%) -0.1 0.508 
  TbN (1/mm) -0.2 0.762 
  TbTh (μm)  1.0 0.905 
  TbSp (μm) -0.2 0.898 
  TbSpSD (μm)  0.9 0.264 
  
  
b) Tibia (n=62) 
  
Area  
  
  Cortical (mm
2
) -0.2 0.661 
  Trabecular (mm
2
)  0.0 0.729 
  
  
Density  
  
  Total  (mg HA/cm
3
)  0.0 0.377 
  Cortical (mg HA/cm
3
) -0.1 0.146 
  Trabecular (mg HA/cm
3
) -0.2 0.066 
       Meta (mg HA/cm
3
) -0.3 0.004 
       Inner (mg HA/cm
3
)  0.0 0.467 
  
  
Micro-architecture 
  
  CtTh (μm) -0.4 0.004 
  BV/TV (%) -0.3 0.070 
  TbN (1/mm) -1.4 0.070 
  TbTh (μm) -0.7 0.223 
  TbSp (μm) -1.0 0.121 
  TbSpSD (μm) -0.9 0.657 
 * Significant differences at P<0.004 
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2.1.5 Discussion 
Our objective was to assess whether postmenopausal women could be measured with 
comparable precision as young adults. Contrary to our hypothesis, there were no statistically 
significant differences between the postmenopausal women and young adults for standard 
outcome variables using HR-pQCT. These data indicate that postmenopausal status does not 
significantly affect the precision errors in skeletal parameters assessed using densitometric 
techniques as was previously suggested
[149,158]
. 
 This study is the first to provide precision results for all standard outcome variables 
produced using HR-pQCT in postmenopausal women and young adults. Overall, our precision 
was comparable with those previously published for young and middle aged adults
[5,29,157]
. Also 
consistent with previous findings
[5,29,157]
, the area and density precision errors appeared to be 
lower in the tibia compared to the radius. This may be due to challenges associated with locating 
the radius landmark for reference line placement, whereas the tibia had a consistently well-
defined landmark. This is evident by the higher agreement in common region between baseline 
and follow-up scans in the tibia (i.e., 97%), relative to the radius (i.e., 93%). Further, the 
precision error appeared smaller for area and density measures (CV%RMS: 0.2-3.1), relative to the 
micro-architectural parameters (CV%RMS: 0.9-8.0). This trend was consistent between the distal 
radius and tibia in both young adults and postmenopausal women. This is likely due to the 
accumulation of error associated with limited resolution and inherent errors in the equations used 
for determining micro-architectural parameters. 
 Postmenopausal status did not affect the precision error for the majority of the standard 
outcome variables obtained using HR-pQCT. This may be the result of careful consideration to 
participant positioning within the cast and scanner, as well as attention to the placement of the 
reference line at follow-up measures and a conscientious effort during the analysis process. 
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Further, the manufacturer's image registration algorithm has previously been shown to reduce 
precision error
[14,168]
. The image registration algorithm uses a common region to match the 
average total cross-sectional area for all slices in the first measurement with all repeated 
measurements on that participant
[14,157,168]
. This is evident from the mean common region for 
total area measures between baseline and follow-up scans for the young adult radii and tibiae 
were 93±5% and 97±2%, respectively, and for the postmenopausal women radii and tibiae were 
93±4% and 97±2%, respectively.  
The assessment and monitoring of densitometric and micro-architectural properties, and 
related errors in repeated measurements, in postmenopausal women are clinically relevant due to 
the high risk of osteoporotic fractures in this population. Based on the observed 95% LOA, 
similar magnitude of change in the HR-pQCT derived standard outcome variables is required in 
both young adults and postmenopausal women. However, the rate and magnitude of change in 
bone micro-architecture likely depends on the age, sex and musculoskeletal health status of the 
participants. Therefore, the 95% LOA, based on short-term precision error, may over- or under-
estimate the ability to monitor changes in participants with slower or faster rate of change in 
bone micro-architecture, respectively. Consequently, prospective follow-up data of bone micro-
architectural changes is needed to confirm our findings.  
 Our study design had certain strengths that merit consideration. First, we compared 
precision errors in postmenopausal women to short-term precision errors observed with a "best 
case" sample of young adults, including both females and males. Second, we not only 
repositioned our participants between measurement times, but we also separated their repeat 
measurements by a minimum of 24 hours. This is important because underestimation of 
precision error in pQCT measurements has been reported when precision was calculated using 
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scans repeated on the same day
[159]
. Third, we had sufficient number of participants in both 
groups to attain a minimum of 27 degrees of freedom and calculated precision error based on 
root-mean-squared averages. Meeting this requirement permits 90% confidence in measurement 
precision
[12,149]
. Finally, 16% of our postmenopausal women had osteoporosis and 63% had 
osteopenia, based on their femoral neck T-scores. These proportions are comparable to the 
osteoporosis reference standards from North America, Europe, Australia and Japan
[161,162]
, 
thereby making our data generalizable to postmenopausal women in these regions. 
 There are some limitations associated with this study that warrant discussion. First, while 
we studied a representative sample of postmenopausal women, skeletal precision may vary 
according to duration of menopause, time from menopause, and disease status (e.g., 
osteoporosis); this merits further investigation into population-specific precision studies. Second, 
osteoporosis status was not accounted for in the analysis because of the small number of 
participants with osteoporosis in our study (n=5). Third, the contouring algorithm is semi-
automatic and the majority of the scans required manual correction of the periosteal contour line. 
This was especially true in the postmenopausal women whose cortex appeared more porous 
relative to the young adult group. However, the analysis for both groups was conducted carefully 
by a single operator, on a slice-by-slice manner, to reduce the error associated with the manual 
correction. 
 In summary, short-term precision errors in HR-pQCT-derived standard bone outcomes 
are comparable in postmenopausal women and in young adults. 
 The standard HR-pQCT evaluation algorithm provides a detailed description of 
trabecular micro-architecture but, beyond cortical thickness, it does not provide information on 
cortical bone micro-architecture. In order to evaluate the micro-architecture of the cortex (e.g., 
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cortical porosity) the dual-threshold contour technique must be used to isolate the cortex. While 
this algorithm is relatively new, it has been widely accepted and utilized in research across all 
age groups. However, the precision of cortical bone micro-architecture provided by the dual-
threshold technique is not fully known and there are some methodological questions that remain. 
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2.2 Cortical Bone Micro-architecture
5
 
2.2.1 Introduction 
Osteoporosis is a major public health problem in older adults
[97,169]
. It is a disease characterized 
by the loss of bone mass and the deterioration of bone micro-architecture, resulting in increased 
fracture risk, particularly in postmenopausal women
[15,33]
. Distal radius fractures are reported as 
being the most common fracture type occurring in postmenopausal women in North America and 
Europe
[33,170-172]
. 
 Despite long bone ends (epiphyses and metaphyses) being predominantly comprised of 
trabecular bone, the thin cortical shell contributes to whole bone strength
[170,173]
 bearing a 
significant proportion of the load
[174]
. Bone's mechanical properties have been associated with 
cortical bone micro-architecture
[104]
. High cortical porosity, in particular, has been negatively 
associated with elastic modulus (tissue stiffness), failure load (strength), toughness (resilience), 
and impact energy-absorption capacity of bone
[71,173,175,176]
. From their cross-sectional cadaveric 
comparison, McCalden and colleagues reported that 76% of the observed age-related decline in 
bone strength was accounted for by cortical porosity
[75]
. Further, in postmenopausal women with 
low-impact fractures, there is evidence of higher cortical porosity when compared to non-
fracture controls
[43,177-179]
. For these reasons, cortical bone micro-architecture is an important 
target to monitor when assessing osteoporosis and treatment effects. 
 Precise measurement of cortical bone micro-architecture is fundamental when monitoring 
skeletal changes and treatment effects. Therefore, consideration must be given to the precision of 
the evaluation protocols used to obtain cortical micro-architectural outcomes. One method of 
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cortical micro-architecture evaluation, using high-resolution peripheral quantitative computed 
tomography (HR-pQCT), is the advanced cortical bone evaluation tool which uses a dual-
thresholding to identify the periosteal (outer) and endocortical (inner) surfaces of the cortex
[5,105]
. 
The dual-threshold method is a semi-automatic process which requires manual modification of 
the contour lines when they appear to deviate from the periosteal and endocortical surfaces
[105]
. 
Cadaveric (ex vivo) evidence from the distal tibia suggested that modification of the endocortical 
contour line affects cortical bone outcomes
[180]
. However, it remains unknown whether manual 
modification of the endocortical contour line affects precision and outcomes of cortical bone 
properties in vivo. If automatic contouring can offer similar precision and outcomes as modified 
contouring, this will lead to time savings and reduced costs as modified contouring can be a 
laborious process. 
 The first objective of this study was to define in vivo precision errors (coefficient of 
variation root-mean-squared, CV%RMS) and least significant change (LSC) for cortical bone 
micro-architecture in postmenopausal women and young adults using 2 different cortical bone 
evaluation methods (automatic endocortical contour, AUTO and modified endocortical contour, 
MOD). The second objective was to compare precision errors and bone outcomes obtained with 
both methods within and between the groups. 
2.2.2 Methods 
2.2.2.1 Participants 
The first group was a random sub-sample of 34 postmenopausal women (74±7 years) from the 
Saskatoon cohort of the Canadian Multi-centre Osteoporosis (CaMos) Study
[1,160]
. 
Postmenopausal status was assessed using a questionnaire; osteoporosis status was based on 
femoral neck (FN) T-scores obtained from the Saskatoon CaMos database
[96]
. The second group 
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of volunteers was a convenient sample of young adults (15 females and 15 males; mean age ± 
standard deviation (SD): 26±7 years)
[1]
. Participant consent was attained prior to the study. This 
study was approved by the University of Saskatchewan Biomedical Research Ethics Board. 
2.2.2.2 HR-pQCT Imaging 
Prior to imaging, all participants had their non-dominant arm and ipsilateral leg immobilized in a 
fiberglass cast provided by the manufacturer
[1]
. HR-pQCT (XtremeCT; Scanco Medical AG, 
Brüttisellen, Switzerland) was used to acquire a standard 9.02 mm region of interest (110 parallel 
CT slices) with an 82 µm isotropic voxel size at the distal radius and tibia
[163]
. The scan time was 
<2.8 minutes and the effective dose was <4 μSv per scan[4]. 
2.2.2.3 HR-pQCT Image Analysis 
One investigator (CK) scanned, graded, and analyzed all HR-pQCT images. The group of 
postmenopausal women had follow-up measures at least 1 week (9.9±3.7 days) after the first 
measurement. The young adult group had follow-up measures with a minimum time period of 1 
day (24±4.8 hours) from the first scan. All images were graded for quality according to the 
manufacturer's 5 point scale
[1,164]
. Images graded as quality 4 and 5 were excluded from the 
study
[1]
. In total: 27 postmenopausal radii, 29 young adult radii, 32 postmenopausal tibiae, and 
30 young adult tibiae were included in the study. 
Image analysis was completed according to the manufacturer‘s standard evaluation and 
the manufacturer-provided advanced cortical micro-architecture evaluation protocols (Scanco 
Module 64-bit IPL V5.08b). Briefly, the standard image evaluation was used to define the 
periosteum of the radius and tibia by separating bone from soft tissue using a semi-automatic 
edge-finding algorithm in a slice-by-slice manner, as described elsewhere
[1,4]
. Subsequently, we 
used the automated dual-threshold method for cortical micro-architecture evaluation to segment 
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the endocortical surface
[5,181]
. The periosteal contour was imported from the standard evaluation 
process while the endocortical contour was automatically created using a series of morphological 
operations (i.e., dilation and erosion) to separate the trabecular and cortical volumes of interest 
(VOI)
[5]
. 
All images underwent two methods for cortical micro-architecture evaluations. The first 
method (automated contour method, AUTO) used the automatic dual-threshold method to define 
the endocortical contour line (Figure 2.2 solid line). The second method (modified contour 
method, MOD) started with the automatically generated endocortical contour line, which was 
then qualitatively inspected for quality assurance and manually modified (via mouse) when the 
contour visually deviated from the apparent endocortical margin (Figure 2.2 dashed line). 
Cortical micro-architecture evaluation was completed using two methods for each bone site 
(radius and tibia), for each group (young adult and postmenopausal women), at both times points 
(baseline and follow-up). AUTO took approximately 5 minutes to complete; MOD took up to 3 
hours per radius and up to 5 hours per tibia, depending on degree of cortical porosity. The 
following outcomes were included in this investigation: cortical porosity (CtPo, %), cortical pore 
volume (CtPoV, mm
3
), cortical pore diameter (CtPoDm, mm), cortical bone total volume (CtTV, 
mm
3
), cortical bone volume (CtBV, mm
3
), cortical bone mineral density (mean mineralization of 
the cortical VOI; CtBMD, mg HA/cm
3
), and cortical thickness (CtTh, mm). 
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Figure 2.2. HR-pQCT scan illustrating 
the radius (a, no contour) and tibia (c, no 
contour) with the automatic contour (b 
and d: solid line) and the modified 
contour (b and d: dashed line) for the 
group of postmenopausal women. 
 
 
 
 
 
2.2.2.4 Statistical Analysis 
To determine the distribution of our dataset, we calculated the skewness z-score for all variables 
for both the automatic contour and the modified contour methods in the postmenopausal women 
and young adults. The variables with skewness z-scores greater than 1.96 had a non-parametric 
distribution and were normalized using log transformation. 
 We assessed the precision of HR-pQCT derived cortical micro-architecture outcomes by 
calculating coefficients of variation root-mean-squared (CV%RMS) for each outcome
[1,12]
. 
Reliable monitoring of skeletal changes and treatment effects requires information regarding the 
minimum difference between baseline and follow-up measures that is necessary for measuring 
real change beyond measurement error. As indicated by the International Society for Clinical 
Densitometry (ISCD), the LSC is the recommended method for determining true skeletal change 
with 95% confidence
[9,149]
. We determined the LSC in relation to measurement precision errors 
using the following equation
[9]
: 
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LSC 1x1 = Z x CV% 
1
n1
+  
1
n2
=   1.96 x CV%RMS 
1
1
+  
1
1
=  2.77 x CV%RMS                              (2.4)
 
Where the '(1x1)' indicates that we performed 1 measurement at each baseline ('n1') and follow-
up ('n2') visit, and the Z-score corresponds a two-tailed 95% confidence level (i.e., 1.96)
[10]
. 
 Within each group, we compared mean CV% and cortical bone outcomes between the 
two methods using repeated-measures analysis of variance (ANOVA) with Bonferroni correction 
for multiple comparisons. We compared mean CV% and cortical bone outcomes (evaluated 
using automatic and modified contour methods) between the postmenopausal women and group 
of young adults using multivariate ANOVA with Bonferroni adjustment for multiple 
comparisons. Significance was set to P<0.05. All statistical analyses were performed using IBM 
SPSS commercial statistics software (PASW, Version 21 for Windows, SPSS Inc., Chicago, IL, 
USA). 
2.2.3 Results 
Cortical bone micro-architecture CV%RMS (precision errors) for AUTO and MOD for both 
groups are summarized in Figure 2.3. Mean (±SD) for outcome variables and LSC are presented 
in Table 2.5 for both contour evaluation methods and for both groups. For both contour methods, 
both measurement sites, and for both age groups, the LSC values were higher for CtPo, CtPoV 
and CtPoDm (range: 10.6-45.0%, Table 2.5) and lower for CtTV, CtBV, CtBMD, and CtTh 
(range: 0.9-9.1%, Table 2.5). 
 There were no significant differences in precision errors between AUTO and MOD 
methods in either group; however, precision errors differed between the groups (Figure 2.3). 
When using AUTO at the distal tibia, precision error for cortical BMD was 0.2% higher for the 
postmenopausal women (P=0.022) (Figure 2.3). When using MOD at the distal radius, precision 
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error for cortical porosity and cortical pore volume was, respectively, 9.3% (P=0.024) and 7.5% 
(P=0.039) lower in postmenopausal women relative to the young adults (Figure 2.3). At the 
distal tibia precision error for cortical thickness was 0.8% higher for the postmenopausal women 
compared to the young adults (P=0.009) (Figure 2.3). All other cortical micro-architectural 
outcome variables did not differ between the two age groups for either evaluation method 
(Figure 2.3). 
 Pertaining to cortical bone micro-architectural outcomes, in postmenopausal women there 
were between-method differences for every variable, except cortical thickness at the distal radius 
(P=0.902) (Table 2.5). For postmenopausal women, MOD resulted in higher cortical porosity 
(Radius: 48.6%; Tibia: 31.2%), pore volume (Radius: 54.3%; Tibia: 41.9%), pore diameter 
(Radius: 14.3%; Tibia: 16.7%), total volume (Radius: 10.8%; Tibia: 15.9%), and bone volume 
(Radius: 6.7%; Tibia: 11.5%) in addition to lower cortical density (Radius: -5.5%; Tibia: -7.5%) 
at both measurement sites (Table 2.5). Also, at the distal tibia in postmenopausal women MOD 
yielded, on average, -0.02 mm (-1.7 %) thinner cortices (P<0.028) (Table 2.5). In the young 
adult group we found no significant differences between the contour methods across all 
outcomes (Table 2.5). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3. Root-mean-square precision errors (CV%) for cortical micro-architecture variables for both contouring methods as well as 
the group of young adults and postmenopausal women at the a) distal radius, and b) distal tibia. Cortical micro-architecture outcomes 
include: cortical porosity (CtPo, %); cortical pore volume (CtPoV, mm
3
); cortical pore diameter (CtPoDm, mm); cortical bone total 
volume (CtTV, mm
3
); cortical bone volume (CtBV, mm
3
); cortical bone mineral density (CtBMD, mg HA/cm
3
);and cortical thickness 
(CtTh, mm). * Indicates significant differences. 
5
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Table 2.5. Mean (±SD) of baseline and follow-up measurements, Least Significant Change (LSC), mean outcome difference between 
evaluation methods (MOD-AUTO), the significance value of log transformed outcomes between evaluation methods for a) 
postmenopausal women and b) young adult group at i) distal radius and ii) distal tibia. 
 
Automatic Contour 
(AUTO) 
 Modified Contour 
(MOD) 
 
Mean Outcome 
Difference Between 
Evaluation Methods P-value* 
a) Postmenopausal Women 
 
i) Radius (n=27) 
  
LSC 
(%) 
  
LSC 
(%) 
 
Mean ±SD 
 
Mean ±SD 
 
CtPo (%) 3.6 ± 1.0 29.0  7.0 ± 3.7  19.5  3.4 ± 2.9 <0.001 
CtPoV (mm
3
) 13.2 ± 3.7 34.0  28.9 ± 15.4 22.8  15.6 ± 13.6 <0.001 
CtPoDm (mm) 0.18 ± 0.02 15.1  0.21 ± 0.04 17.4  0.03 ± 0.02 <0.001 
CtTV (mm
3
) 375.6 ± 90.9 9.8  421.2 ± 94.2 9.1  45.6 ± 43.1 <0.001 
CtBV (mm
3
) 368.8 ± 86.4 9.1  393.5 ± 84.8 8.8  24.7 ± 19.5 <0.001 
CtBMD (mg HA/cm
3
) 918.1 ± 77.2 4.5  867.8 ± 101.3 4.0  -50.3 ± 38.6 <0.001 
CtTh (mm) 1.187 ± 0.060 2.7  1.189 ± 0.068 3.0  0.002 ± 0.032   0.902 
 
  
 
        
ii) Tibia (n=32)   
 
        
CtPo (%) 9.7 ± 3.4 12.6  14.1 ± 5.3 16.6  4.4 ± 3.5 <0.001 
CtPoV (mm
3
) 77.9 ± 33.7 15.4  134.1 ± 58.7 21.4  56.2 ± 38.1 <0.001 
CtPoDm (mm) 0.20 ± 0.02 12.3  0.24 ± 0.05 15.3  0.04 ± 0.5 <0.001 
CtTV (mm
3
) 803.6 ± 200.3 4.6  955.2 ± 198.0 6.1  151.6 ± 85.4 <0.001 
CtBV (mm
3
) 734.8 ± 178.4 3.8  830.4 ± 177.4 4.2  95.6 ± 85.4 <0.001 
CtBMD (mg HA/cm
3
) 841.4 ± 71.5 2.3  778.7 ± 92.7 3.2  -62.7 ± 40.5 <0.001 
CtTh (mm) 1.17 ± 0.08 3.3  1.15 ± 0.06 3.1  -0.02 ± 0.07 0.028 
 
   
 
        
b) Young Adults        
i) Radius (n=29)            
CtPo (%) 2.19 ± 1.67 42.0  2.16 ± 1.37 45.0  -0.03 ± 0.40  0.188 
CtPoV (mm
3
) 14.2 ± 17.4 41.3  13.5 ± 13.0 43.5  -0.8 ± 5.1 0.319 
CtPoDm (mm) 0.151 ± 0.010 13.2  0.152 ± 0.010 13.1  0.001 ± 0.005 0.432 
6
0
 
  
CtTV (mm
3
) 567.2 ± 155.3 7.0  564.3 ± 144.3 6.8  -2.9 ± 18.7 0.564 
CtBV (mm
3
) 556.3 ± 141.9 7.0  554.1 ± 134.4 6.9  -2.2 ± 13.7 0.403 
CtBMD (mg HA/cm
3
) 963.76 ± 53.12 4.1  963.79 ± 51.23 4.3  0.03 ± 4.24 0.882 
CtTh (mm) 1.130 ± 0.056 2.6  1.126 ± 0.055 2.7  -0.004 ± 0.009 0.063 
 
  
 
        
ii) Tibia (n=30)   
 
        
CtPo (%) 4.5 ± 1.8 20.6  4.3 ± 1.5 16.8  -0.2 ± 1.2 0.440 
CtPoV (mm
3
) 58.8 ± 36.5 21.4  53.9 ± 27.0 17.5  -4.8 ± 22.3 0.492 
CtPoDm (mm) 0.185 ± 0.019 15.0  0.183 ± 0.024 10.6  -0.002 ± 0.018 0.474 
CtTV (mm
3
) 1223.3 ± 287.5 2.8  1202.8 ± 253.3 2.7  -20.5 ± 84.6 0.194 
CtBV (mm
3
) 1165.8 ± 256.8 2.6  1149.9 ± 232.8 2.6  -15.9 ± 63.0 0.178 
CtBMD (mg HA/cm
3
) 981.6 ± 38.7 1.7  983.7 ± 37.4 1.7  2.1 ± 15.9 0.479 
CtTh (mm) 1.068 ± 0.026 1.5  1.067 ± 0.018 0.9  0.001 ± 0.009 0.473 
*Assessed using repeated measures ANOVA comparison of logarithm transformed data with Bonferroni adjustment for multiple comparisons 
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2.2.4 Discussion 
Our primary objective was to define in vivo precision errors and LSC for cortical bone micro-
architecture in 2 groups (postmenopausal women and young adults) using 2 different cortical 
bone micro-architecture evaluation methods (automatic endocortical contour, AUTO; modified 
endocortical contour, MOD). Results suggest that precision errors appear higher for micro-
architectural outcomes requiring higher resolution. For instance, cortical porosity had a CV% 
range between 7 and 16%, while cortical bone mineral density had a CV% range of 1-2%. These 
precision errors, especially those from the AUTO method, appeared to be similar to those 
previously reported
[5]
.  
 Our percent LSCs were also comparable to those previously published
[5]
. For example, 
the percent LSC at the distal radius of postmenopausal women for cortical pore volume was 34% 
(AUTO) and 23% (MOD), while Burghardt et al. reported 33% (combined AUTO & MOD)
[5]
. 
For ease of interpretation, percent LSCs can be used to determine (with 95 % confidence) that 
the observed change is clinically meaningful
[149]
. For example, in postmenopausal women, the 
minimum difference required to measure change in cortical pore volume would be 4.5 mm
3
 
(AUTO) and 6.6 mm
3 
(MOD). This LSC is 2-3 times higher than previously reported (2.2 
mm
3
)
[5]
 likely due to larger pore volumes in our cohort of older postmenopausal women 
(CtPoVPM-Radius[4]: 9.1 mm
3
; CtPoVAUTO: 13.2 mm
3
, CtPoVMOD: 28.9 mm
3
). 
Precision Errors Comparison: AUTO and MOD 
In terms of our secondary objectives, CV% precision errors did not differ between AUTO and 
MOD endocortical contour methods. That is, user-error associated with endocortical contour 
manipulation did not appear to affect repeatability for cortical bone micro-architecture. 
Importantly, this suggests that the endocortical contour line can be manually modified, in both 
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postmenopausal women and young adults, with similar repeatability as the automatically 
generated contour line. 
Precision Errors Comparison: Postmenopausal Women and Young Adults 
Our precision comparison between the group of postmenopausal women and young adults found 
no differences for the AUTO method, except for cortical BMD. Specifically, postmenopausal 
women had slightly higher (0.2%) precision error (i.e., lower repeatability) for distal tibial 
cortical BMD. In contrast, when using MOD, postmenopausal women had lower precision errors 
for cortical porosity (-9%) and cortical pore volume (-8%) at the radius and a 1% higher 
precision error for cortical thickness at the tibia. These results highlight challenges associated 
with automatically separating cortical from trabecular bone
[182]
. Specifically, in postmenopausal 
women, trabecularized cortices with large irregular cortical pores make it difficult to know what 
to include as cortical versus trabecular bone
[4,51]
. Previous research indicates that trabecularized 
cortical remnants are thicker and less organized compared to the trabecular bone network; 
however, the resolution of HR-pQCT is not sufficient enough to capture such subtleties
[51,180]
. 
Though, quantitative assessment of cortical micro-architecture will improve with advancements 
in HR-pQCT technology (e.g., XtremeCT II with 61µm voxel size) and with new techniques to 
optimize image analysis. 
Cortical Outcomes Comparison: AUTO and MOD 
In the group of postmenopausal women all cortical micro-architectural outcomes (except cortical 
thickness at the distal radius) differed between AUTO and MOD. The manually modified 
endocortical contour line at both the distal radius and tibia included a higher amount of bone and 
void (i.e., higher cortical bone volume and total volume), which resulted in a higher percentage 
of cortical pores, greater pore volume and diameter, leading to lower cortical BMD measures. 
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This is logical because with higher total volume more bone and void (pores) are included within 
the cortical envelope. Essentially, the manually modified contouring resulted in larger 
trabecularized cortex when compared to automatic contouring. This issue seems to pertain to 
more porous cortices since there were no differences in cortical bone micro-architecture 
outcomes between AUTO and MOD in young adults.  
By comparing our results to previous findings using Synchrotron Radiation µCT (SR-
µCT), manual modification of the endocortical contour appears to capture cortical properties 
more accurately than the automatic contour method, particularly when analyzing thin cortices 
with large and irregularly shaped cortical pores (as in postmenopausal women). These findings 
are supported by Ostertag and colleagues who reported differences in site-matched cortical 
micro-architecture outcomes from intact cadaveric tibiae between HR-pQCT and SR-µCT
[180]
. A 
comparison of in vivo HR-pQCT results from the distal tibiae of our postmenopausal women to 
those obtained with SR-µCT by Ostertag et al
[180]
 suggests that the modified contour method 
with HR-pQCT images generate outcomes comparable to the data produced by SR-µCT. For 
instance, the average cortical pore diameter obtained from SR-µCT was 0.28 mm
[180]
, which is 
closer to the modified contour method (0.24 mm) than the automatic method (0.20 mm). 
Jorgenson and colleagues recently reported a good agreement between HR-pQCT and SR-µCT 
derived cortical bone micro-architecture (R
2
=0.977-0.983)
[183]
. It is unknown whether these 
results would be similar at the clinically relevant distal radius and this should be addressed in 
future research. However, it is worthwhile noting that while manual contouring may provide 
comparable results relative to higher resolution imaging (i.e., SR-µCT), these benefits may not 
outweigh the time required to obtain them. Therefore, it may be more feasible to use the AUTO 
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method with minor modification to the endocortical contour line where obvious and gross 
contour defects occur. 
 Study strengths pertain to study design and randomly selected study sample. First, repeat 
measurements of participants were obtained on separate days with a minimum of 24 hours 
between scans. This approach minimized precision error underestimation found when precision 
is calculated using scans repeated on the same day or without repositioning
[159]
. Second, we had 
sufficient number of participants in both groups to attain a minimum of 27 degrees of freedom 
required to achieve 90% confidence in our precision error estimate
[12,149]
. Third, based on 
femoral neck T-scores, 16% of our postmenopausal women had osteoporosis and 63% had 
osteopenia. These proportions are comparable to the osteoporosis reference standards from North 
America, Europe, Australia and Japan
[161,162]
, thereby making our data generalizable to 
postmenopausal women in these regions. 
 Study limitations pertain to sample size. While our study included a random sample of 
older postmenopausal women, skeletal precision may vary according to disease status (e.g., 
osteoporosis vs osteopenia); this merits further investigation into population-specific precision 
studies. Further, our sample size was based on precision analysis and likely limited in our 
secondary comparisons of small between-method differences observed in young adults.  
 In summary, precision errors of cortical bone micro-architecture from high-resolution 
pQCT ranged from 1-16% did not differ between automatic or manually modified endocortical 
contour methods in postmenopausal women or young adults. Precision results suggest that both 
the automatic and manually modified endocortical contour method provide similar repeatability. 
In postmenopausal women, manual modification of endocortical contours led to generally higher 
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cortical bone properties when compared to the automated method, while no between-method 
differences were observed in young adults. 
 Bone mineral density, geometry and micro-architecture all provide indirect estimates of 
bone strength. However, when assessing fracture risk it would be advantageous to provide 
estimates in terms of force―particularly the force required to create a fracture. While the most 
direct way to determine this fracture force would be to break a bone, it is not ideal. Therefore, 
computer-based fracture simulation programs incorporating bone mineral density, geometry, and 
micro-architecture as well as bone material properties into bone strength estimates would be 
optimal. Finite element models are such programs  
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2.3 Bone Strength Estimates
6
 
2.3.1 Introduction 
Osteoporosis and related fractures are global public health concerns that currently affect 200 
million people worldwide
[95]
 and are a major cause of mortality, morbidity, chronic pain, and 
loss of independence
[96]
. Distal radius fractures are the most common fracture type occurring in 
postmenopausal women in North America and Europe
[33,170-172]
. Importantly, individuals who 
have suffered a distal radius fracture have greater risk of future osteoporotic wrist, hip and spine 
fractures
[117,136,184]
. Information regarding bone‘s ability to resist fracture (i.e., bone strength) and 
the factors underpinning bone strength are important in estimating wrist fracture risk.  
 Fractures occur when the load applied to bone exceeds bone's strength
[185]
. The gold 
standard to determine bone strength is direct mechanical testing to failure
[112,186]
; however, 
because of the destructive nature of this process, it is only done ex vivo. Finite element (FE) 
modeling is an engineering technique that can be applied to simulate mechanical testing in bone 
using inputted geometry, micro-architecture, and tissue material properties from computed 
tomographic (CT) images
[6,112]
. FE modeling has recently been integrated with high resolution 
peripheral quantitative computed tomography (HR-pQCT) to provide estimates of distal radius 
and tibia bone strength, tissue stiffness, as well as tissue-level stresses and strains
[6]
. 
 Currently, there are 3 main types of (linear) FE models available using HR-pQCT: 1) 
homogeneous single-tissue model (STM) which models the distal radius or tibia as being 
comprised of empty voids and bone tissue with the same material stiffness (i.e., elastic modulus, 
E) for both cortical and trabecular bone
[112]
; 2) homogeneous dual-tissue model (DTM) which 
separates cortical and trabecular bone (as well as voids) using different E's for each bone 
                                                 
6
 Manuscript submitted as: Kawalilak CE, Kontulainen SA, Lanovaz JL, Amini MA, Johnston JD (2015). In vivo 
precision of three HR-pQCT-derived finite element models of the distal radius and tibia in postmenopausal women. 
Bone. 
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tissue
[44]
; and 3) a scaled model which links imaged bone mineral density (BMD) with E for each 
voxel via density-modulus E-BMD relationships
[7]
.  
 Validation studies demonstrate close correlations between experimental findings and FE-
derived bone failure load or ultimate stress (STM: R
2
=0.66-0.94; E-BMD: R
2
=0.95)
[7,111,112,116]
 
and stiffness (STM: R
2
=0.97; E-BMD: R
2
=0.98)
[7]
. These promising results offer great potential 
for HR-pQCT-derived FE assessments of wrist fracture risk in populations prone to osteoporotic 
fractures, such as postmenopausal women. While the validity of the STM and E-BMD models 
have been investigated, there is little known about the repeatability (or precision) of all three FE 
models (i.e., STM, DTM, and E-BMD). 
 In order to detect and monitor small changes in bone strength over time and assess 
intervention/treatment effects, high measurement precision is fundamental
[9,12]
. Other than the 
time period between repeat scans
[159]
, factors that may affect precision at distal bone sites 
include: limb and reference line repositioning (quantified as scan common region)
[10,166]
, and the 
degree of movement artifact (scan quality)
[166,187]
. To date, two precision studies report 
reproducibility for the STM of HR-pQCT-derived FE outcomes using cadaveric forearms
[188]
 and 
young adults
[157]
. Cadaveric precision errors, reported as percent coefficient-of-variation (CV%), 
were 2.9% and 2.6% for stiffness and failure load, respectively
[188]
. Short-term in vivo precision 
errors, reported as root-mean-squared coefficient-of-variation (CV%RMS), were 2.0% and 2.5% 
for average von Mises stress at the radius and tibia, respectively
[157]
. Other commonly reported 
variables include apparent modulus, and percent load carried by the cortical and trabecular bone 
(for DTM) (Table 2.6)
[7,30,32,40,44,94,111,112,155,157,166,174,188-192]
; however, precision for these 
outcomes is unknown. Further, it remains unknown whether outcomes of the commonly used FE 
models are comparably repeatable―especially in postmenopausal women. 
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The primary objective of our study was to define and compare in vivo precision errors 
across 3 FE models (STM, DTM, scaled E-BMD) at the distal radius and tibia in postmenopausal 
women. Secondary objective was to determine the associations regarding time between follow-
up scans, scan quality, and common region on precision errors of all outcomes for each of the 3 
FE models.  
2.3.2 Methods 
2.3.2.1 Participants 
Measurements were completed on a sample of 34 postmenopausal women (74±7 years) from the 
Saskatoon cohort of the Canadian Multi-centre Osteoporosis (CaMos) Study
[1]
. Postmenopausal 
status was assessed using a questionnaire
[160]
. Osteoporosis status was based on femoral neck 
(FN) T-scores obtained from the Saskatoon CaMos database
[1,96]
. Participant consent was 
attained prior to the study. This study was approved by the University of Saskatchewan 
Biomedical Research Ethics Board. 
2.3.2.2 HR-pQCT Imaging 
Repeat measurements were performed with an average 1 week (9.9±3.7 days) between baseline 
and follow-up. As per standard protocol, all participants had their non-dominant arm and 
ipsilateral leg immobilized in the manufacturer-provided cast during scanning
[1]
. At the distal 
radius and tibia, a standard 9.02 mm region of interest (110 parallel CT slices) was obtained 
using HR-pQCT (XtremeCT; Scanco Medical AG, Brüttisellen, Switzerland) with an isotropic 
voxel size of 82 µm
[4]
. The scan time was <2.8 minutes and the effective dose was <4 μSv per 
scan
[4]
. 
 
  
Table 2.6. Current literature using HR-pQCT finite element (FE) modeling for uniaxial compression simulations in elderly human; 
illustrating the type of FE model used, elastic modulus (E) used in the model, the reported outcomes, and the sites measured per study. 
Literature listed in chronological order by year. 
Reference 
FE 
Model
a
 
Elastic Modulus (E) Outcomes Reported 
Site 
Measured 
Pistoia et al. Bone 2002; 30(6): 
842-848. 
STM 10 GPa 1. Failure Load (N) 
Cadaver 
Radius 
MacNeil et al. Med Eng and 
Phys 2007; 29: 1096-1105. 
STM 10 GPa 
1. Reaction Load (N) 
2. Strain Energy Density 
3. Average von Mises Stress (MPa) 
Cadaveric 
Radius (Cube 
Sample) 
MacNeil et al. Med Eng and 
Phys 2008; 30: 792-799.
b STM Calculated
c 
1. Elastic Modulus (CV%RMS)
b 
2. Reaction Force (CV%RMS)
b 
3. Average von Mises Stress (CV%RMS)
b
 
4. Strain Energy Density (CV%RMS)
b 
In vivo 
Radius and 
Tibia 
MacNeil et al. Bone 2008; 42: 
1203-1213. 
STM 
 
 
E-BMD 
6829 MPa 
 
Eelement = 15004 x (ρ/1200 
mg HA/cm
3
)
1.7
 
1. Apparent Bone Strength (Ultimate 
Stress) (GPa) 
In vivo 
Radius 
Boutroy et al. JBMR 2008; 
23(3): 392-399. 
DTM 
Cortical: 20 GPa 
Trabecular: 17.5 GPa 
1. Stiffness (kN/mm) 
2. % Load Carried by Each Tissue
d
 
3. Average von Mises Stress for Each 
Tissue
d
 (MPa) 
Iv vivo 
Radius and 
Tibia 
Mueller et al. Bone 2009; 44: 
364-371. 
STM 10 GPa 
1. Strength (N) 
2. Stiffness (N/mm) 
Cadaveric 
Radius 
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Dalzell et al. Osteoporos Int 
2009; 20: 1683-1694. 
STM 10 GPa 
1. Stiffness (N/mm) 
2. Failure Load (N) 
In vivo 
Radius and 
Tibia 
Varga et al. J Biomech 2009; 
42: 1726-1731. 
DTM 
Cortical: 16.5 GPa 
Trabecular: 2974.0 MPa 
1. Failure Load (N) 
2. Stiffness (N/mm) 
Cadaveric 
Radius 
Burghardt et al. JBMR 2010; 
25(12): 2558-2571. 
DTM 
Cortical: 10 GPa 
Trabecular: 10 GPa 
1. Stiffness (N/mm) 
2. Apparent Modulus (N/mm
2
) 
3. Failure Load (N) 
4. % Load Carried by Cortex
 
In vivo  
Radius and 
Tibia 
Vilayphiou et al. Bone 2010; 
46: 1030-1037. 
DTM 
Cortical: 20 GPa 
Trabecular: 17 GPa 
1. Failure Load (N) 
2. Stiffness (kN/mm) 
3. % Load Carried by Each Tissue
d
 
4. Average von Mises stress for Each 
Tissue
d
 (MPa) 
In vivo 
Radius and 
Tibia 
Varga et al. Bone. 2010; 47: 
982-988. 
STM 15 GPa 
1. Stiffness (kN.mm) 
2. Failure Load (kN) 
Cadavers 
Radius 
Vilayphiou et al. JBMR 2011; 
26(5): 965-973. 
DTM 
Cortical: 20 GPa 
Trabecular: 17 GPa 
1. Failure Load (N) 
2. Stiffness (kN/mm) 
3. % Load Carried by Each Tissue
d
 
4. Average von Mises stress for Each 
Tissue
d
 (MPa) 
In vivo  
Radius and 
Tibia 
Macdonald et al. JBMR 2011; 
26(1): 50-62. 
STM 6829 MPa 
1. Stiffness (N/mm) 
2. Apparent Bone Strength (Ultimate 
Stress) (MPa) 
3. Failure Load (N) 
4. % Elastic Strain Energy Carried by 
Each Tissue
d
 
In vivo 
Radius and 
Tibia 
7
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Varga et al. Biomech Model 
Mecahnobiol 2011; 10: 431-
444. 
DTM 
Cortical: 15 GPa 
Trabecular: 15 GPa 
1. Stiffness (kN/mm) 
2. Failure Load (kN) 
3. Apparent Modulus (kN/mm
2
) 
4. % Load Carried by Each Tissue
d
 
Cadaver 
Radius 
Rizzoli et al. Osteoporos Int 
2012; 23: 305-315. 
DTM 
 
 
E-BMD 
Cortical: 20 GPa 
Trabecular: 17 GPa 
 
Eelement = 15004 x (ρ/900 
mg HA/cm
3
)
1.1
 
1. Failure Load (N) 
2. Stiffness (kN/mm)  
3. Average von Mises stress for Each 
Tissue
d
 (MPa) 
In vivo 
Radius and 
Tibia 
Nishiyama et al. Osteoprosis 
Int 2012; 24(5): 1733-1740 
STM 6829 MPa 
1. Apparent Bone Strength (Ultimate 
Stress) (MPa) 
2. % Load Carried by Each Tissue
d
 
In vivo 
Radius and 
Tibia 
Ellouz et al. Bone 2014; 63: 
147-157 
DTM 
Cortical: 20 GPa 
Trabecular: 17 GPa 
1. Stiffness (kN/mm) 
2. Average von Mises stress (MPa) for 
Each Tissue
d 
3. % Load Carried by Each Tissue
d 
In vivo 
Radius and 
Tibia 
a
 STM = Single Tissue Model; DTM = Dual Tissue Model; E-BMD = Scaled model based on bone mineral density 
b
 Results of this study only report long-term and short-term precision errors (CV%), but outcome values not reported. 
c
 Elastic modulus (E) was calculated in this study based on the reaction force required to induce 1% strain over the average area of the slices within the section. 
d
 “Each tissue” refers separately to the cortical and trabecular tissues. 
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2.3.2.3 HR-pQCT Image Analysis 
All images were graded for quality according to the manufacturer's 5 point scale
[1,164]
. Five 
radius and 2 tibia images with a quality of 4 or 5 were excluded from the study. In total, 27 radii 
and 32 tibiae were included in this current investigation.  
 Image analysis was completed according to the manufacturer‘s standard evaluation and 
dual-threshold evaluation protocols (Scanco Module 64-bit IPL V5.08b). Briefly, standard image 
evaluation was used to define the periosteal surface of the radius and tibia using a semi-
automatic edge-finding algorithm in a slice-by-slice manner, as described elsewhere
[1,4]
. 
Modification of the periosteal contour line was done when it deviated from the outer bone 
surface. Once the standard evaluation was completed, the dual-threshold method was performed 
to separately define the cortical and trabecular bone tissues at both skeletal sites
[5]
. For the dual-
threshold technique, the periosteal contour was imported from the standard evaluation image 
files and the endocortical contour was automatically created using a series of morphological 
operations (i.e., dilation and erosion) to separate the trabecular and cortical regions
[5]
. 
Modification of the endocortical contour line was done when it deviated from the endocortical 
surface, as previously described
[2]
. To separate bone from all other voxels (i.e., void, marrow, 
etc.), a set global threshold (400 mg HA/cm
3
) was applied automatically by the software during 
image processing. 
2.3.2.4 Finite Element (FE) Modeling 
All 3 FE models (STM, DTM, E-BMD) had linear-elastic, isotropic material properties. They 
were generated and solved using the Image Processing Language (IPL; version 1.15) software 
provided by Scanco Medical. FE models were created by converting every voxel in the scanned 
volume of interest (VOI) into brick elements
[6,193]
. Image voxels in the VOI were converted to 
~2.6 million brick elements at the radius and ~4.1 million brick elements at the tibia. Boundary 
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conditions were set to simulate a "high-friction" axial compression test applied to the distal 
surface of the bone VOI at 1% strain, with the proximal bone surface suppressed in all direction. 
High friction corresponds to the suppression of displacement in all directions at the proximal 
region of the bone, while displacement is suppressed in the x and y directions (but not z 
direction) at the distal region of the bone―where the bone is loaded in axial compression. 
2.3.2.4.1 Single Tissue Model (STM) 
The STM is a discrete homogeneous model where all the bone voxels are assigned to one tissue 
and given a user-defined E, in this case the standard E=10 GPa with Poisson‘s ratio = 0.3[6,112]. 
The segmented image file created from the standard outcome evaluation procedure (_SEG.AIM) 
was imported into the model. Segmentation, with manual contour correction, took ~30 minutes 
per radius or tibia. The STM solved in ~3 hours per radius scan and ~5 hours per tibia scan. 
2.3.2.4.2 Dual Tissue Model (DTM) 
The DTM is a discrete model with cortical and trabecular bone assigned their own tissues and 
given a user-defined E-value of 20 GPa (cortical tissue) and 17 GPa (trabecular tissue)
[44,189]
; 
Poisson's ratio was set to 0.3
[6]
. To identify cortical and trabecular bone tissue, the segmented 
image from the dual-threshold evaluation procedure were imported into the model 
(_COMBI.AIM). Segmentation, with manual contour correction, took <3 hours per radius image 
and <5 hour per tibia. The DTM solved in ~3 hours per radius scan and ~5 hours per tibia scan. 
2.3.2.4.3 Density-Based (E-BMD) Model 
The density-based E-BMD model is a scaled model where each element within the model was 
assigned E values based on the relative gray-value density of that element, as defined within the 
image
[7,194]
. Assigned E were based on the image-derived density (ρ) using a density-modulus 
equation (2.5) proposed by MacNeil and Boyd
[7]
: 
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𝐸 = 15,004  
ρ
1200
 
1.7
                                                                                                                 (2.5) 
With this equation, individual E are scaled in relation to fully mineralized bone (ρ=1200 mg 
HA/cm
3
) and the 15,004 and 1.7 terms have been derived from experimental testing
[7]. Poisson‘s 
ratio was set to 0.3
[6]
. The unsegmented image file (.AIM) was imported into the model and a 
global threshold (400 mg HA/cm
3
) was applied to remove the majority of the surrounding soft 
tissue. The scaled E-BMD model solved in ~5 hours per radius scan and ~10 hours per tibia scan. 
 The four primary outcomes for each model included: bone stiffness (kN/mm), calculated 
as the average reaction force divided by the applied displacement (0.0902 mm, corresponding to 
1% strain with a 9.02 mm thick region); apparent modulus (MPa), calculated as reaction force 
divided by estimated cross-sectional area and a fixed known strain (1%); average von Mises 
stress (MPa); and failure load (kN), defined using the criterion developed by Pistoia et al
[112]
 
where fracture was assumed to occur when 2% of the bone tissue exceeded a critical (von Mises) 
strain limit of 7000 µɛ. Of note, a critical strain limit of 3500 µɛ was used with the DTM because 
E for cortical bone (E=20 GPa) was twice that used with the STM (E=10 GPa)
[44]
. We chose 
these 4 primary outcomes because they are the most commonly reported in the literature (Table 
1) and common to all 3 FE models. Secondary outcomes included: the proportion of von Mises 
stress and the percentage of the ultimate failure load carried by the cortex and trabecular bone 
tissues (DTM only). 
2.3.2.5 Statistical Analysis 
We assessed the precision error of each outcome for all FE models by calculating root-mean-
squared coefficients of variation (CV%) (equation 2.6)
[1,12]
. 
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𝐶𝑉%𝑅𝑀𝑆 =     
 
𝑆𝐷 𝑗
𝑥 𝑗
 𝑥  100% 
2
𝑚
 𝑚𝑗=1                                                                                           (2.6) 
where SDj was the standard deviation between the two measurements, xj was the mean of the two 
measurements, and m was the number of participants in the analysis
[12]
. 
 We compared individual CV% across the three FE models using multivariate analysis of 
variance (MANOVA) followed by pairwise comparison. MANOVA models were adjusted for 
multiple comparisons using Bonferroni correction. We performed Spearman correlation (ρ) to 
determine the associations regarding time between follow-up scans, scan quality, and common 
region on precision errors of all outcomes for each of the 3 FE models for the radius and tibia. 
Significance was set to P<0.05. All statistical analyses were performed using IBM SPSS 
commercial statistics software (PASW, Version 23 for Windows, SPSS Inc., Chicago, IL, USA). 
2.3.3. Results 
For each of the 3 FE models, mean (±SD) for outcome variables and CV% precision are 
summarized in Table 2.7 for the distal radius and in Table 2.8 for the distal tibia. For the primary 
outcomes at the distal radius, CV% precision for all models were <10% (Range STM: 2.8-5.3%; 
DTM: 3.0-5.4%; E-BMD: 2.6-8.7%). Generally, the lowest precision errors at the distal radius 
were noted for the STM, followed by the DTM, and then the E-BMD model (Table 2.7, Figure 
2.4). At the distal tibia, the precision error for the primary outcomes was <5% (Range STM: 2.9-
4.8%; DTM: 3.0-3.8%; E-BMD: 1.6-2.1%). The lowest precision errors for the primary 
outcomes at the distal tibia were for the E-BMD model, followed by the DTM, and then the STM 
(Table 2.8, Figure 2.5).  
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 At the radius, precision for the main outcomes across all 3 FE models were different from 
one another (F=3.824, P<0.001). Apparent modulus differed between E-BMD model and STM 
(mean CV% difference(E-BMD – STM): 3.4%, P=0.010), as well as between E-BMD and DTM 
(mean CV% difference(E-BMD – DTM): 3.3%, P=0.013) (Figure 2.4, Table 2.7). Compared to STM 
and DTM, the scaled E-BMD model had significantly higher precision error for average von 
Mises stress (mean CV% difference(E-BMD – DTM/STM): 3.3%, P<0.001) (Figure 2.4, Table 2.7). At 
the distal tibia, the precision for the main outcomes across all 3 FE models were not different 
from one another (F=1.511, P=0.156) (Figure 2.5, Table 2.8).  
 There were no associations regarding the time between follow-up scans and precision of 
main FE outcomes for any of the models at the radius and tibia (P>0.05). Similarly, there were 
no associations between scan quality and precision of main FE outcomes for any of the models at 
the radius and tibia (P>0.05). The only associations were for the E-BMD model between the 
common scan region and the precision of von Mises stress (ρ=0.603; P=0.001), apparent 
modulus (ρ=-0.553; P=0.003), and stiffness (ρ=-0.422; P=0.028) at the distal radius.  
  
Table 2.7. Mean (±SD) of the baseline and follow-up scans, mean (±SD) of both measurements, root-mean-square precision error 
(CV%RMS) for stiffness, apparent stiffness, average von Mises stress, and failure load from 3 different FE models at the distal radius in 
postmenopausal women. 
Radius (n=27) 
First 
Scan  ± SD 
Second 
Scan  ± SD Mean  ± SD CV%RMS 
Single Tissue Model (STM) 
       Stiffness (kN/mm) 57.2 ± 11.7 56.1 ± 11.7 56.6 ± 11.7 3.4 
Apparent Modulus (MPa) 1296.3 ± 340.2 1257.1 ± 307.7 1276.7 ± 320.6 5.3 
Average von Mises Stress (MPa) 5803.5 ± 609.2 5695.5 ± 585.3 5749.5 ± 578.7 3.8 
Failure Load (kN) 2.835 ± 0.543 2.784 ± 0.547 2.809 ± 0.543 2.8 
         Dual Tissue Model (DTM) 
 
      
 
Stiffness (kN/mm) 106.8 ± 22.3 105.2 ± 22.3 106.0 ± 22.2 3.3 
Apparent Modulus (MPa) 2428.5 ± 652.3 2355.2 ± 583.90 2391.9 ± 611.6 5.4 
Average von Mises Stress (MPa) 108.1 ± 12.2 106.2 ± 11.5 107.2 ± 11.5 3.8 
Failure Load (kN) 2.790 ± 0.544 2.752 ± 0.542 2.770 ± 0.540 3.0 
         
Cortical Bone 
        Average von Mises Stress (MPa) 153.5 ± 7.9 152.2 ± 7.4 152.8 ± 7.5 1.5 
% Minimum Load Carried (%) 48.3 ± 8.4 48.4 ± 7.7 48.3 ± 7.8 6.1 
% Maximum Load Carried (%) 77.6 ± 9.0 77.8 ± 8.9 77.7 ± 8.8 2.2 
         
Trabecular Bone 
 
       Average von Mises Stress (MPa) 76.6 ± 12.1 74.4 ± 11.9 75.5 ± 11.4 6.7 
% Minimum Load Carried (%) 51.8 ± 8.4 51.6 ± 7.7 51.7 ± 7.8 7.1 
% Maximum Load Carried (%) 22.4 ± 9.0 22.2 ± 8.9 22.3 ± 8.8 9.5 
 
 
       Scaled E-BMD Model  
       Stiffness (kN/mm) 41.1 ± 12.6 40.6 ± 12.0 40.8 ± 12.2 4.4 
Apparent Modulus (MPa) 595.2 ± 215.1 583.7 ± 184.1 589.4 ± 196.0 8.7 
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Average von Mises Stress (MPa) 13.2 ± 4.0 13.0 ± 3.4 13.1 ± 3.6 7.1 
Failure Load (kN) 2.99 ± 0.44 3.00 ± 0.47 2.99 ± 0.45 2.6 
 
 
Table 2.8. Mean (±SD) of the baseline and follow-up scans, mean (±SD) of both measurements, root-mean-square precision error 
(CV%RMS) for stiffness, apparent stiffness, average von Mises stress, and failure load from 3 different FE models at the distal tibia in 
postmenopausal women. 
Tibia (n=32) 
First 
Scan  ± SD 
Second 
Scan  ± SD Mean  ± SD CV%RMS 
Single Tissue Model (STM) 
       Stiffness (kN/mm) 172.7 ± 33.7 173.1 ± 34.1 172.9 ± 33.7 3.7 
Apparent Modulus (MPa) 1896.8 ± 375.2 1908.3 ± 374.3 1902.5 ± 372.0 4.0 
Average von Mises Stress (MPa) 6659.4 ± 578.2 6680.9 ± 543.1 6670.1 ± 513.6 4.8 
Failure Load (kN) 8.234 ± 1.524 8.248 ± 1.540 8.241 ± 1.525 2.9 
         Dual Tissue Model (DTM) 
 
      
 
Stiffness (kN/mm) 316.1 ± 60.9 317.2 ± 61.8 316.6 ± 61.0 3.4 
Apparent Modulus (MPa) 3477.5 ± 685.3 3500.6 ± 685.3 3489.1 ± 680.7 3.8 
Average von Mises Stress (MPa) 120.6 ± 10.2 120.9 ± 9.4 120.7 ± 9.3 3.8 
Failure Load (kN) 8.232 ± 1.540 8.244 ± 1.554 8.240 ± 1.540 3.0 
         
Cortical Bone 
        Average von Mises Stress (MPa) 166.4 ± 5.4 166.6 ± 5.6 166.5 ± 5.5 0.8 
% Minimum Load Carried (%) 41.5 ± 9.1 41.9 ± 9.7 41.7 ± 9.4 3.5 
% Maximum Load Carried (%) 61.6 ± 9.9 61.8 ± 10.2 61.7 ± 10.0 2.1 
         
Trabecular Bone 
 
       Average von Mises Stress (MPa) 97.9 ± 11.6 97.8 ± 11.4 97.9 ± 10.8 5.9 
7
9
 
  
% Minimum Load Carried (%) 58.5 ± 9.1 58.2 ± 9.7 58.3 ± 9.4 2.6 
% Maximum Load Carried (%) 38.4 ± 9.9 38.2 ± 10.2 38.3 ± 10.0 3.5 
 
 
       Scaled E-BMD Model 
 
       Stiffness (kN/mm) 118.7 ± 27.8 118.7 ± 27.5 118.8 ± 27.6 2.1 
Apparent Modulus (MPa) 910.6 ± 223.7 912.8 ± 224.9 911.7 ± 224.0 1.8 
Average von Mises Stress (MPa) 16.7 ± 3.3 16.8 ± 3.2 16.7 ± 3.2 2.0 
Failure Load (kN) 7.82 ± 1.37 7.81 ± 1.34 7.81 ± 1.35 1.6 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4. Comparison of root-mean-square precision 
errors (CV%) for tissue stiffness, apparent modulus, 
average von Mises stress, and failure load in 
postmenopausal women at the distal radius. * Significant at 
P<0.05. 
 
Figure 2.5. Comparison of root-mean-square precision 
errors (CV%) for tissue stiffness, apparent modulus, 
average von Mises stress, and failure load in 
postmenopausal women at the distal tibia. 
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2.3.4. Discussion 
The primary objective of our study was to define and compare in vivo precision errors for 3 FE 
models (2 homogeneous and 1 scaled) using postmenopausal women. Precision error was 
significantly higher for apparent modulus and average von Mises stress using the scaled E-BMD 
model at the distal radius. At the distal tibia, however, all models had comparable outcomes. 
Reported in vivo precision errors at the radius for STM and DTM, but not E-BMD, were 
comparable to those reported in cadaveric forearms (CV%: Failure Load: 2.6%; Stiffness: 
2.9%)
[188]
 as well as previous in vivo precision at the radius (CV%RMS: Average von Mises stress: 
2.0%)
[157]
. Our in vivo precision error at the tibia for average von Mises stress using E-BMD, but 
not STM or DTM, was more comparable to those previously reported (CV%RMS: 2.5%)
[157]
. 
 The secondary objective of our study was to determine the associations regarding time 
between follow-up scans, scan quality, and common region on precision errors of all outcomes 
for each of the 3 FE models. Results indicated that the noted differences in precision errors at the 
radius were strongly associated with the common scan region. It is likely that this relationship 
was not found at the tibia because the common region was higher at this site. The common 
region for the distal radius was 93% (range: 81-99%) with an average absolute slice shift of 7.0 
(SD 4.8) between successive scans, whereas at the distal tibia, the common region was 97% 
(range: 88-99%) with an absolute average slice shift of 2.9 (2.6)
[1]
. Previous research has 
suggested that even small rotation angles can lead to considerable variance in the scan region
[166]
. 
While the use of the CSA registration within the HR-pQCT software aids in the correction of 
axial misplacement between baseline and follow-up scans, it does not account for possible 3D 
misalignments in the limb within the cast
[166]
. The arm cast allows for the possibility of more 
rotation at the wrist, while it is easier to consistently place the leg within the leg cast. The 
compounded effect of reference line inconsistencies between successive scans also affects the 
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common region. This illustrates the importance of repositioning (both the limb in the cast and the 
reference line).  
 Superficially, the STM has the shortest total analysis time (i.e., image segmentation and 
FE analysis) per scan for both the radius (3.5 hours) and tibia (5.5 hours). The DTM and the E-
BMD model, however, have approximately equal per scan analysis times at both sites (radius: 5 
hours; tibia: 9-10 hours); though, the E-BMD model does not require invested manual time in the 
segmentation part of the analysis because it uses the unsegmented files—effectively resulting in 
overall time and cost savings. 
 Our study design and study cohort had strengths that warrant consideration. First, repeat 
measurements were separated by an average of 1 week—an important condition because 
underestimation of precision error has been reported when precision is calculated using scans 
repeated on the same day
[159]
. Second, our study contained enough repeat scans which provides 
the recommended 27 degrees of freedom necessary to establish reliable precision errors with an 
upper 90% confidence limit
[12,149]
. Third, the reported bone health status of our sample of 
postmenopausal women was comparable to their peers in North America, Europe, Australia and 
Japan
[1,161,162]
, thereby suggesting our data to be generalizable to postmenopausal women in these 
regions. 
 Limitations associated with this study pertain to our study sample and sample size. First, 
although we studied older postmenopausal women, skeletal precision may vary according to 
duration of menopause, time from menopause, and disease status—this merits further 
investigation into population-specific precision studies. Second, our sample size, while sufficient 
to obtain the required degrees of freedom for accurate precision error estimates, limited assessing 
the possible role of osteoporosis status in the comparisons. 
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 In summary, the STM and DTM models appeared more precise for modeling the distal 
radius whereas all methods provided comparable precision for modeling the distal tibia. Results 
suggest that the E-BMD model could be used when the common region between follow-up scans 
is high (>93%), while STM or DTM should be considered when the common region is lower 
(<93%). 
 The precision of bone strength estimates has been defined using bone density, geometry, 
and micro-architecture indirectly through the use of the standard HR-pQCT evaluation 
(trabecular bone) and the dual-threshold technique (cortical bone), as well as through the 
application of FE modeling. Now the question become, ―how can clinicians and researchers 
apply this precision information?‖ While the answer may seem simple—precision information 
will assist when planning to monitor or when interpreting change within these outcomes—there 
still remains the methodological question of how? 
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3 STUDY 2: MONITORING SKELETAL CHANGES 
SYNOPSIS: How do researchers and clinicians know whether actual skeletal 
change has occurred for their patients'? Is meaningful change merely having 
statistically significant differences between follow-up measures? What is the 
time interval required to guarantee change can be captured without 
unnecessary testing to the patient? The aim of this study is to define the least 
significant change (LSC) and the monitoring time interval (MTI)—tools that 
will facilitate the answering of these questions. 
3.1 LSC and MTI for HR-pQCT
7
 
3.1.1 Introduction 
The advent of high-resolution peripheral quantitative computed tomography (HR-pQCT) has 
enabled the measurement of 3D micro-architectural properties at the distal tibia and fracture-
prone distal radius. Importantly, fragility fractures at the distal radius are a sentinel for future 
fragility fractures at other sites
[117,118]
. Further, because the tibia is a weight-bearing skeletal site, 
it may reflect bone strength at other weight-bearing sites, such as the hip and vertebrae
[41]
. As 
such, HR-pQCT is an important tool for advancing our understanding of osteoporosis-related 
bone deterioration and for providing new targets for investigations and strategies aiming to 
optimize osteoporotic fracture prevention. 
Measuring and monitoring minute skeletal changes over time using any imaging modality 
requires a high degree of measurement precision or repeatability (i.e., low precision error) to 
ensure measurement sensitivity to capture changes and treatment effects
[12]
. There are several 
                                                 
7
 Published as: Kawalilak CE, Johnston JD, Olszynski WP, Kontulainen SA (2015). Least significant changes and 
monitoring time intervals for high-resolution pQCT-derived bone outcomes in postmenopausal women. Journal of 
Musculoskeletal and Neuronal Interactions, 15(2):190-196. 
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reports of HR-pQCT short-term precision in young adults
[1,29,157]
, postmenopausal women
[1,195]
, 
and mixed age cohort
[13]
 (Table 3.1). Two studies reported long-term precision in young adults 
and postmenopausal women
[46,157]
 (Table 3.1). The International Society for Clinical 
Densitometry (ISCD) recommends estimating the least significant change (LSC) to determine if 
true skeletal change has occurred
[149]
. LSC is estimated based upon measurement error 
(estimated via root-mean-squared coefficient of variation (CV%RMS) precision errors) and an 
adjusting Z-score derived from the selected level of statistical confidence (typically two-tailed 
95% confidence, with a Z-score of 1.96 used in the equation LSC = 2.77 x CV% RMS). LSC 
essentially serves as a quantitative metric for ensuring (with a certain level of statistical 
confidence) that observed differences or changes are sufficiently larger than precision errors 
associated with a technique. Currently, the only available LSC data for HR-pQCT reports 
estimated LSC values which ranged from 1-40% for bone micro-architectural outcomes at the 
distal radius and tibia
[46]
. These estimates, however, need to be interpreted with caution as the 
LSCs were calculated using long-term precision estimates from postmenopausal women with 
and without fractures and osteoporosis medication
[12,150]
. Long-term precision estimates 
determined using follow-up data 1 year from baseline incorporate both precision error and non-
linear skeletal changes, thereby obfuscating the measurement's actual precision
[12]
. Further, 
measurement precision should be applicable to the group being studied, such as postmenopausal 
women without fracture history
[12]
.  
To facilitate the design of therapeutic interventions and longitudinal follow-up studies in 
postmenopausal women
[94,196,197]
, information of the LSC, together with the information of 
median annual changes, can be used to estimate a monitoring time interval (MTI) between HR-
pQCT measurement occasions
[9,149]
. MTIs provide a time estimate (in years) to reliably measure 
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bone change
[9,10,151]
, thereby allowing follow-up measures to be performed within the optimal 
window for capturing true skeletal change, as well as minimizing patient radiation exposure and 
costs associated with repeated scanning in prospective studies. To our knowledge, there have 
been no reported MTIs for bone parameters using HR-pQCT in postmenopausal women. 
The first objective of our study was to define the LSC using short-term precision data in 
postmenopausal women. Our second objective was to define MTIs for HR-pQCT derived bone 
area, density, and micro-architecture in postmenopausal women. 
 
  
Table 3.1. Literature reporting in vivo precision using high-resolution peripheral quantitative computed tomography (HR-pQCT), with 
breakdown of precision dependent components including: type of precision, participant number and degrees of freedom, age, follow-
up criteria, method used in determining precision error, and reported precision results. 
Reference 
In vivo Precision 
Type of 
Precision 
Participant Number  
(Degrees of Freedom)
† 
Age 
(years) 
Follow-up 
Criteria 
Method of 
Determining 
Precision 
Error Precision Results 
Boutroy et al 
(2005).
[29] 
Short-term 
Precision 
15 F Radii and Tibiae 
(30) 
21-47 
3 Scans within 
1 month
§ 
Gluer et al 
(1995)
[12]
: 
CV%RMS 
Radius: 
Densities: 0.9-1.5% 
Micro-architecture: 
0.9-4.4% 
Tibia: 
Densities: 0.9-1.5% 
Micro-architecture: 
0.9-4.4% 
Kazakia et al 
(2008).
[13] 
Short-term 
Precision 
8 Radii
‡
 (16)
 
7 Tibiae
‡
 (14) 
25-65 
29-73 
3 Scans
§ Not Specified: 
CV% 
BV/TV: 1.2% 
Micro-architecture: 1.0-5.8% 
MacNeil & 
Boyd 
(2008).
[157] 
Short-term 
Precision 
14 M (14) 
15 F (15) 
20-37 
20-40 
2 Scans within 
1 week 
Not Specified: 
CV%RMS 
M -Radius: 
Densities:0.3-0.7% 
Micro-architecture: 
0.6-4.4% 
 
F - Radius: 
Densities: 0.4-0.5% 
Micro-architecture: 
0.5-3.4% 
M - Tibia: 
Densities: 0.2-0.5% 
Micro-architecture: 
0.5-3.6% 
 
F - Tibia: 
Densities: 0.6-1.0% 
Micro-architecture: 
0.8-4.0% 
Kawalilak et al 
(2013).
Study 1 
Short-term 
Precision 
Young Adult: 
28 F Radii (28) 
32 F Tibiae (32) 
 
Postmenopausal 
Women: 
29 M and F Radii (29) 
30 M and F Tibiae (30) 
19-48 
19-48 
 
 
 
62-88 
62-88 
2 Scans on 2 
separate days 
within 24 
hours 
 
 
2 Scans within 
1 week 
Gluer et al 
(1995)
[12]
: 
CV%RMS 
Young Adult Radius: 
Area: 0.6-3.1% 
Densities: 0.8-1.6% 
Micro-architecture: 
0.9-8.0% 
 
Postmenopausal 
Radius: 
Area: 0.4-2.9% 
Young Adult Tibia: 
Area: 0.2-0.9% 
Densities: 0.4-1.4% 
Micro-architecture: 
0.9-5.0% 
 
Postmenopausal 
Tibia: 
Area: 0.1-1.1% 
8
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Densities: 1.1-2.1% 
Micro-architecture: 
1.2-6.5% 
Densities: 0.3-1.9% 
Micro-architecture: 
1.3-6.8% 
Wong et al 
(2014) 
(Part I).
[195] 
 
Short-term 
Precision 
31 M and F  
Radii and Tibiae (31) 
20-69 
2 Scans 
repeated within 
same day 
Gluer et al 
(1995)
[12]
: 
CV%RMS 
Radius: 
Densities: 0.5-0.7% 
Micro-architecture: 
0.7-4.8% 
Tibia: 
Densities: 0.2-0.4% 
Micro-architecture: 
0.4-4.1% 
MacNeil & 
Boyd 
(2008).
[157]
 
Long-term 
Precision 
14 M (14) 
15 F (15) 
20-37 
20-40 
2 Scans within 
4 months 
Langton & Njeh 
(2004)
[150]
: 
SEE 
M -Radius: 
Densities:0.3-0.7% 
Micro-architecture: 
0.6-3.9% 
F - Radius: 
Densities: 0.3-0.5% 
Micro-architecture: 
0.5-3.2% 
M - Tibia: 
Densities: 0.3-0.5% 
Micro-architecture: 
0.4-3.4% 
F - Tibia: 
Densities: 0.5-1.0% 
Micro-architecture: 
0.8-3.8% 
Wong et al 
(2014) 
(Part II).
[46] 
 
Long-term 
Precision 
All Participants: 
38 F Radii (38) 
38 F Tibiae (38) 
 
 
Non-fracture, Non-
medicated: 
13 F Radii (13) 
13 F Tibiae (13) 
61-89 
 
 
 
 
63-81 
2 Scans 
repeated within 
1 year 
Gluer et al 
(1995)
[12]
: 
SEE 
All Participants 
Radius: 
Densities: 1.9-2.5% 
Micro-architecture: 
2.6-6.2% 
 
Non-fracture, Non-
medicated Radius: 
Densities: 1.7-2.5% 
Micro-architecture: 
1.7-6.8% 
All Participants 
Tibia: 
Densities: 1.1-1.9% 
Micro-architecture: 
2.0-7.7% 
 
Non-fracture, Non-
medicated Tibia: 
Densities: 0.7-0.9% 
Micro-architecture: 
1.0-8.1% 
Abbreviations: M = Male; F = Female; CV%RMS = Root-mean-squared percent coefficient of variation; SEE = Standard Error of the Estimates 
 
† Degrees of Freedom = m∙(n-1) where m=number of subjects, n = repeat measures; equation from Gluer et al. (1995)
[12]
 
§
 Time between scans not specified 
‡
 Sex not specified 
 
8
8
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3.1.2 Methods 
3.1.2.1 Participants 
In 2011, 104 community-dwelling postmenopausal women (mean age ± standard deviation: 75±8 
years), who were a part of the Saskatoon cohort of the Canadian Multi-centre Osteoporosis 
(CaMos) Study, enrolled to receive HR-pQCT measurements. Approximately 1 year later 
(410±54 days; 2012-2013), fifty-one women (78±7 years) returned for follow-up HR-pQCT 
measurements. There were no differences in osteoporosis status or HR-pQCT outcomes at 
baseline between the women who returned and those who did not return for follow-up measures 
(Appendix A). We excluded 18 women who were using hormone replacement therapy or 
bisphosphonates. Thirty-three women (77±7 years) were included in this study. Postmenopausal 
status was determined by a questionnaire and defined as not menstruating for at least 12 
months
[160]
. Osteoporosis status was based on DXA-derived femoral neck (FN) T-scores 
obtained from the Saskatoon CaMos database (Table 3.2)
[96]
. Of the participants not using bone 
altering medication, 33% had normal FN T-Scores, 52% were osteopenic, and 15% had 
osteoporosis (Table 3.2). Participant consent was obtained prior to the study. This study was 
approved by the University of Saskatchewan Biomedical Research Ethics Board. 
Table 3.2. Participant demographics including the number (n) and proportion (%) of participants 
with osteopenia or osteoporosis at the baseline. 
 
 
 
 
 
 
(n = 33) Minimum Maximum Mean ± SD 
Age (years) 62 88 77 ±  7 
Height (cm) 147.9 177.6 160.3 ±  5.9 
Weight(kg) 54.5 101.5 73.5 ±  12.8 
DXA Measures   
  FN aBMD (g/cm
2
) 0.4 1.1 0.7 ±  0.1 
FN T-score -3.5 2.0 -1.2 ±  1.1 
Osteoporosis Status       n (%)  
  Normal 11 (33%)  
 Osteopenia 16 (49%)  
 Osteoporosis   6 (18%)  
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3.1.2.2 HR-pQCT Imaging 
The non-dominant arm and ipsilateral leg of all participants were immobilized in the standard 
carbon fiber cast prior to imaging, as per the manufacturer‘s standard in vivo protocol. A scout 
view scan was used to set the reference line and define the volume of interest for each scan, 
further defined elsewhere
[1]
. Using HR-pQCT (XtremeCT; Scanco Medical AG, Brüttisellen, 
Switzerland) we obtained a 9.02 mm region of interest (110 parallel CT slices) located 9.5 mm 
(radius) and 22.5 mm (tibia) proximal to the reference line. Using the standard in vivo imaging 
protocol, an isotropic voxel size of 82 μm was used to collect our data. The effective dose was 
<4 μSv[1]. Measurement time was approximately 2.8 minutes for each scan[1].  
3.1.2.3 HR-pQCT Image Analysis 
One operator (CK) scanned, graded, and analyzed all images. Based on the 5 point image 
grading scale, all images with a quality of 4 and 5 were deemed unacceptable and removed from 
the study without further analysis
[163,164]
. We included scans of grade quality 1-3. 
Image analysis was completed according to the manufacturer‘s standard in vivo 
evaluation protocol, described in detail elsewhere
[1]
. Briefly, we outlined the periosteal surface of 
the bone of interest (i.e., radius or tibia) to separate the bone from the surrounding soft tissue. A 
semi-automatic edge-finding algorithm was used to detect the periosteal bone surface and 
facilitated the contour iteration process from the first slice through the subsequent 109 slices in a 
slice-by-slice manner. For every slice the contour line was examined and adjustments were 
manually made to correct the line when it strayed from the periosteal surface of the bone. We 
analyzed standard HR-pQCT outcome variables
[1]
. Bone area outcomes were: cortical and 
trabecular area. Bone density outcomes were: total, cortical, and trabecular bone densities 
(including: meta and inner densities). Bone micro-architecture outcomes were: cortical thickness 
(CtTh), bone volume fraction (BV/TV), trabecular number (TbN), trabecular thickness (TbTh), 
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trabecular separation (TbSp), and trabecular heterogeneity (TbSpSD). The methods to define 
these outcome variables are described elsewhere
[14,25,167,168,198]
. 
3.1.2.4 Statistical Analysis 
We determined the LSC, median annual percent change, and MTI. As the LSC calculation 
requires CV%RMS, short-term CV%RMS precision errors were first obtained from repeated 
measures of the 32 postmenopausal women, reported earlier
[1]
. This sample size provided 32 
degrees of freedom (DOF), which exceeded Glüer‘s recommendation of 27 DOF required to 
establish reliable precision errors with an upper 90% confidence limit less than 30% (e.g., if the 
precision error is 2%, we are 90% confident that the true precision error is less than 2.6%)
[12]
. 
CV%RMS was calculated using the following equations: 
𝐶𝑉%𝑗 =   
𝑆𝐷𝑗
𝑥 𝑗
  𝑥 100%                                                                                                            (3.1) 
𝐶𝑉%𝑅𝑀𝑆 =    
𝐶𝑉%𝑗
2
𝑚
𝑚
𝑗=1                                                                                                             (3.2) 
Where j refers to an individual participant, SDj is the standard deviation between the baseline and 
follow-up measurements (for that individual participant), 𝑥 j is the mean of these two 
measurements, and m is the total number of participants in the analysis
[12]
.  
 LSC was then calculated as follows:  
LSC(1x1) = Z x CV%RMS 
1
n1
+  
1
n2
=   2.77 x CV%RMS                                                                  (3.3) 
Where (1x1) indicates that we performed 1 measurement at each visit (i.e., baseline and follow-
up); Z-score corresponds a two-tailed 95% confidence level (Z=1.96), while n1and n2 are the 
number of measures performed at baseline (n1=1) and follow-up (n2=1), respectively
[10]
.  
(
3
) 
(
1
) (
2
) 
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The median annual percent change was determined using the median difference in bone 
measures between baseline and 1 year follow-up, expressed in relation to the baseline 
measurement.  
MTI was defined as the ratio of LSC to median annual percent change, and specifies the 
period after which half the participants demonstrate a measured change exceeding the 
LSC
[9,10,151]
. We calculated MTI using the following equation, defined by Glüer
[9]
: 
𝑀𝑇𝐼 =  
𝐿𝑆𝐶
𝑀𝑒𝑑𝑖𝑎𝑛  𝐴𝑛𝑛𝑢𝑎𝑙  𝑃𝑒𝑟𝑐𝑒𝑛𝑡  𝐶ℎ𝑎𝑛𝑔𝑒
                                                                                         (3.4) 
3.1.3 Results 
3.1.3.1 Least Significant Change (LSC) 
At the distal radius, trabecular area, bone volume fraction, and all density measures had LSC 
values that were <6.0% (range: 1.1-5.9%; Table 3.3). LSCs for distal radius cortical area and 
micro-architecture (excluding bone volume fraction) were >8.0% (range: 8.1-18.2%; Table 3.3). 
At the distal tibia, all area and density measures, as well as cortical thickness and bone volume 
fraction had LSC values that were <5.5% (range: 0.3-5.3%; Table 3.3). Distal tibia micro-
architecture measures (excluding bone volume fraction) had LSC values that were >17% (range: 
17.4-19.0%; Table 3.3). 
3.1.3.2 Monitoring Time Interval (MTI) 
At the distal radius, all area and density measures exhibited MTIs >3.7 years (Table 3.3). MTIs 
for density measures ranged from 3.9 years (total density) to 29.5 years (inner trabecular density) 
(Table 3.3). MTIs for micro-architectural measures were ~2 years for trabecular number (TbN), 
thickness (TbTh), separation (TbSp) and heterogeneity (TbSpSD) (Table 3.3). The MTI for distal 
radius cortical thickness was 4.4 years.  
(
4
) 
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At the distal tibia, all area measures exhibited MTIs of ~1 year (Table 3.3). MTIs for 
density measures ranged from 0.5 years (cortical density) to >7.8 years (all trabecular density 
variables) (Table 3.3). MTIs for micro-architectural measures were >6 years for trabecular 
number (TbN), thickness (TbTh), separation (TbSp) and heterogeneity (TbSpSD) (Table 3.3). 
The MTI for distal tibia cortical thickness was 1.3 years. 
Table 3.3. Mean±SD of combined baseline and follow-up measures, median annual percent 
change, Least Significant Change (LSC; 2.77*CV%RMS), and the Monitoring Time Interval 
(MTI; LSC/median change) for the bone outcomes at the distal radius and distal tibia. 
 
Mean of 
Both 
Measures ± SD 
Median 
Annual 
Percent 
Change (%) 
LSC 
(%) 
MTI 
(Years)
 
Radius 
(n=31) 
   
 
 
 
Area 
   
 
  
Cortical (mm
2
) 38.7 ± 13.3 -1.1 8.1 7.4 
Trabecular (mm
2
) 239.2 ± 46.0 0.3 1.1 3.7 
    
 
  
Density 
   
 
  
Total  (mg HA/cm
3
) 248.7 ± 55.1 -1.0 3.9 3.9 
Cortical  (mg HA/cm
3
) 771.6 ± 84.2 -0.5 3.1 6.2 
Trabecular (mg HA/cm
3
) 134.1 ± 44.4 -0.2 3.4 17.0 
Meta (mg HA/cm
3
) 188.8 ± 39.4 -0.6 4.5 7.5 
Inn (mg HA/cm
3
) 96.2 ± 49.8 -0.2 5.9 29.5 
 
 
  
 
  
Micro-architecture 
  
 
  
CtTh (μm) 533.6 ± 188.1 -2.0 8.7 4.4 
BV/TV (%) 11.2 ± 3.7   0.0 3.4 ∞ 
TbN (1/mm) 1.8 ± 0.5 -8.3 16.8 2.0 
TbTh (μm) 63.6 ± 10.1  6.8 15.1 2.2 
TbSp (μm) 598.5 ± 397.0  9.0 17.1 1.9 
TbSpSD (μm) 361.9 ± 352.8  10.5 18.2 1.7 
     
  
Tibia (n=32) 
  
 
  
Area 
   
 
  
Cortical (mm
2
) 78.3 ± 27.5 -3.6 3.1 0.9 
Trabecular (mm
2
) 644.7 ± 100.9   0.3 0.3 1.0 
    
 
  
Density 
   
 
  
Total (mg HA/cm
3
) 236.9 ± 52.7 -1.4 2.5 1.8 
Cortical  (mg HA/cm
3
) 750.7 ± 72.3 -1.7 0.8 0.5 
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Trabecular (mg HA/cm
3
) 158.8 ± 39.0 -0.1 3.6 36.0 
Meta (mg HA/cm
3
) 265.1 ± 32.5 -0.4 3.1 7.8 
Inn (mg HA/cm
3
) 110.4 ± 45.0   0.1 5.3 53.0 
    
 
  
Micro-architecture 
  
 
  
CtTh (μm) 733.9 ± 264.5 -3.1 3.9 1.3 
BV/TV (%) 13.3 ± 3.3  0.0 3.6 ∞ 
TbN (1/mm) 1.8 ± 0.4  2.0 18.8 9.4 
TbTh (μm) 76.8 ± 15.3 -2.9 17.4 6.0 
TbSp (μm) 544.1 ± 251.6 -2.1 19.0 9.0 
TbSpSD (μm) 342.7 ± 437.5 -1.5 17.4 11.6 
 
3.1.4 Discussion 
The first objective of our study was to define the LSC using short-term precision data in 
postmenopausal women. These are the first reported LSCs using HR-pQCT measurements for 
postmenopausal women derived from short-term precision data with adequate degrees of 
freedom
[1]
. Generally, bone area and density measures, as well as bone volume fraction, tended 
to have lower LSCs (i.e., <6.0%) when compared to micro-architectural measures (LSCs 
>8.0%).  
 The second objective of our study was to define the MTI required to observe true change 
in bone properties in postmenopausal women using HR-pQCT. To our knowledge, these are the 
first MTIs for HR-pQCT derived bone properties. Obtained MTIs suggest that: a) changes in 
distal radius trabecular bone micro-architecture can be measured within ~2 years, and b) changes 
in distal tibial cortical area, density and thickness, as well as trabecular area, can be measured 
within ~1 year. Conversely, measuring change of distal radius cortical bone properties and distal 
tibia trabecular micro-architectural properties require longer monitoring times in postmenopausal 
women (>6 years). 
 Bone properties with short MTIs had either low precision errors (consequently low LSC) 
and/or large median annual changes; the opposite seemed to explain long MTIs. For instance, our 
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precision error (expressed as CV%RMS) for trabecular area at the radius was a low 0.4%
[1]
, and 
though the median change was also low at 0.3% per year, the resulting MTI was 3.7 years. 
Alternatively, the MTIs for micro-architectural measures at the distal radius exhibited smaller 
MTIs of ~2 years for trabecular number (TbN), thickness (TbTh), separation (TbSp) and 
heterogeneity (TbSpSD). These short MTIs may be explained by the observed median annual 
changes ranging from -8 to 11%, despite of 4-7%  precision error in the same outcomes
[1]
. 
Longer MTIs (especially for trabecular density and bone volume fraction) appeared to reflect a 
low (<1%) annual percent change observed in this cohort of older postmenopausal women. For 
example, bone volume fraction, which had an infinite MTI, was due to near zero median annual 
percent change. The longer MTIs may also be due to the image processing algorithms used with 
HR-pQCT to register (match) repeated scans, as well as scan quality. HR-pQCT uses area 
measures to matches image slices acquired at different time points. With this approach, images 
that have larger common region between measurement times will have more accurate 
representation of the true change because of the reduced influence of error (e.g., unequal slice 
comparison). Similarly, images that are graded as better quality will also have a more accurate 
representation of true change due to the reduced influence of movement artifacts and associated 
errors. Importantly, when compared to the distal radius, the distal tibia scans tended to be more 
easily landmarked resulting in more shared common region between baseline and follow-up 
images (radius common region mean: 91±7%; tibia common region mean: 96±2%) and had 
higher scan quality (radius scan quality grades: 1-3; tibia scan quality grades: 1-2)—likely 
explaining shorter MTIs for distal tibia outcomes. 
This study has strengths and limitations that warrant some consideration. Study strengths 
pertain to participants pool from a population-based cohort of community-dwelling 
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postmenopausal women
[160]
. Given the proportionally similar osteopenia and osteoporosis bone 
health status within our sample relative to postmenopausal women in North America, Europe, 
Australia, and Japan
[162]
, we anticipate that the observed bone changes and MTIs can be 
generalized to postmenopausal women of similar ages in these regions. Further, both LSC and 
median annual percent changes were derived from the same sample by the same operator using 
the same scanner, thereby minimizing measurement variability and resulting to accurate time 
interval predictions. With regards to study limitations, our findings were restricted to the 
monitoring of bone changes in a small sample of postmenopausal women over 1 year. Multiple 
measurement years in a larger  sample may provide a more representative estimates of the annual 
rates of skeletal changes and associated MTIs
[9]
. Further, skeletal changes may vary according to 
the cohort's age, ethnicity, disease status, and sex; therefore, monitoring disease progression and 
skeletal changes associated with intervention will likely require population-specific MTIs
[9]
. 
 The results of this HR-pQCT study suggest that, for the distal radius, MTIs of ~2 years 
duration are required in order to have skeletal changes exceeding the LSC for micro-architectural 
parameters (trabecular number, thickness, separation and heterogeneity). At the distal tibia, MTIs 
of ~1 year duration are required in order to have skeletal changes exceeding the LSC for cortical 
area, density and thickness, as well as trabecular area. HR-pQCT derived MTIs warrant 
consideration when designing and interpreting prospective studies and interventions in 
postmenopausal women. 
 To date, there are numerous HR-pQCT studies available characterizing the effect of age 
on skeletal mass, geometry, and micro-architecture using cross-sectional evidence
[29-35]
, and only 
one prospective study to illustrate change
[14]
. However, Laib et al (1998)
[14]
 used the prototype 
HR-pQCT scanner; therefore, it would be inappropriate to apply the provided LSC and MTIs to 
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this published change information. Consequently, there is need for a prospective follow-up study 
using the standard HR-pQCT in order to demonstrate the use of the above LSC and MTI 
statistics as they pertain to skeletal change. The following chapter will provide this necessary 
information. 
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4 STUDY 3: CHARACTERIZING SKELETAL CHANGES 
SYNOPSIS: Understanding how bone density, geometry, and micro-
architecture change with age can improve osteoporosis prevention, diagnosis, 
and treatment options. Research has provided us with DXA-derived measures 
of how bone density changes. However, there is still need for longitudinal 
research to characterize how bone geometry and micro-architecture change 
with age—especially in postmenopausal women. The aim of this study is to 
characterize changes in bone density, geometry, and micro-architecture in 
postmenopausal women over 1 year. 
4.1 Characterizing Micro-architectural Changes Using HR-pQCT
8
 
4.1.1 Introduction 
Osteoporosis has been clinically defined as a multi-factorial disease characterized by low bone 
mass and the deterioration of bone micro-architecture, leading to bone fragility and a subsequent 
increase in fracture risk
[15]
. Areal bone mineral density (aBMD) measured using dual-energy x-
ray absorptiometry (DXA) is the gold-standard imaging modality for diagnosing and monitoring 
osteoporosis
[161]
. However, 50-60% of fragility fractures are sustained by women who are above 
the World Health Organization (WHO) threshold for osteoporosis (i.e., they are classified as 
being 'normal' or 'osteopenic' by DXA-derived aBMD)
[153,161,199]
. This may partially be the 
related to DXA‘s inability to measure 3-dimensional (3D) micro-architectural properties of the 
cortical and trabecular bone
[101,108,200]
. 
                                                 
8
 Published as: Kawalilak CE, Johnston JD, Olszynski WP, Kontulainen SA (2014). Characterizing micro-
architectural changes at the distal radius and tibia in postmenopausal women using HR-pQCT. Osteoporosis 
International, 25(8): 2057-2066. 
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The advent of high-resolution peripheral quantitative computed tomography (HR-pQCT) 
has enabled measurement of 3D micro-architectural properties at peripheral bone sites (i.e., distal 
radius and tibia). While the distal radius and tibia are not clinically used to diagnose 
osteoporosis
[120,201]
, they are clinically relevant. For instance, approximately 80% of all fragility 
fractures in postmenopausal women are non-vertebral in nature
[202]
. Moreover, fragility fractures 
at the distal radius are a sentinel for future fragility fractures at other sites
[117,118]
. A fragility 
fracture sustained at the distal radius will precede a vertebral fracture by an average of 5-7 years, 
and a hip fracture by an average of 10 years
[117]
. Further, because the tibia is a weight-bearing 
skeletal site it may better reflect bone strength at other weight-bearing sites, such as the hip and 
vertebrae
[41]
. Therefore, evidence of micro-architectural changes in cortical and trabecular bone 
properties at the distal radius and tibia in postmenopausal women will advance our 
understanding of bone deterioration beyond bone mass and provide new targets for investigations 
and strategies for optimizing osteoporotic fracture prevention. 
Using cross-sectional data, HR-pQCT has been used to postulate and describe probable 
alterations in bone micro-architecture over time
[29-33,51,203]
. Only one prospective longitudinal 
study, however, has focused on age-related changes in bone micro-architecture at the distal 
radius in postmenopausal women
[14]
. This research was described as being 'preliminary' by the 
authors as they measured 17 postmenopausal women (53±3 years) using a prototype HR-pQCT 
with an isotropic resolutions of 165μm (60 slices per scan; 9.90 mm total scan thickness; image 
matrix: 512 x 512)
[14]
. This warrants investigation of micro-architectural changes using the 
standard HR-pQCT with an isotropic resolution of 82μm (110 slices per scan; 9.02 mm total scan 
thickness; image matrix: 1536 x 1536)
[163]
, at both the distal radius and tibia in postmenopausal 
women; a population highly susceptible to osteoporotic fracture. In addition to the limited 
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prospective evidence of bone micro-architectural changes in postmenopausal women, evidence 
of micro-architectural changes in women receiving treatments influencing bone tissue, such as 
hormone replacement therapy (HRT), is warranted. Therefore, our first objective was to 
characterize annual changes in bone area, density, and micro-architecture at the distal radius and 
tibia using HR-pQCT in postmenopausal women. We hypothesized that observing bone loss and 
micro-architectural deterioration in both cortical and trabecular bone would occur in women not 
using any anti-resorptive medications (i.e., HRT or bisphosphonate). Based on the previous ex 
vivo cross-sectional findings
[51,52,91]
, we anticipated that the majority of bone loss would be from 
cortical bone. Our secondary objective was to provide preliminary data of bone micro-
architectural changes in women receiving hormone replacement therapy or bisphosphonate 
treatment. 
4.1.2 Materials and Methods 
4.1.2.1 Participants 
In 2010, we recruited 147 community-dwelling postmenopausal women (mean age ± standard 
deviation, SD: 75±8 years) from the Saskatoon cohort of the Canadian Multi-centre Osteoporosis 
Study (CaMos)
[160]
 to participate in a prospective investigation of musculoskeletal health
[204]
. In 
2011, 104 women participated in the first follow-up and underwent baseline HR-pQCT scanning. 
Approximately 1 year later (2012-2013; mean time between measurements: 412±56 days), 51 
women (77±7 years) returned for follow-up HR-pQCT measurements and were included in this 
study. Postmenopausal status was assessed using a questionnaire, as defined elsewhere
[160]
. 
Osteoporosis status was based on femoral neck (FN) aBMD obtained from the Saskatoon CaMos 
database
[96]
 (Table 4.1). There appeared to be no difference in osteoporosis status between those 
women who returned for follow-up measures (aBMD ranges—normal: 27%; osteopenia: 57%; 
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osteoporosis: 16%) versus those who did not return (aBMD ranges—normal: 20%; osteopenia: 
62%; osteoporosis: 11%). Participant consent was obtained prior to the study. This study was 
approved by the University of Saskatchewan Biomedical Research Ethics Board. 
4.1.2.2 Medication Use 
All participants filled out a questionnaire pertaining to their medication use for 12 months prior 
to their visit at study baseline and each follow-up. We recorded medications related to hormone 
replacement (e.g., conjugated estrogens tablets) and bisphosphonate therapies (e.g., risedronate, 
alendronate) based on reported medication use since 2009. 
Table 4.1. Participants baseline demographics (mean±SD) categorized according to use of bone 
altering medication (no medication, hormone replacement therapy (HRT),or bisphosphonates), 
including DXA-derived osteoporosis status, number (n) of women in each category and the 
mean±SD of their areal bone mineral density (aBMD). 
(N = 51) 
Variable Units 
No Medication Use  
(n=33; 64%) 
HRT  
(n=8; 16%) 
Bisphosphonates 
(n=10; 20%) 
Age (years) 77 ± 7 81 ± 7 76 ± 8 
Height (cm) 160.3 ± 5.9 158.3 ± 7.4 158.6 ± 3.9 
Weight (kg) 73.5 ± 12.8 67.3 ± 5.1 64.9 ± 11.9 
Osteoporosis Status 
   
  
Normal n (aBMD) 11 (0.80±0.06) 3 (0.81±0.08)  -- 
   
     
Osteopenia n (aBMD) 16 (0.70±0.11) 5 (0.69±0.16) 7 (0.67±0.04) 
   
     
Osteoporosis n (aBMD) 6 (0.54±0.05)  -- 3 (0.54±0.02) 
 
4.1.2.3 HR-pQCT Imaging 
All participants had their non-dominant arm and ipsilateral leg immobilized in the standard 
carbon fiber cast prior to imaging, as per the manufacturer‘s standard in vivo protocol. Prior to 
scanning, a 2D anterior-posterior scout view scan was used to set the reference line and define 
the volume of interest, as defined elsewhere
[1]
. HR-pQCT (XtremeCT; Scanco Medical AG, 
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Brüttisellen, Switzerland) was used to acquire a 9.02 mm region (110 parallel CT slices) located 
9.5 mm (radius) and 22.5 mm (tibia) proximal to the reference line placement. Using an isotropic 
resolution of 82 μm, the field of view was reconstructed over a 1536 x 1536 matrix. The 
effective dose was <4 μSv and the measurement time was approximately 2.8 minutes for each 
scan. Our measurement precision error for bone area is between 0.1-3.0%, for density measures 
is between 0.3-2.0%, and for micro-architecture parameters is between 1.2-6.5% at the distal 
radius and tibia, as described elsewhere
[1]
. The precision for cortical perimeter measures was 
0.4% at both the distal radius and tibia. 
4.1.2.4 HR-pQCT Analysis 
One investigator (CK) scanned, graded, and analyzed all images. All images were graded for 
quality according to the 5-point scale defined by the manufacturer and reported previously
[164]
. 
Upon detection of motion artifacts (e.g., streaking or broken cortices), a repeat scan was 
performed. All images graded as quality 4 and 5 were removed without further analysis. All 
scans included in this analysis were of grades 1-3 for both the distal radius and distal tibia. 
 Image analysis was completed according to the manufacturer‘s standard in vivo 
evaluation protocol to acquire cortical and trabecular bone density, area, and micro-architectural 
values. We described the technique in detail elsewhere
[1]
. Briefly, the periosteal surface of the 
region of interest was contoured from the surrounding soft tissue using a semi-automatic edge-
finding algorithm that morphed the contour to subsequent slices in a slice-by-slice manner over 
the entire volume-of-interest. The contour line was qualitatively inspected and corrected using 
manual manipulation when the line strayed from the periosteal surface. The baseline measures 
were automatically matched to follow-up measures by HR-pQCT software. The matching 
criterion is based on the total cross-sectional area within the contours of each measurement. In 
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the database, the total cross-sectional area for each contour on each slice is recorded and then the 
algorithm finds the best slice range that the average contoured area matches the follow up 
measurements. The average common regions for the distal radius measurements was 92% (±7%), 
and 96% (±2%) for the distal tibia measurements. The standard HR-pQCT outcomes represent an 
average of all slices in the common scan region and include area, density, and micro-
architectural variables
[14,25,167,168,198]
. Area outcomes included: cortical and trabecular areas. 
Density outcomes included: total, cortical, and trabecular bone (including: meta and inner 
trabecular) densities. Micro-architectural outcomes included: cortical thickness (CtTh), 
trabecular bone volume fraction (BV/TV), trabecular number (TbN), trabecular thickness (TbTh), 
trabecular separation (TbSp), and trabecular heterogeneity (TbSpSD). In addition to the standard 
HR-pQCT outcomes, we report cortical perimeter (the outer boundary of the periosteal surface, 
mm). Further, we calculated bone mineral content (mg/mm) as the product of density and area 
for both cortical and trabecular compartments. 
4.1.2.5 Statistical Analysis 
To determine the distribution of our dataset, we calculated the z-score for skewness and kurtosis 
for all bone outcome variables. Z-score for skewness was calculated by dividing the skewness 
value by the standard error of skewness for each parameter, Z-score was calculated similarly for 
kurtosis
[205]
. The variables with skewness or kurtosis z-scores greater than 1.96 were deemed to 
have non-parametric distribution. The non-parametric parameters (i.e., TbSp and TbSpSD) were 
skewed to the right and therefore log transformed outcomes were used in the analysis. 
 We first used repeated measures analysis of covariance (ANCOVA) with Bonferroni 
adjustment for multiple comparisons to compare the change in bone parameters between baseline 
and follow-up and to assess possible interactions between time from baseline to follow-up and 
  
104 
covariates of age, height or weight. The only main effect was noted for the time from baseline to 
follow-up. Therefore, we assessed bone changes using analysis of variance (ANOVA), without 
covariates, and adjusted for multiple comparisons. 
Using linear regression we assessed the relationship between absolute change in cortical 
and trabecular area at both sites in women without bone altering medication. We reported both 
equation and Pearson‘s correlation coefficient for each analysis. Significance was set to P<0.05. 
All statistical analyses were performed using IBM SPSS commercial statistics software (PASW, 
Version 21 for Windows, SPSS Inc., Chicago, IL, USA). 
4.1.3 Results 
We report mean age, height, weight, DXA-measured femoral neck aBMD (to describe 
osteoporosis status), and categorized participants according to reported history of hormone 
replacement and bisphosphonate therapy (Table 4.1). At the distal radius, there were a total of 43 
scans analyzed; 31 from postmenopausal women not using medication, 6 were from women 
using HRT, and 6 were from women using bisphosphonates (Table 4.1). At the distal tibia, there 
were 50 scans analyzed; 32 from postmenopausal women not using medication, 8 were from 
women using HRT, and 10 were from women using bisphosphonates (Table 4.1). 
 We observed the following changes (P<0.05) in the distal radius. In women without bone 
altering medications, total density (-1.7%) and trabecular number (-6.4%) decreased while 
trabecular thickness (+6.0%), trabecular separation (+8.6%), and trabecular heterogeneity 
(+12.1%) increased (Table 4.2). Women using HRT had an increase in trabecular area (+1.3%), 
and decreases in cortical area (-6.5%), total density (-3.2%), cortical density (-2.8%), cortical 
content (-9.1%), and cortical thickness (-6.8%) (Table 4.2). In women using bisphosphonates, 
bone volume fraction (+3.8%) and trabecular density (+3.8%) increased, particularly in the inner 
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trabecular region (+5.5%) (Table 4.2). There was a negative relationship (r = -0.82) between 
cortical area and trabecular area change at the distal radius (Figure 4.1).  
 At the distal tibia, we observed bone changes only in women not using bone altering 
medications. Specifically, there were decreases in total density (-1.9%), cortical area (-4.5%), 
cortical density (-1.9%), cortical content (-6.3%), and cortical thickness (-4.4%), while trabecular 
area (+0.4%) increased and trabecular content did not change (Table 4.3, Figure 4.2). There was 
a negative relationship (r = -0.91) between trabecular area and cortical area change at the distal 
tibia (Figure 4.1).  
 
Figure 4.1. Relationship between 
absolute change in cortical and 
trabecular areas (mm
2
) at a) the 
distal radius, and b) distal tibia. 
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Figure 4.2. Absolute mean changes in cortical and trabecular bone mineral content (mg/mm) 
and area (mm
2
) at the distal tibia. Error bars show SDs. *P<0.05. 
 
  
 
Table 4.2. Mean (±SD) of the baseline and follow-up scans, mean annual change (percent), the lower and upper bounds for the 95% 
confidence interval, and P-value for the observed changes in the distal radius for those participants not taking medications, those 
participants using HRT, and those participants using bisphosphonates. 
(N=43) 
Baseline 
Scan  ± SD 
Follow-
up Scan  ± SD 
Mean Annual 
Change (%) 
95% Confidence 
Interval 
P-value Lower Upper 
No Medication (n=31) 
     
   
Area 
      
   
Cortical (mm
2
) 38.9 ± 13.3 38.4 ± 13.2 -0.4 (-1.0) -1.306 0.448 0.326 
Trabecular (mm
2
) 238.9 ± 46.2 239.5 ± 45.8 0.6 (0.3) -0.082 1.237 0.084 
       
   
Perimeter 
      
   
Cortical (mm) 71.95 ± 4.78 71.89 ± 4.82 -0.06 (-0.08) -0.258 0.142 0.558 
       
   
Density 
      
   
Total  (mg HA/cm
3
) 250.8 ± 55.2 246.5 ± 55.0 -4.4 (-1.7) -8.232 -0.536 0.027 
Cortical  (mg HA/cm
3
) 773.1 ± 83.6 770.0 ± 84.8 -3.1 (-0.4) -10.061 3.945 0.380 
Trabecular (mg HA/cm
3
) 135.5 ± 44.2 132.6 ± 44.6 -2.9 (-1.5) -7.840 2.072 0.244 
Meta (mg HA/cm
3
) 190.1 ± 39.8 187.5 ± 39.0 -2.5 (-1.1) -6.550 1.530 0.214 
Inn (mg HA/cm
3
) 97.7 ± 49.0 94.6 ± 50.6 -3.2 (-3.4) -9.412 3.063 0.307 
       
   
Content 
      
   
Cortical (mg/mm) 31.0 ± 13.0 30.6 ± 12.9 -0.4 (-1.2) -1.271 0.393 0.290 
Trabecular (mg/mm) 32.1 ± 10.6 31.6 ± 10.9 -0.5 (-1.2) -1.670 0.625 0.360 
       
   
Micro-architecture 
     
   
CtTh (μm) 535.8 ± 189.5 531.3 ± 186.6 -4.5 (-0.5) -0.018 0.009 0.499 
BV/TV (%) 11.3 ± 3.7 11.0 ± 3.7 -0.2 (-1.4) -0.007 0.002 0.257 
TbN (1/mm) 1.8 ± 0.5 1.7 ± 0.5 -0.1 (-6.4) -0.218 -0.065 0.001 
TbTh (μm) 61.9 ± 10.0 65.3 ± 10.2 3.4 (6.0) 0.001 0.006 0.010 
TbSp
§
 (μm) 584.2 ± 422.2 612.8 ± 371.8 28.6 (8.6) 0.029 0.121 0.002 
TbSpSD
§
 (μm) 352.3 ± 368.1 371.4 ± 337.4 19.1 (12.1) 0.042 0.161 0.002 
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HRT Use (n=6) 
      
   
Area 
      
   
Cortical (mm
2
) 49.0 ± 16.3 46.3 ± 16.6 -2.8 (-6.5) -4.526 -1.007 0.010 
Trabecular (mm
2
) 238.4 ± 58.1 240.9 ± 56.9 2.4 (1.3) 0.294 4.572 0.033 
       
   
Perimeter 
      
   
Cortical (mm) 74.07 ± 6.70 73.95 ± 6.69 -0.12 (-0.16) -0.559 0.326 0.528 
       
   
Density 
      
   
Total  (mg HA/cm
3
) 282.0 ± 93.2 273.3 ± 90.6 -8.7 (-3.2) -16.319 -0.981 0.034 
Cortical  (mg HA/cm
3
) 832.9 ± 92.0 810.6 ± 102.1 -22.3 (-2.8) -39.037 -5.630 0.018 
Trabecular (mg HA/cm
3
) 137.9 ± 36.3 139.2 ± 37.7 1.3 (0.8) -4.344 6.978 0.576 
Meta (mg HA/cm
3
) 191.5 ± 34.6 192.0 ± 36.9 0.5 (0.2) -8.608 9.575 0.897 
Inn (mg HA/cm
3
) 100.8 ± 38.4 102.7 ± 38.8 1.9 (1.7) -2.037 5.771 0.274 
       
   
Content 
      
   
Cortical (mg/mm) 42.0 ± 17.5 38.8 ± 17.4 -3.2 (-9.1) -4.613 -1.654 0.003 
Trabecular (mg/mm) 31.3 ± 3.4 31.8 ± 3.1 0.6 (2.0) -2.039 0.839 0.333 
       
   
Micro-architecture 
     
   
CtTh (μm) 671.7 ± 261.7 633.3 ± 261.1 -38.3 (-6.8) -0.062 -0.015 0.008 
BV/TV (%) 11.5 ± 3.0 11.6 ± 3.1 0.1 (0.7) -0.004 0.006 0.597 
TbN (1/mm) 1.8 ± 0.3 1.9 ± 0.3 0.1 (7.5) -0.266 0.482 0.490 
TbTh (μm) 63.0 ± 11.6 59.8 ± 11.1 -3.2 (-4.2) -0.013 0.007 0.453 
TbSp
§
 (μm) 497.7 ± 85.7 471.3 ± 93.3 -26.3 (-4.0) -0.269 0.154 0.518 
TbSpSD
§
 (μm) 228.3 ± 62.9 224.5 ± 80.3 -3.8 (-2.2) -0.245 0.169 0.659 
       
   
Bisphosphonates Use (n=6) 
     
   
Area 
      
   
Cortical (mm
2
) 35.0 ± 11.4 34.7 ± 10.1 -0.3 (-0.7) -1.792 1.292 0.694 
Trabecular (mm
2
) 229.8 ± 30.0 230.6 ± 28.4 0.8 (0.4) -0.593 2.126 0.207 
       
   
Perimeter 
      
   
Cortical (mm
2
) 77.12 ± 3.48 77.03 ± 3.67 -0.08 (-0.11) -0.624 0.458 0.708 
       
   
1
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Density 
      
   
Total  (mg HA/cm
3
) 240.9 ± 34.0 242.4 ± 27.8 1.5 (1.0) -5.791 8.757 0.623 
Cortical  (mg HA/cm
3
) 773.1 ± 95.8 768.7 ± 84.4 -4.5 (-0.4) -16.795 7.895 0.397 
Trabecular (mg HA/cm
3
) 131.1 ± 14.2 135.8 ± 13.3 4.8 (3.8) 0.920 8.646 0.024 
Meta (mg HA/cm
3
) 187.9 ± 22.5 192.6 ± 19.9 4.7 (2.7) -0.443 9.776 0.066 
Inn (mg HA/cm
3
) 91.7 ± 11.4 96.7 ± 11.8 5.0 (5.5) 1.493 8.441 0.014 
       
   
Content 
      
   
Cortical (mg/mm) 27.9 ± 11.2 27.4 ± 9.9 -0.6 (0.4) -2.065 0.999 0.412 
Trabecular (mg/mm) 30.3 ± 6.3 31.5 ± 6.3 1.2 (4.1) -6.019 9.186 0.615 
       
   
Micro-architecture 
     
   
CtTh (μm) 495.0 ± 17.1 488.3 ± 15.1 -6.7 (-0.3) -0.029 0.016 0.484 
BV/TV (%) 10.9 ± 1.2 11.3 ± 1.1 0.4 (3.8) 0.001 0.007 0.018 
TbN (1/mm) 1.8 ± 0.2 1.8 ± 0.1 0.0 (1.3) -0.201 0.221 0.908 
TbTh (μm) 60.7 ± 5.8 62.7 ± 86.0 2.0 (3.4) -0.005 0.009 0.508 
TbSp
§
 (μm) 497.2 ± 57.0 489.3 ± 34.5 -7.8 (-0.7) -0.128 0.096 0.794 
TbSpSD
§
 (μm) 212.7 ± 24.9 217.7 ± 14.3 5.0 (3.4) -0.096 0.151 0.594 
§ Non-parametric variables normalized using log transformation  
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Table 4.3. Mean (±SD) of the baseline and follow-up scans, mean annual change (percent), the lower and upper bounds for the 95% 
confidence interval, and P-value for the observed changes in the distal tibia for those participants not taking medications, those 
participants using HRT, and those participants using bisphosphonates. 
(N=50) 
Baseline 
Scan  ± SD 
Follow
-up 
Scan  ± SD 
Mean 
Annual 
Change (%) 
95% Confidence 
Interval 
P-value Lower Upper 
No Medication (n=32) 
     
  
 Area  
     
  
 Cortical (mm
2
) 79.9 ± 27.3 76.7 ± 27.7 -3.1 (-4.5) -4.259 -1.997 <0.001 
Trabecular (mm
2
) 643.5 ± 100.9 645.8 ± 100.9 2.3 (0.4) 1.448 3.165 <0.001 
  
     
  
 
Perimeter  
     
  
 Cortical (mm) 104.42 ± 7.56 104.44 ± 7.59 -0.02 (-0.03) -0.182 0.238 0.787 
  
     
  
 
Density  
     
  
 Total  (mg HA/cm
3
) 239.0 ± 52.4 234.7 ± 52.9 -4.3 (-1.9) -6.126 -2.399 <0.001 
Cortical  (mg HA/cm
3
) 758.0 ± 71.9 743.4 ± 72.7 -14.6 (-1.9) -18.829 -10.440 <0.001 
Trabecular (mg HA/cm
3
) 159.1 ± 38.7 158.5 ± 39.2 -0.6 (-0.5) -1.887 0.750 0.386 
Meta (mg HA/cm
3
) 230.3 ± 32.1 299.9 ± 32.9 -0.4 (-0.2) -2.048 1.205 0.601 
Inn (mg HA/cm
3
) 110.7 ± 44.7 110.0 ± 45.2 -0.7 (-1.5) -2.039 0.570 0.260 
  
     
  
 
Content  
     
  
 Cortical (mg/mm) 62.1 ± 26.0 58.7 ± 26.0 -3.4 (-6.3) -4.609 -2.266 <0.001 
Trabecular (mg/mm) 102.0 ± 28.3 102.0 ± 28.9 0.01 (-0.1) -0.942 0.942 0.999 
  
     
  
 
Micro-architecture 
     
  
 CtTh (μm) 748.1 ± 262.6 719.4 ± 266.3 -28.8 (-4.4) -0.040 -0.018 <0.001 
BV/TV (%) 13.3 ± 3.2 13.2 ± 3.3 -0.1 (-0.5) -0.002 0.001 0.369 
TbN (1/mm) 1.7 ± 0.4 1.8 ± 0.4 0.1 (2.8) -0.024 0.103 0.214 
TbTh (μm) 77.8 ± 15.4 75.7 ± 15.2 -2.1 (-2.2) -0.005 0.001 0.138 
TbSp (μm) 550.1 ± 252.2 538.0 ± 251.0 -12.1 (-1.7) -0.059 0.015 0.228 
TbSpSD (μm) 342.7 ± 424.6 342.6 ± 450.4 -0.1 (-0.9) -0.055 0.024 0.431 
  
     
  
 
1
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HRT Use (n=8)  
     
  
 Area  
     
  
 Cortical (mm
2
) 94.7 ± 26.7 93.1 ± 26.0 -1.6 (-1.1) -6.344 3.194 0.460 
Trabecular (mm
2
) 619.1 ± 148.1 619.2 ± 149.3 0.1 (0.0) -3.407 3.632 0.942 
  
     
  
 
Perimeter  
     
  
 Cortical (mm) 108.04 ± 9.61 108.15 ± 9.47 -0.11 (-0.10) -0.079 0.304 0.208 
  
     
  
 
Density  
     
  
 Total  (mg HA/cm
3
) 252.8 ± 65.4 251.4 ± 64.0 -1.4 (-0.3) -7.513 4.813 0.620 
Cortical  (mg HA/cm
3
) 806.8 ± 68.9 793.1 ± 65.4 -13.6 (-1.6) -27.607 0.332 0.054 
Trabecular (mg HA/cm
3
) 148.8 ± 34.5 149.7 ± 33.8 0.8 (0.7) -2.306 3.956 0.553 
Meta (mg HA/cm
3
) 214.5 ± 31.6 215.1 ± 30.9 0.6 (0.3) -3.533 4.658 0.755 
Inn (mg HA/cm
3
) 104.2 ± 36.5 105.3 ± 36.0 1.0 (1.2) -2.036 4.111 0.451 
  
     
  
 
Content  
     
  
 Cortical (mg/mm) 77.9 ± 27.6 75.2 ± 26.7 -2.6 (-2.6) -7.235 1.885 0.208 
Trabecular (mg/mm) 91.0 ± 26.4 91.5 ± 25.8 0.5 (0.7) -1.242 2.192 0.534 
  
     
  
 
Micro-architecture 
     
  
 CtTh (μm) 903.8 ± 310.6 893.8 ± 310.1 -10.0 (-0.8) -0.052 0.032 0.592 
BV/TV (%) 12.4 ± 2.9 12.5 ± 2.8 0.1 (0.6) -0.002 0.003 0.588 
TbN (1/mm) 1.7 ± 0.2 1.8 ± 0.3 0.0 (3.2) -0.230 0.297 0.771 
TbTh (μm) 72.8 ± 17.7 71.5 ± 15.7 -1.3 (-0.4) -0.013 0.010 0.800 
TbSp (μm) 516.3 ± 70.4 509.3 ± 81.9 -7.0 (-0.3) -0.175 0.139 0.798 
TbSpSD (μm) 240.1 ± 44.5 234.4 ± 48.7 -5.8 (-1.7) -0.171 0.112 0.633 
  
     
  
 Bisphosphonates Use (n=10) 
     
  
 Area  
     
  
 Cortical (mm
2
) 75.2 ± 26.8 74.3 ± 26.6 -0.9 (-1.6) -2.723 0.903 0.286 
Trabecular (mm
2
) 581.3 ± 110.4 582.1 ± 109.5 0.8 (0.2) -0.918 2.518 0.319 
  
     
  
 
Perimeter  
     
  
 Cortical (mm) 109.73 ± 6.90 109.65 ± 7.13 -0.08 (-0.07) -0.336 0.176 0.498 
  
     
  
 
1
1
1
 
  
 
Density  
     
  
 Total  (mg HA/cm
3
) 237.2 ± 35.5 235.8 ± 35.3 -1.4 (-0.6) -4.985 2.185 0.400 
Cortical  (mg HA/cm
3
) 755.7 ± 96.6 746.5 ± 99.9 -9.2 (-1.3) -19.781 1.421 0.082 
Trabecular (mg HA/cm
3
) 151.2 ± 21.3 151.9 ± 22.4 0.7 (0.4) -1.716 3.116 0.529 
Meta (mg HA/cm
3
) 222.2 ± 18.3 222.8 ± 20.3 0.5 (0.2) -3.486 4.526 0.776 
Inn (mg HA/cm
3
) 102.9 ± 24.4 103.8 ± 24.7 0.9 (0.8) -0.942 2.642 0.311 
  
     
  
 
Content  
     
  
 Cortical (mg/mm) 59.0 ± 25.6 57.7 ± 25.3 -1.2 (-2.8) -2.821 0.361 0.114 
Trabecular (mg/mm) 87.9 ± 20.4 88.5 ± 21.2 0.6 (0.5) -0.551 1.791 0.261 
  
     
  
 
Micro-architecture 
     
  
 CtTh (μm) 747.0 ± 277.7 735.0 ± 272.7 -12.0 (-1.9) -0.029 0.005 0.140 
BV/TV (%) 12.6 ± 1.8 12.7 ± 12.9 0.1 (0.5) -0.001 0.003 0.448 
TbN (1/mm) 1.6 ± 0.2 1.7 ± 0.2 0.1 (3.9) -0.106 0.222 0.445 
TbTh (μm) 77.2 ± 10.2 75.1 ± 11.5 0.0 (-2.3) -0.009 0.005 0.494 
TbSp (μm) 538.7 ± 60.9 524.8 ± 81.0 -13.9 (-2.3) -0.128 0.066 0.485 
TbSpSD (μm) 255.4 ± 50.5 248.5 ± 53.8 -6.9 (-1.6) -0.175 0.079 0.415 
 
 
 
 
 
 
 
1
1
2
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4.1.4 Discussion 
Our primary objective was to characterize annual skeletal changes in bone area, density, and 
micro-architecture at the distal radius and distal tibia using HR-pQCT in postmenopausal women 
from a community-dwelling, population-based cohort living in Saskatoon, Canada. Women who 
did not use bone altering medication had 6-12% increase in trabecular thickness, separation, and 
heterogeneity together with a 6% decrease in trabecular number with no change in trabecular 
density at the distal radius. Observed changes suggest that small trabeculae were lost while 
partially resorbed cortical bone remnants were detected as new, thicker trabeculae. While we did 
not detect changes in bone mineral content within the cortical bone at the distal radius, cortical 
content decreased at the distal tibia. Trabecular bone density and content did not change at the 
tibia, while the 0.4% increase in trabecular area was accompanied by 2-6% decreases in cortical 
area, density, content, and thickness.  
These findings, especially from the distal tibia, suggest that the majority of bone was lost 
due to intracortical remodeling adjacent to the trabecular bone and marrow. Based on the 
negative correlation between the changes in cortical and trabecular area, women with the greatest 
decreases in cortical area had the greatest increases in trabecular area at both sites. Altogether, 
these observations lend credence to the suggestion that with advancing age, resorption at the 
endocortex results in the appearance of cortical remnants resembling trabecular bone (i.e., 
trabecularization of the cortex)
[51,52,91]
. Observed changes agree with reported histomorphometric 
(ex vivo) data from the femur
[51,52,91]
. As the cortical bone is being resorbed the area of the cortex 
decreases while the trabecular area increases to incorporate the cortical remnants into the 
trabecular volume, which simultaneously results in an increase in the apparent trabecular 
thickness measured using HR-pQCT. Our results suggest that cortical thinning maybe more 
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apparent at weight-bearing bone sites (such as tibia) than non-weight bearing sites (such distal 
radius). 
 Study findings are consistent with others suggesting that the majority of bone loss in 
postmenopausal women is from cortical bone
[51,58,91,206,207]
. Using longitudinal pQCT measures at 
the distal tibia, Lauretani and colleagues reported that age-related medullary expansion at the 
tibia shaft was not balanced by periosteal apposition leading to cortical bone loss and thinning of 
the cortex
[208]
. These findings are consistent with our results showing no changes in the cortical 
perimeter at the distal radius or tibia over the 1-year follow-up. These observations are important 
because a thin cortical shell at the femoral neck and lumbar spine has been associated with lower 
tissue toughness and elasticity thereby compromising load-bearing capacity and increasing the 
probability of sustaining a fracture
[209,210]
. This evidence suggests that cortical bone should be 
targeted when monitoring osteoporosis treatments and fracture-prevention strategies. It further 
highlights the need for 3D imaging techniques to monitor both cortical and trabecular bone 
deterioration in fracture prone populations. 
 Our secondary objective was to describe micro-architectural changes over 1 year for 
those women using bone altering medication. Our findings at the distal radius of postmenopausal 
women using HRT showed similar results to that of the distal tibia in the non-medicated group of 
our cohort. That is, over 1 year there was approximately 1% increase in trabecular area with a 
simultaneous 3-9% decrease in cortical area, density, content, and thickness. These data suggest 
that despite the use of HRT, cortical bone is lost and partly trabecularized at the distal radius. In 
contrast, no skeletal changes in 1 year occurred at the distal tibia in those women using HRT, 
which may indicate that HRT can maintain cortical and trabecular bone properties at the weight-
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bearing skeleton. This preliminary evidence can assist in designing interventions to address this 
hypothesis. 
 The women in our cohort using bisphosphonates had an approximate 3-5% increase in 
distal radius bone volume fraction and trabecular density, particularly in the inner trabecular 
region. These increases in the trabecular micro-architecture were consistent with the reported 
effects of bisphosphonates in postmenopausal women
[94]
. The lack of observed changes at the 
distal tibia with our bisphosphonate users may reflect the small sample size and limited power to 
detect small changes reported with bisphosphonate therapy. Alendronate treatment has shown to 
decrease trabecular area and increase cortical thickness at the tibia
[94]
. 
 This study has specific strengths which require consideration. First, our sample of older 
community-dwelling postmenopausal women represents a clinically relevant population most 
likely to sustain an osteoporotic related fragility fracture
[169,208]
. Based on the similar bone health 
status (proportion of osteopenia and osteoporosis) between our sample and reports from 
postmenopausal women in North America, Europe, Australia, and Japan
[162]
, we anticipate that 
the observed bone changes can be generalized to older postmenopausal women in these regions. 
 Limitations of this study relate to the study duration, possible bias and scanning 
locations. First, this was a short, one year follow-up study of postmenopausal women. Longer 
follow-ups are needed to characterize individual changes and identify factors associated with 
greater bone loss and micro-architectural deterioration. Future research should also define a time 
interval required to reliably monitor bone changes with HR-pQCT in postmenopausal women. 
Second, our study was limited to follow-up measures of only 51 of the initial 104 women (49%) 
and the possibility of attrition bias related to the participants bone health status exists. However, 
we assume this was not the case because of the similar osteoporosis status at baseline between 
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the women who returned for the follow-up measures relative to those women who did not return. 
Third, our results are limited to the distal radius and distal tibia measured with HR-pQCT 
(XtremeCT) and may not be generalizable to other skeletal sites or measures obtained using 
other imaging methods. 
 In summary, this study characterized skeletal changes at the distal radius and tibia using 
standard HR-pQCT measurements in community-dwelling postmenopausal women over 1 year. 
The observed loss of trabeculae with concomitant increase in trabecular size at the distal radius 
and the declined cortical thickness, content, density and area with increase in trabecular area at 
the distal tibia indicated a site-specific trabecularization of the cortical bone in postmenopausal 
women. 
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5: DISCUSSION AND CONCLUSION 
5.1 Overview of Findings 
The overall goal of this thesis was to provide a careful investigation of precision for all HR-
pQCT outcomes, establish the least significant change (LSC) and monitoring time interval 
(MTI), as well as characterize bone changes in density, geometry, and micro-architecture using 
HR-pQCT. 
5.1.1 Study 1: HR-pQCT Precision 
The first study of my thesis defined HR-QCT precision errors using: 1) the full array of standard 
outcomes, 2) two contour methods for the dual-threshold analysis, and 3) 3 different FE models 
using sufficient degrees of freedom to provide accurate precision errors (with 90% confidence), 
using unmixed age groups. The primary finding from study 1 was that HR-pQCT precision 
errors were <10% for bone densitometric, geometric, and mechanical properties; while precision 
errors were <16% for cortical and trabecular micro-architectural outcomes. These results were 
comparable to previous studies reporting precision error for standard outcomes
[5,13,29,157,195]
, 
cortical micro-architecture
[5,180]
, and FE modeling 
[157,188]
. 
 Study 1 also highlighted that postmenopausal women (74±7 years) and young adults 
(26±8 years) could be measured with comparable precision errors using HR-pQCT. This finding 
is important because previous research suggested that precision errors derived from young adults 
would likely underestimate errors in postmenopausal women
[149,158]
. Further, study 1 
demonstrated that manual modification of the endocortical contour did not significantly affect 
precision error. However, the manual modification of endocortical contours led to generally 
higher cortical bone properties compared to the automated method―thereby making results 
more comparable to higher resolution imaging techniques, nevertheless these benefits do not 
 118 
outweigh the time investment. This is of particular importance as it will lead to time savings and 
reduced costs for future evaluation of cortical bone micro-architecture. 
 Interestingly, when comparing the cortical density between the advanced cortical micro-
architecture evaluation (AUTO and MOD) to the standard evaluation, the cortical density 
increased when the cortical thickness increased. Specifically, the average cortical density for the 
standard evaluation was 773.0 mg HA/cm
3
 with an average cortical thickness of 0.523 mm, 
however, with the AUTO contour the average cortical density was 918.1 mg HA/cm
3
 with an 
average cortical thickness of 1.187 mm (MOD contouring provided the same trends but to a 
lesser extent). It would be logical to observe a decrease in cortical density with increased cortical 
thickness because of the inclusion of more cortical pores. However, the increased cortical density 
observed with the both AUTO and MOD contour methods of the dual-threshold technique was 
likely the result of using the manufacturer recommended cortical density outcome for which the 
pores were filled; thereby providing a more comparable outcome to cortical mineralization
[180]
. 
This emphasizes the need for careful reporting and comparing of cortical density outcomes 
between HR-pQCT analysis methods (i.e., standard evaluation and the advanced cortical micro-
architecture evaluation). 
 Regarding FE modeling, the STM and DTM models appeared more precise for modeling 
the distal radius (STM: 2.8-3.8%; DTM: 3.0-3.8%; E-BMD: 2.6-7.1%) whereas all methods 
provided comparable precision for modeling the distal tibia (STM: 2.9-4.8%; DTM: 3.0-3.8%; E-
BMD: 1.6-2.1%). Results suggested that the E-BMD model could be used when the common 
region between follow-up scans are high (>93%), while STM or DTM should be considered 
when the common region is lower (<93%). These findings provide guidance for future studies 
investigating bone strength estimates using HR-pQCT-based FE modeling. 
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 All sections of study 1 indicated the importance of acquiring a high percent of image 
overlap among follow-up scans (i.e., common region) in order to acquire low precision 
error―especially for subsequent advanced bone analyses (i.e., advanced cortical micro-
architecture evaluation and finite element modeling). This highlights the significance of 
consistent (re)positioning of participants in the cast as well as careful placement of the reference 
line prior to scanning. These findings are important because they indicate that HR-pQCT can be 
used to monitor skeletal change, particularly changes in skeletal micro-architecture—which was 
not possible to quantitatively measure non-invasively, in vivo prior to the advent of HR-pQCT. 
5.1.2 Study 2: Monitoring Skeletal Changes 
Study 2 used precision errors outlined in the first study to define the tools needed to assess and 
monitor skeletal change―specifically the LSC and MTI. The primary findings from study 2 
indicated that HR-pQCT follow-up measures in postmenopausal women can be performed every 
2 years at the distal radius and every 1 year at the distal tibia to monitor true skeletal changes as 
indicated by the LSCs. This was the first study to provide MTIs for HR-pQCT and to define the 
LSC for all standard outcomes using short-term precision—an important attribute because short-
term precision is not confounded by skeletal changes. MTI and LSC results are important when 
designing and interpreting prospective studies (including interventions) in postmenopausal 
women of similar demographics to that presented in this dissertation.  
5.1.3 Study 3: Characterizing Skeletal Changes 
The primary findings from study 3 characterized natural skeletal changes at the distal radius and 
tibia over 1 year in postmenopausal women not using bone altering medications (e.g., 
bisphosphonates or hormone replacement therapy). At the distal radius, annual changes were 
described primarily as micro-architectural deterioration in the trabeculae. At the distal tibia, 
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however, annual changes were established in both cortical and trabecular tissues. The observed 
loss of trabeculae with concomitant increase in trabecular size at the distal radius, as well as the 
thinned cortex, decreased cortical density and content at the distal tibia indicated a site-specific 
trabecularization of the cortical bone in postmenopausal women. This is the first study that 
characterized natural bone changes in postmenopausal women over 1 year using the standard 
HR-pQCT scanner. Using in vivo data, this study confirmed ex vivo findings regarding cortical 
trabecularization at the tibia
[180]
 and added to the literature by reporting a different pattern of 
cortical trabecularization at the radius in postmenopausal women. The trabecularization of the 
cortex observed in this study provides evidence regarding the prospective effect of aging at the 
distal radius and tibia, especially as it pertains to micro-architectural deterioration. 
 Studies where change is expected (i.e., monitoring or intervention studies) should not 
only focus on the statistical significance between baseline and follow-up measures or between 
treatment and control group, but also the effect size of the change or difference between the 
compared groups
[211]
. In cases where there is a large effect size, the anticipated MTI may be 
lower than what is presented in study 2. In contrast, interpreting changes that falls within the 
precision error of the measurement is challenging and warrants caution when reported. 
5.2 Strengths and Limitations 
Thesis strengths pertain to participant pool and study design. First, our sample of older 
community-dwelling postmenopausal women represented a clinically relevant population most 
likely to sustain an osteoporotic fragility fracture
[169,208]
. Based on the proportion of DXA-
derived femoral neck T-scores, the postmenopausal women involved in these studies had 
comparable bone health status to the osteoporosis reference standards from North America, 
Europe, Australia and Japan
[161,162]
, thereby making the data in this thesis generalizable to 
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postmenopausal women in these regions. Regarding study design, precision errors in 
postmenopausal women were compared to short-term precision errors observed with a ‗best 
case‘ sample of young adults, including both females and males. Further, participants were 
repositioned between measurement times and repeat measures were completed with a minimum 
of 24 hours between scans. This is important because underestimation of precision error has been 
reported when precision was calculated using scans repeated on the same day
[159]
. Also, 
sufficient number of participants in all precision studies were acquired to attain a minimum of 27 
degrees of freedom required to achieve 90% confidence in our precision error estimate
[12,149]
. 
Data from all studies was measured from the same operator using the same scanner, thereby 
minimizing measurement variability and allowing for the most accurate time interval predictions 
and skeletal change measurements. 
 Limitations relate to the study duration, small sample size, x-ray tube changes, and lack 
of independence between follow-up measures. Studies 2 and 3 were based on a short, one year 
follow-up study of 51 postmenopausal women. Longer follow-ups with multiple measurement 
years using a larger sample (>51 participants) would more accurately characterize individual 
changes, identify factors associated with greater bone loss and micro-architectural deterioration, 
and may provide a more representative estimate of the annual rates of skeletal changes and 
associated MTIs
[9]
. A caveat to this research is that skeletal precision, LSC/MTIs, and annual 
changes may vary according to the cohort's age, ethnicity, disease status, and sex; therefore, 
monitoring disease progression and skeletal changes associated with intervention will likely 
require population-specific precision and MTI studies
[9]
. During the studies in this thesis, the x-
ray tube was replaced twice without cross-validation. While this replacement will not affect the 
precision studies, it may affect the architectural outcomes of studies 4 and 5, which rely on 1 
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year follow-up data. Because the HR-pQCT evaluation scripts use a common region to 
translationally match the cross-sectional areas among baseline and follow-up measures (creating 
a common region), the outcomes are not independent of one another. The use of matched 
common regions has been shown to reduce precision error by 3-4%
[14]
 and therefore obfuscates 
the actual precision error estimate of the machine and user. Further, because the precision error 
and LSC metrics presented in this thesis used a matched common region, applying these metrics 
to cross-sectional studies may challenge the interpretation of results since matching common 
regions are not used in cross-sectional comparisons. 
5.3 Clinical Significance 
Using the standard information provided in all three studies the overarching goal and the clinical 
significance of this thesis can be summed in one final example. Recall, MTI suggested annual 
follow-up measures would be sufficient to acquire skeletal changes exceeding the LSC for 
cortical area, density and thickness, as well as trabecular area at the distal tibia. Therefore, using 
baseline data from the standard outcomes reported in study 1 (chapter 2), the MTI and LSC 
information provided in study 2 (chapter 3), and the annual change at the distal tibia provided in 
study 3 (chapter 4), it can be determined whether true skeletal change occurred at this site 
beyond the precision error of the HR-pQCT with 95% confidence. In order to be 95% confident 
that skeletal change over one year at the distal tibia in postmenopausal women was measured 
there should be a difference between baseline and follow-up of 3.1% (±2.6 mm
2
) in cortical area, 
0.8% (±6.2 mg HA/cm
3
) in cortical density, 3.9% (±31.7 µm) in cortical thickness, and 0.3% 
(±1.9 mm
2
) in trabecular area. The skeletal changes reported in the non-medicated women of 
study 3 (chapter 4) indicated a difference between baseline and follow-up of -3.1 mm
2
 in cortical 
area, -14.6 mg HA/cm
3
 in cortical density, -28.8 µm in cortical thickness, and +2.3 mm
2
 in 
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trabecular area. Measured changes exceed the minimum required difference provided by the LSC 
for all outcomes except cortical thickness (LSC difference: ±31.7µm; measured difference: -
28.8µm). This indicates that we are 95% confident skeletal change was measured for cortical and 
trabecular areas, and cortical density, but not for cortical thickness; even though the average 
follow-up measures were statistically different from baseline. This highlights the importance of 
knowing lab precision for imaging modalities used in investigations anticipating change. Further, 
this example emphasizes the difference between statistically significant differences between 
baseline and follow-up measures relative to capturing actual change measured beyond precision 
error. 
5.4 Conclusion 
Overall this thesis provides a careful assessment of precision errors using HR-pQCT and is an 
example for how precision information can be used to plan prospective or longitudinal studies 
(MTI) as well as for the interpretation of results from investigations anticipating observing 
skeletal change (LSC). 
5.5 Future Directions 
Areas of future study include (but are not limited to): population specific studies, cortical 
porosity accuracy study, finite element model optimization and comparison study, further 
investigation into the effects of hormone replacement therapy on bone micro-architecture, and a 
longer term follow-up study to characterize bone changes.  
1. As mentioned throughout Study 1, our research is limited by sample size to determine 
population specific precision beyond ‗postmenopausal women‘. While we studied a 
representative sample of postmenopausal women, skeletal precision may vary according 
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to time from menopause, disease status (e.g., osteoporosis), and skeletal site assessed; this 
merits further investigation into population-specific precision studies.  
2. As indicated in section 2.2, an objective of study 1 was to investigate the differences 
between the automatic and modified contour method for the advanced cortical bone 
micro-architecture evaluation. Future research should determine whether the automatic or 
manual contouring method more accurately represent cortical bone micro-architecture. 
Once this information is obtained, it would be prudent to determine how cortical bone 
micro-architecture changes with age. This is important because bone's mechanical 
strength is influenced by cortical bone micro-architecture
[71,75,173,175,176]
 and this research 
will improve our understanding of osteoporosis and factors underpinning bone strength.  
3. Another area for further investigation would be to optimize the FE model to more 
accurately represent falls onto the outstretched hand. Current FE models primarily 
estimate failure load under axial compressive loading
[32,33,44,112,155,188,189,192,212-214]
. 
However, this falling scenario involves a combination of axial compressive loads and 
―off-axis‖ dorsal- and lateral-directed loads that result in bending. It would be interesting 
and important to determine whether the optimized "off-axis" FE model provides better 
prediction of wrist fractures relative to the currently used compression models.  
4. An objective of study 3 was to prospectively characterize skeletal changes in a sub-
sample of postmenopausal women using hormone replacement therapy. However, 
because our sample size was small (i.e. n=8) we were limited to characterize bone micro-
architectural changes in this group of women. Future research should go beyond our 
preliminary evidence to fully discover the effects of hormone replacement therapy on 
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bone micro-architecture and how bone micro-architecture changes using this 
pharmaceutical agent. It would also be interesting to apply FE modeling and determine 
whether bone strength also changes using this medication. 
5. Study 3 focused on characterizing the change of bone outcomes from the standard HR-
pQCT evaluation over 1 year. Future research should also characterize how bone strength 
estimates (from finite element modeling) change over at least one year or preferably 
longer. 
6. As indicated in the Study 3 and further demonstrated in the ‗Clinical Relevance‘ section 
of this discussion, Study 3 was limited by the sample size and the follow-up time. It 
would be prudent for future research to follow a larger sample of postmenopausal women 
for a longer period of time (at least 3 years as defined by our MTIs) in order to fully 
characterize how bone density, geometry, micro-architecture and strength change in 
postmenopausal women. This research will improve our understanding of osteoporosis 
and help to develop new fracture prevention interventions. 
7. It would be prudent to consider analysis techniques beyond those provided by the 
manufacturer―especially for more advanced bone analyses such as cortical and 
trabecular segmentation (e.g., circumferential rings or texture profiles to separate the 
cortical and trabecular tissues and identify the endocortex). 
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APPENDIX A.  RETURN BIAS POSSIBILITY 
Of the 104 baseline postmenopausal women recruited into the Saskatoon cohort of CaMos, 51 
women returned for follow-up measurement. Therefore, 51% of the original Saskatoon cohort 
did not return for follow-up measurements. However, this participant attrition has not biased our 
follow-up findings because when comparing the osteoporosis status between those that returned 
(n=33 included study 2; n=18 removed from study 2 because of medication use; total of n=51 
included in study 3) relative to those that did not return (n=53) and the total participants of 2011 
(n=104), the ratios among normal status, osteopenic, and osteoporotic were similar (Table A1). 
Further, when comparing the standard HR-pQCT outcomes between those non-medicated 
postmenopausal women that returned (n=33) and those that did not return (n=53) there were no 
statistically significant differences (Table A2). 
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Table A1. Osteoporosis status ratios among those participants that returned for follow-up testing 
(n=51; n=33 not using bisphosphonates or hormone replacement therapy, n=18 using BIS or 
HRT) to those participants that did not return for follow-up testing (n=53). These ratios are also 
combined for the total participants in the baseline testing (n=104). 
Included in the study (n=33) 
Removed from study based on 
medication use (n=18) 
Did not return for follow-up measures 
(n=53) 
Normal Osteopenic Osteoporotic Normal Osteopenic Osteoporotic Normal Osteopenic Osteoporotic 
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) 
11 
(33%) 
17 
(52%) 
5 
(15%) 
4 
(22%) 
12 
(67%) 
2 
(11%) 
17 
(32%) 
30 
(57%) 
6 
(11%) 
 
Combined (n=51) 
Normal Osteopenic Osteoporotic 
n (%) n (%) n (%) 
   
15  
(29%) 
29  
(57%) 
7  
(14%) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total (n=104) 
Normal Osteopenic Osteoporotic 
n (%) n (%) n (%) 
   
32  
(31%) 
61  
(59%) 
11  
(10%) 
 145 
Table A2. Comparison of standard HR-pQCT outcomes between those participants that returned 
for follow-up testing (n=33 not using bisphosphonates or hormone replacement therapy) to those 
participants that did not return for follow-up testing (n=53) for a) radius and b) tibia. 
a) Radius   
Returning 
(n=31) 
Not Returning  
(n=49)   95% CI 
  
Mean ± SD Mean ± SD P-value Lower Upper 
Age (years) 76.6 ± 6.5 75.2 ± 8.7 0.432 -5.0351 2.1734 
Height (cm) 159.8 ± 6.2 158.3 ± 6.2 0.325 -4.2618 1.4314 
Weight (kg) 73.5 ± 13.0 68.2 ± 13.1 0.082 -11.2817 0.6846 
Area 
        Total (cm
2
) 285.0 ± 39.6 274.9 ± 37.4 0.253 -27.6147 7.3812 
Cortical (cm
2
) 38.9 ± 13.3 37.9 ± 11.9 0.522 -7.7508 3.9666 
Trabecular (cm
2
) 238.9 ± 46.2 226.5 ± 38.8 0.219 -31.0262 7.2352 
Density 
        Total (mg HA/cm
3
) 250.8 ± 55.2 253.3 ± 58.1 0.991 -26.6141 26.3176 
Cortical (mg HA/cm
3
) 773.1 ± 83.6 785.8 ± 81.2 0.687 -30.4741 46.0333 
Trabecular (mg HA/cm
3
) 135.5 ± 44.2 133.9 ± 37.9 0.874 -19.9552 17.0039 
Meta (mg HA/cm
3
) 190.1 ± 39.8 190.3 ± 36.9 0.988 -17.2625 17.5187 
Inn (mg HA/cm
3
) 97.7 ± 49.0 95.0 ± 42.0 0.801 -23.0911 17.8908 
Micro-architecture 
       CtTh (μm) 535.8 ± 189.5 532.4 ± 174.3 0.703 -0.1009 0.0684 
BV/TV (%) 11.3 ± 3.7 11.2 ± 3.2 0.867 -0.0167 0.0141 
TbN (1/mm) 1.8 ± 0.5 1.8 ± 0.4 0.825 -0.1846 0.2308 
TbTh (μm) 61.9 ± 10.0 61.0 ± 11.5 0.603 -0.0064 0.0037 
TbSp (μm) 584.2 ± 422.2 526.8 ± 230.2 0.411 -0.2054 0.0850 
TbSpSD (μm) 352.3 ± 368.1 285.0 ± 261.4 0.333 -0.2087 0.0715 
b) Tibia 
  
Returning 
(n=32) 
Not Returning  
(n=53) 
 
95% CI 
  
Mean ± SD Mean ± SD P-value Lower Upper 
Age (years) 76.9 ± 6.5 75.1 ± 8.3 0.279 -5.3075 1.5495 
Height (cm) 159.8 ± 6.1 158.3 ± 6.1 0.280 -4.2055 1.2310 
Weight (kg) 73.5 ± 12.8 68.3 ± 13.8 0.089 -11.1637 0.8052 
Area 
        Total (cm
2
) 733.5 ± 93.8 698.8 ± 96.6 0.109 -77.2734 7.8466 
Cortical (cm
2
) 79.9 ± 27.3 82.0 ± 25.9 0.867 -10.8936 12.8954 
Trabecular (cm
2
) 643.5 ± 100.9 604.6 ± 104.5 0.121 -80.8704 9.5712 
Density 
        Total (mg HA/cm
3
) 239 ± 52.4 245.1 ± 55.1 0.679 -19.1201 29.1957 
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Cortical (mg HA/cm
3
) 758 ± 71.9 768.5 ± 79.3 0.730 -28.3638 40.3494 
Trabecular (mg HA/cm
3
) 159.1 ± 38.7 155.7 ± 38.9 0.567 -0.0861 0.1561 
Meta (mg HA/cm
3
) 230.3 ± 32.1 227.9 ± 36.2 0.769 -19.8154 14.6950 
Inn (mg HA/cm
3
) 110.7 ± 44.7 106.7 ± 43.3 0.808 -17.3548 13.5692 
Micro-architecture 
       CtTh (μm) 748.1 ± 262.6 796.2 ± 274.4 0.567 -0.0861 0.1561 
BV/TV (%) 13.3 ± 3.2 13.0 ± 3.2 0.773 -0.0165 0.0123 
TbN (1/mm) 1.7 ± 0.4 1.7 ± 0.4 0.394 -0.2481 0.0988 
TbTh (μm) 77.8 ± 15.4 78.5 ± 14.9 0.714 -0.0055 0.0080 
TbSp (μm) 550.1 ± 252.2 553.6 ± 169.2 0.922 -0.0866 0.0955 
TbSpSD (μm) 342.7 ± 424.6 300.8 ± 219.3 0.533 -0.1807 0.0974 
* All comparison completed using independent samples t-test using Bonferroni correction for multiple comparisons. 
Significance accepted at P<0.004. 
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